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ABSTRACT 
Hypervalent iodine(III) compounds are efficient, selective and environmentally friendly 
reagents. Due to their electrophilic nature and excellent leaving group ability, they can be 
used to mediate oxidative transformations; for example, the oxidation of sulfides to 
sulfoxides, the α-functionalisation of ketones, the dearomatisation of phenols, the 
functionalisation of alkenes and, more recently, the rearrangement of various substrates. 
In this thesis, the stereoselective rearrangement of propiophenone derivatives mediated 
by chiral hypervalent iodine reagents is described (Scheme i). A chiral lactate-based 
iodine(III) reagent was used to synthesise 2-arylpropionate derivatives with moderate to 
good yields and enantioselectivities. These compounds are highly attractive as they are 
direct precursors to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). 
 
Scheme i. Rearrangement of propiophenone derivatives to 2-aryl-propionates. 
The cyclisation of malonate derivatives, mediated by hypervalent iodine reagents has also 
been investigated (Scheme ii). Several δ-valerolactone derivatives were synthesised with 
this method, achieving moderate to good yields. 
 
Scheme ii. Cyclisation of malonate derivatives to synthesise functionalised lactones. 
Finally, the design of a new hypervalent iodine reagent is described (Figure i). After its 
synthesis, the pyridine-based reagent was tested in several model reactions, usually 
mediated by iodine(III) reagents. Its reactivity was similar to the one of other hypervalent 
iodine reagents. However, its ability to induce stereoselectivity to different products was 
quite poor.  
 
Figure i. Structure of the new hypervalent iodine reagent. 
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 General considerations about iodine 
Iodine was first isolated in 1811 by the French chemist Bernard Courtois from seaweed’s 
ash as black metallic crystals. With an atomic number of 53, it is the heaviest and most 
polarisable atom of the halogen group. Its name comes from Greek ιώδης meaning violet 
or purple, due to the characteristic colour of its vapour.  
Nowadays, iodine is mainly extracted from brines present in natural gas (Japan, 30% of 
the world production) and in oil fields (United States) as well as from the caliche deposits 
(Chile, 60% of the world production). In Chile, calcium iodate [Ca(IO3)2] is one of the 
components of caliche deposit extracted from the mines. In contact with an alkaline 
solution, the iodate ions are liberated in solution and can be reduced to iodide using sulfur 
dioxide. In Japan, iodine is a by-product resulting from the production of natural gas from 
brine deposit.[1] 
Iodine is a useful tool in analytic chemistry due to its ability to react with alkenes but also 
starch or sugar to give a blue coloured solution. It can also be oxidised or reduced and 
therefore, it can be used to determine the amount of reductant or oxidant in a mixture 
(iodometry). Organoiodides are also well-known reagents for organic synthesis 
transformations such as oxidative reactions using hypervalent iodine reagents.[2] 
Iodine possesses different isotopes but only 127I is stable. However, 123I, with a half-life 
of 13 h, is often used for the nuclear imaging of thyroid gland where iodine is naturally 
present. This gland produces a prohormone named thyroxine T4 which can be deiodinated 
to the active triiodothyronine T3, responsible for metabolism regulation (Figure 1.1). 
 
Figure 1.1. Structure of thyroxine T4 and triiodothyronine T3.  
Iodine is a non-metallic element of the halogen family and can be found in different 
oxidation states: -1, +1, +3, +5, +7. Due to its high electronegativity, it usually forms 
iodides with almost all elements with a formal oxidation state of -1.  
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 Hypervalent iodine 
The first hypervalent iodine was discovered in 1886 by the German chemist Conrad 
Willgerodt.[3] He noticed that by passing chlorine gas through a solution of iodobenzene 
in chloroform, dichloroiodobenzene [PhICl2] was formed. Since then, the use of these 
compounds has increased, especially during the last few decades. 
 Structure of polyvalent iodine 
In 1969, J. Musher defined that a hypervalent molecule was a molecule with a least one 
element from group V-VIII bearing more than eight electrons in its valence shell, 
therefore not respecting the octet rule. Common examples of this type of molecule are 
phosphorus pentachloride (PCl5), sulfur hexafluoride (SF6) and the triiodide anion (I3
-).[4] 
According to the 1983 IUPAC rules, the term λ3-iodane and λ5-iodane are respectively 
used for iodine(III) and iodine(V) compounds. Trivalent iodine derivatives have 
10 electrons at the iodine centre. The most common λ3-iodane, ArIL2 (L = heteroatom 
ligand), has a pseudo-trigonal bipyramidal structure (Figure 1.2. a). In this structure, the 
aryl group (less electronegative group) is in the equatorial position, while the two 
heteroatom ligands are in the apical positions.  
  
Figure 1.2. a) Pseudo-trigonal bipyramid structure of ArIL2. b) Molecular orbitals of 3c-4e bond in 
hypervalent iodine(III) compounds. 
The hypervalent bond LIL can be explained using the three-centre-four-electron 
(3c-4e) bond model, described independently by G. C. Pimentel[5] and R. E. Rundle[6] in 
1951. In this model, three molecular orbitals can be formed from the interaction of the 
filled 5p orbitals of the central iodine and the partially filled orbitals from the two ligands: 
bonding, non-bonding and anti-bonding (Figure 1.2. b). As a result of the node in the 
Highest Occupied Molecular Orbital (HOMO), the hypervalent bond is highly polarised 
with a strong electrophilic character at the central iodine atom and partial negative charge 
on the two heteroatom ligands.  
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Another type of λ3-iodanes are diaryliodonium salts Ar2IX, where the most electron-rich 
aryl group is in the equatorial position. The ArIAr bond tends to adopt a T-shape and 
the IX bond is more ionic in nature than in the case of ArIL2.  
In the case of λ5-iodane (ArIL4), the four ligands tend to be in the equatorial position, 
forming two orthogonal hypervalent 3c-4e bonds. With regards to the aryl group, it is 
covalently bound to the iodine centre in the apical position. In other terms, the iodine(V) 
adopts a square bipyramidal structure as shown in Figure 1.3. 
 
Figure 1.3. Square bipyramidal structure of iodine(V) ArIL4. 
 Common hypervalent iodine reagents  
Hypervalent iodine reagents are now widely used in organic synthesis as mild, selective 
and efficient reagents. Due to their high interest and their easy synthesis, some have 
become commercially available. A few examples of hypervalent iodine reagents are 
shown in Figure 1.4. 
 
Figure 1.4. Structure of common hypervalent iodine reagents. 
The syntheses of (diacetoxyiodo)benzene (DIB),[7,8] [bis(trifluoroacetoxy)iodo]benzene 
(PIFA)[9] and [hydroxy(tosyloxy)iodo]benzene (HTIB, also known as Koser’s 
reagent)[10,11] are straightforward with only one step synthesis from iodobenzene in the 
presence of an oxidant followed by a simple recrystallisation to obtain the pure 
corresponding iodine(III) compounds. Iodosylbenzene is usually prepared from DIB 
using an aqueous solution of sodium hydroxide.[12] The resulting yellowish solid can 
simply be filtered to obtain iodosylbenzene in its polymeric form. This polymeric form 
can be broken down by addition of water, alcohols or a catalyst (e.g. Lewis or BrØnsted 
acid) to liberate the monomeric reactive iodine(III) reagent. o-Iodoxybenzoic acid (IBX) 
can also easily be synthesised from iodobenzoic acid using Oxone® as the oxidant. 
Because of its high insolubility, IBX is not largely used in organic syntheses but replaced 
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by the more soluble Dess-Martin periodinane (DMP). These iodine(V) reagents are 
commonly used for the oxidation of alcohols into their corresponding carbonyl 
compounds.[13–15] 
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 General reactivity of hypervalent iodine reagents 
Hypervalent iodine reagents have largely been used in organic syntheses due to their low 
toxicity and their ability to replace heavy metal catalysts in similar reactions. Not only 
are they mild, selective and efficient reagents for the oxidation of alcohols, but they can 
also mediate the functionalisation of alkenes and ketones or the dearomatisation of 
phenols. More recently, they have been used in rearrangement reactions.[2,16–21]  
Its electrophilic nature at the iodine centre and the super leaving ability of the 
phenyliodonio group (106 times the triflate’s one) when bonded to an sp3 carbon make 
this compound an excellent reagent for all the reactions mentioned above. 
Different mechanisms are proposed to explain the reactivity of hypervalent iodine 
reagents. The first one involved a ligand exchange followed by a reductive elimination. 
However, for iodine(III) with chloro-, oxygen-, nitrogen-ligands, it is also common to 
propose a radical mechanism due to the small dissociation energy required for the 
homolytic cleavage in these hypervalent iodine compounds. Typical reactions involving 
this mechanism are the chlorination of alkanes and alkenes using (dichloroiodo)benzene 
[PhICl2]
[22,23] and the azidation[24–26] of C-H bond with iodine(III) reagents of type 1 
(Figure 1.5). 
 
Figure 1.5. Structure of hypervalent iodine 1. 
 Ligand exchange and reductive elimination mechanism 
Most reactions involving a λ3-iodane ArIL2 proceed via the following mechanism. Firstly, 
the nucleophile exchanges with one of the ligands to obtain intermediate 3. Secondly, as 
the iodine is now bonded to an sp3 carbon and therefore, is an excellent leaving group, a 
reductive elimination can take place. The nucleophile and the ligand can finally 
recombine to generate NuL type product. However, if a second nucleophile is present, 
it can react with Nu+ to afford NuNu’ type product (Scheme 1.1). 
Florence Malmedy Introduction 
7 
 
 
Scheme 1.1. Schematic mechanism for the ligand exchange and reductive elimination pathway. 
The addition of the nucleophile to the hypervalent iodine species can either follow an 
associative or a dissociative pathway. In the first case, the nucleophile attacks the 
hypervalent iodine reagent to form a square bipyramidal intermediate 2b before the 
elimination of the ligand (Scheme 1.2. a). In the second pathway, the ligand is removed 
leading to the formation of the iodonium ion ArIL+ 2e which can react with a nucleophile 
to obtain the intermediate 3a (Scheme 1.2. b).  
 
Scheme 1.2. a) Associative and b) dissociative pathway for the ligand exchange step. 
In Scheme 1.1, the reactivity of the original nucleophile is changing. In the first step, it 
reacts as a nucleophile but later on, after the reductive elimination and in the presence of 
another nucleophile, it has become an electrophile. This Umpolung reactivity is widely 
harnessed in hypervalent iodine chemistry. 
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 Introduction to chiral hypervalent iodine reagent 
Hypervalent iodine compounds are efficient reagents for a broad range of reactions such 
as the oxidation of alcohols and sulfides to the corresponding carbonyls or sulfoxides, 
respectively. They have also been used for the functionalisation of double bonds and 
carbonyls, the dearomatisation of phenols and more recently, they have been involved in 
rearrangement transformations. All these reactions can lead to products with one or 
several new chiral centres. Therefore, it would be interesting to use hypervalent iodine 
reagents to induce stereoselectivity.  
Iodine(III) reagents can have either one aryl/alkyl substituent and two ligands or two 
aryl/alkyl substituents and one ligand. Each moiety can bear a chiral auxiliary which can 
induce stereoselective transformations. The first option is to have the chiral auxiliary 
attached as one ligand of the hypervalent iodine as in iodine(III) reagent 4[27] or Chen’s 
iodine(III) compound 5[28] (Figure 1.6). 
 
Figure 1.6. Structure of different chiral hypervalent iodine reagents. 
The second option is to have the chiral auxiliary on the aryl group like in Ishihara-type 
reagents 6.[29] Finally, it would also be possible to use a non-chiral hypervalent iodine 
reagent in the presence of a chiral ligand in a catalytic amounts. 
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 Asymmetric syntheses mediated by chiral hypervalent 
iodine(III) reagents 
 Oxidation of sulfides to sulfoxides 
The first asymmetric oxidation of sulfides to sulfoxides was described by Inamoto et al. 
in 1986. In this work, the authors developed a new chiral iodine(III) reagent combining 
iodosylbenzene and tartaric anhydride derivatives 7 which they believed to form a C2-
symmetric 7-membered ring 8. With this reagent, a variety of sulfides 9 were oxidised in 
good yields and with up to 53% ee (Scheme 1.3).[30]  
 
Scheme 1.3. First stereoselective oxidation of sulfides 9 to sulfoxides 10 mediated by hypervalent iodine 
reagent. 
A few years later, Koser demonstrated that the structure of the chiral hypervalent iodine 
compounds 8 does not actually contain a 7-membered ring but that it is in a polymeric 
form as shown in Figure 1.7.[31] 
 
Figure 1.7. Polymeric structure of 8’ proposed by Koser in 1992. 
At the same time, Koser et al. also designed another chiral hypervalent iodine reagent 
from menthol. With this reagent 4, sulfides were oxidised to the corresponding salts in 
good yields and with low to moderate diastereoselectivity. However, after hydrolysis, the 
sulfoxides were synthesised with up to 56% ee or up to 99% ee after recrystallisation.[31] 
Kita et al. developed a catalytic version of this transformation using 10 mol% of the 
tartaric acid derivative and iodylbenzene as stoichiometric oxidant in the presence of a 
catalytic amount of cetyltrimethylammonium bromide.[32] The oxidation occurred with 
excellent yield and moderate enantioselectivity (up to 72% ee). This reaction is highly 
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solvent dependant. The authors used the insolubility of iodylbenzene in most solvents to 
their advantage. Indeed, the reaction did not work with just the iodine(V) reagent as it 
was insoluble in the solvent mixture. However, when coordinated to the chiral tartaric 
acid derivatives, the complex became soluble and could mediate the stereoselective 
oxidation reaction. 
Since then, different new iodine(III) and (V) reagents have been developed and used to 
mediate this oxidation but none of them gave the corresponding sulfoxides with improved 
enantioselectivity.[28,33–35] 
 Dearomatisation of phenols 
In 2008, Kita et al. published the first enantioselective intramolecular dearomatisation of 
naphthols 11. The group developed the reaction both stoichiometrically and catalytically 
and products 12 were obtained in good yields and with up to 86% ee and 69% ee, 
respectively (Scheme 1.4).[36] To achieve this stereoselectivity, chiral hypervalent iodine 
reagent 13 was used for the stoichiometric transformation. For the catalytic 
dearomatisation, spiroindane 14a was oxidised in situ using m-CPBA in the presence of 
acetic acid. 
 
Scheme 1.4. Enantioselective dearomatisation of naphthols by Kita et al. and Ishihara et al. 
In 2013, the same group improved their catalyst 14b with an extra ethyl group on the aryl 
group and the corresponding spirolactones were generated in up to 96% yield and with 
up to 92% ee.[37] The ethyl group in the ortho-position to the iodine centre allows for a 
better enantioselectivity because of the steric hindrance of the ethyl group with the ligand 
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(in the apical position) and the substrate. Furthermore, the conformation of the catalyst is 
maintained due to the rigid backbone of the spirobiindane moiety. 
In 2010, Ishihara developed a new series of hypervalent iodine reagent of type 6b bearing 
a C2-symmetry and where there could be possible n-σ* interactions between the electron-
deficient iodine(III) centre and the two carbonyl groups or intramolecular hydrogen 
bonding. This chiral environment should allow selectivity in the dearomatisation reaction. 
With their best catalyst, very similar results to the one of Kita’s were achieved, with up 
to 92% ee.[29] In 2016, Muñiz and Ishihara demonstrated the hydrogen bonding between 
the NH group and the acetoxy group of compound 6b by X-Ray crystallography as well 
as its derivative bearing a methyl group in the para-position to the iodine substituent on 
the aryl ring. It was also confirmed by 1H NMR that these hydrogen bondings were 
maintained in solution.[38] 
Quideau et al. reported in 2009 an enantioselective intermolecular hydroxylative 
dearomatisation of phenols. Iodoarene 18 was used in catalytic amount with a 
stoichiometric amount of m-CPBA to oxidise the iodine in situ. The dearomatisation led 
to products 16 in good yield (83%) and with 50% ee. If an excess of m-CPBA 
(2.5 equivalents) was used, product 16 was not observed as the double bond overreacted 
to generate the epoxide 17 in 90% yield but with only 29% ee (Scheme 1.5).[39]  
Recently, the same group synthesised a range of biphenylic iodanes 19 and applied them 
to the enantioselective hydroxylative dearomatisation of phenols to form products 16 in 
moderate yield but with an improved ee of 73%.[40] 
Scheme 1.5. Intermolecular hydroxylative phenol dearomatisation. 
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In 2009, Birman and Boppisetti synthesised chiral hypervalent iodine 22 and reacted it 
with phenols 20. The generated o-quinol derivatives can undergo a [4+2] cycloaddition 
to generate dimerised products 21 in moderate to good yields and with up to 77% ee 
(Scheme 1.6).[41]  
 
Scheme 1.6. Tandem dearomatisation and [4+2] cycloaddition of phenols. 
In 2013, Ishihara et al. published the same type of tandem dearomatisation and 
dimerisation reaction of phenols in good to excellent yield and with up to 99% ee. The 
reaction was performed catalytically, using iodoarene 25 and m-CPBA as the oxidant.[42] 
In 2015, Gong et al. developed an enantioselective catalytic spirocyclisation of 
compounds 23 leading to the formation of products 24 in up to 84% yield and with up to 
91% ee. Iodoarene 25 was oxidised with m-CPBA in situ and used to activate the naphthol 
derivatives. This underwent an intramolecular SN2’-like Friedel-Craft substitution to 
yield products 24 (Scheme 1.7).[43]  
 
Scheme 1.7. Enantioselective spirocyclisation of compounds 23. 
Finally, Harned and Volp developed a para-hydroxylative oxidation of phenols 26 using 
catalyst 28 to yield p-quinols 27 in low to good yields and with 6 to 60% ee (Scheme 
1.8).[44] 
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Scheme 1.8. Synthesis of p-quinols by dearomatisation of phenols 26.  
 α-Functionalisation of carbonyl compounds 
In 1990, Vargolis et al. reported an α-oxytosylation using chiral reagent 5 in good yield. 
However, the reaction suffered from low diastereoselectivity for all substrates 
investigated.[45] Later on, Wirth et al. designed a series of new chiral hypervalent 
iodine(III) reagents 31-32. With these new reagents, the corresponding α-oxytosylated 
products were obtained with enantioselectivities of up to 15% (Scheme 1.9).[46]  
 
Scheme 1.9. α-Oxytosylation of propiophenone 29a. 
A year later, the same group slightly modified the structure of their hypervalent iodine(III) 
reagent (33a) and the desired product was formed with 28% ee.[47] In 2001, the effect of 
the R group on the aryl moiety was investigated and it was found that reagent 33b gave 
the best enantioselectivity (40% ee).[48] 
A few years later, the same group developed the first catalytic α-oxytosylation of 
carbonyls in good yields and moderate enantioselectivities. Catalytic amount of 
aryliodides (10 mol%) was used in combination with an excess of m-CPBA and 
p-TsOH•H2O.[49] They also designed other iodoarene catalysts but none of them improved 
the reaction stereoselectivity.[50,51] More recently, Moran,[52] Legault[53], Zhang[54] and 
Berthiol[55] groups described new iodine catalysts for this transformation and the desired 
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products 30 were obtained with moderate enantioselectivities with 51%, 36%, 58% and 
up to 34% ee, respectively. 
In 2015, Legault et al. studied the mechanism for this transformation in more detail. The 
calculations suggest an iodonium enolisation process to form intermediate 38. This 
intermediate should not isomerise to the intermediate 39 due to a too high isomerisation 
barrier (ΔG‡ = 32.5 kcal/mol). The following reductive elimination on the prochiral 
enolate 40 was found to be the determining step for the stereoselectivity on the final 
product 30 (Scheme 1.10).[56] 
  
Scheme 1.10. New mechanism for the α-oxytosylation of propiophenone derivatives proposed by Legault. 
The same year, they applied this method onto enol esters 42 to generate α-oxytosylated 
products 30 in high yields using Koser’s reagent (up to 94%).[57] The reaction also 
proceeded under catalytic conditions (20 mol% of chiral iodoarene 43 and m-CPBA as 
the oxidant) and gave the corresponding products 30 in up to 94% yield and with up to 
89% ee (Scheme 1.11).[58]  
 
Scheme 1.11. Catalytic enantioselective α-oxytosylation of substrates 42. 
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Finally, Wirth et al. applied the concept of “silyl temporary tethers” for the 
α-functionalisation of carbonyl derivatives. The method allowed the easy generation of 
nitrogen- and oxygen- α-substituted carbonyl compounds 45 from silyl enol ether 44 in 
good yields and with up to 94% ee (Scheme 1.12).[59] 
 
Scheme 1.12. Flexible stereoselective α-functionalisation of ketones through Umpolung reaction with 
hypervalent iodine reagents. 
In 2010, Ishihara reported the enantioselective oxidative cycloetherification of 
ketophenols 46 using a catalytic amount of the chiral quaternary ammonium (hypo)iodite 
salt 48 in combination with a stoichiometric amount of hydrogen peroxide. The 
corresponding dihydrobenzofurans 47 were obtained in low to excellent yields and with 
up to 96% ee  (Scheme 1.13).[60] 
 
Scheme 1.13. Oxidative cycloetherification of ketophenols 46. 
In 1999, Ochiai et al. described the asymmetric phenylation of β-ketoesters 49 using 
chiral diaryliodonium salts 51 in the presence of potassium tert-butoxide to give 
compounds 50 in moderate to good yield and with up to 53% ee (Scheme 1.14).[61] Since 
then, other groups have synthesised chiral diaryliodonium salts but none of them have 
been reported in an asymmetric phenylation reaction yet.[62,63] 
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Scheme 1.14. α-Phenylation of β-ketoesters 49.  
In 2005, Aggarwal and Olofsson reported another approach for the asymmetric 
α-arylation of ketones 52. A non-chiral diaryliodonium salt 55 was used in combination 
with a chiral base (Simpkins’ base) 54 to yield products 53 in moderate to good yields 
and with high enantioselectivities (up to 94%) (Scheme 1.15). This strategy was applied 
to the asymmetric synthesis of the alkaloid (-)-epibatidine 56.[64] 
 
Scheme 1.15. α-Arylation of cyclohexanone derivative 52. 
Recently, Shibata et al. demonstrated the asymmetric addition of fluorine onto 
β-ketoesters 49 using 10 mol% of catalyst 58 and m-CPBA as an internal oxidant in the 
presence of an HF source (either hydrogen fluoride pyridine or 46% aqueous hydrofluoric 
acid). With this method, the α-fluorinated products 57 were obtained in up to 71% yield 
and with up to 56% ee (Scheme 1.16).[65] 
 
Scheme 1.16. α-Fluorination of β-ketoesters 49. 
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 Rearrangements 
Due to the electrophilic nature of hypervalent iodine(III) reagents and their excellent 
leaving group ability, they are highly suitable species to generate cationic intermediates. 
Those intermediates can then react with a broad range of nucleophiles or rearrange via 
1,2-aryl migrations, ring contractions, ring expansions, Hoffmann-type rearrangements 
or Wagner-Meerwein-type rearrangements. A brief summary of those oxidative 
rearrangements mediated by hypervalent iodine(III) reagents is described in Chapter 2.  
 Functionalisation of C-C double bonds 
The functionalisation of alkenes is a very important reaction in synthetic chemistry as it 
allows quick access to more complex molecules. Hypervalent iodine(III) reagents are well 
known to activate carbon-carbon double bonds to encourage their reaction with a 
nucleophile. As the iodine reagent is then connected to an sp3 carbon centre, it is an 
excellent leaving group and therefore, a second nucleophile can displace the iodine(III), 
reducing it to iodine(I). A broad variety of nucleophiles can be used and a brief summary 
can be found in Chapter 4. 
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 Conclusion 
In conclusion, hypervalent iodine reagents are mild, environmentally friendly and 
selective oxidants for a large number of transformations such as the oxidation of alcohols, 
the dearomatisation of phenols and the functionalisation of double bonds or ketones. 
More recently, they have been used in oxidative rearrangement reactions. These reagents 
are also becoming more and more involved in recent syntheses of natural and biologically 
active compounds. Their ability to induce stereoselectivity in the final products render 
hypervalent iodine compounds even more attractive. 
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 Introduction of oxidative rearrangement 
In the last few decades, hypervalent iodine(III) reagents have been used in a lot of organic 
syntheses including oxidative rearrangements.[1–5] Due to their electrophilic nature and 
their excellent leaving group ability, they are highly suitable species to generate cationic 
intermediates. Those intermediates can then react with a broad range of nucleophiles or 
undergo rearrangement via 1,2-aryl migrations, ring contractions, ring expansions, 
Hofmann-type rearrangements or Wagner-Meerwein-type rearrangements. A brief 
summary of oxidative rearrangements mediated by hypervalent iodine(III) reagents is 
described below. 
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 1,2-Aryl migrations 
The theory that these migration reactions involve an aryl moiety as a cationic species was 
first proposed by Cram in the late 1940s.[6–11] However it is only quite recently that 
phenonium ions have been used to explain the rearrangement mediated by hypervalent 
iodine(III) reagents. In 2003, Wirth et al. described the lactonisation of 4-aryl-4-pentenoic 
acids 59 involving phenonium ion intermediates 61. The corresponding lactones 60 were 
obtained in 87% yield when R=H but the yield for the rearranged product dropped 
drastically when a substituent was in para position. Chiral hypervalent iodine reagent 62 
also mediated this rearrangement in moderate yield (56%) but with only 4% enantiomeric 
excess (Scheme 2.1).[12] 
 
Scheme 2.1. Oxidative 1,2-aryl migration of 4-aryl-4-pentenoic acids 59 mediated by hypervalent iodine 
reagent. 
The next year (2004), Yusobov et al. reported the rearrangement of α-substituted styrenes 
63 mediated by a hypervalent iodine(III) reagent. They proposed that the reaction started 
with the activation of the double bond by the iodine reagent in the presence of methanol 
to generate intermediate 65. This was followed by the aryl migration to form the 
phenonium ion 66. After nucleophilic attack of methanol and hydrolysis, the 
corresponding arylacetones 64 were obtained in up to 92% yield (Scheme 2.2).[13] 
 
Scheme 2.2. Oxidative 1,2-aryl migration of styrene 63 mediated by hypervalent iodine reagent. 
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Later on, Wirth et al. described the rearrangement of unsaturated carboxylic acids 68 into 
furanones 69. It was found that only phenyliodine bistriflate was sufficiently reactive to 
mediate this reaction. The mechanism was also investigated in detail and DFT 
calculations confirmed that the 1,2-aryl migration was followed by a 1,2-hydride shift as 
shown in Scheme 2.3. With this method, different furanones 69 were obtained with up to 
95% yield.[14] 
 
Scheme 2.3. Oxidative 1,2-aryl migration of unsaturated carboxylic acids 68 mediated by hypervalent iodine 
reagent. 
In 2013, Zhao et al. reported the oxidative 1,2-aryl migration of N-methyl-N-
phenylcinnamides 72 to generate 3-aryl-quinolin-2ones 77 in up to 90% yield. The 
rearrangement proceeded in the presence of [bis(trifluoroacetoxy)iodo]benzene (PIFA) 
and BF3•OEt2 as Lewis acid (Scheme 2.4).[15]  
The proposed mechanism consists of the attack of the carbonyl oxygen onto the iodine 
centre to form the 3-azatriene intermediate 73 which can undergo an electrocyclic ring 
closure and subsequent rearomatisation to yield intermediate 75. Finally, assisted by the 
lone-pair of the nitrogen atom, a 1,2-aryl migration proceeds leading to the breakdown of 
the OI bond and the desired products 77 are obtained after deprotonation.  
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Scheme 2.4. Oxidative 1,2-aryl migration of N-methyl-N-phenylcinnamides 72 mediated by PIFA. 
In 2013, Wirth et al. published the first stereoselective rearrangement mediated by 
hypervalent iodine(III) reagents.[16] This transformation was based on the seminal work 
of Moriarty et al. from 1985 describing the rearrangement of chalcones 78.[17] 
Compounds 80 were obtained in good yields (up to 92%) and with high 
enantioselectivities (up to 97% ee). However, the enantioselectivity was directly related 
to the choice of solvent mixture. Indeed, 2,2,2-trifluoroethanol was essential for the 
reaction to proceed with high stereoselectivities (Scheme 2.5).  
 
Scheme 2.5. Oxidative 1,2-aryl migration of chalcone derivatives 78 mediated by hypervalent iodine reagent. 
Zhao et al. reported that acrylic amides 81 were converted into α-ketoamides 82 in the 
presence of PhI(OAc)2 and concentrated sulfuric acid (Scheme 2.6). The reaction 
proceeded via a tandem aryl migration/ C-C bond cleavage. The same method can be 
applied for the conversion of acrylates into α-ketoesters (40 to 90% yield).[18] 
 
Scheme 2.6. Tandem aryl migration/ C-C bond cleavage sequence for the synthesis of α-ketoamides 82. 
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In the 1980s, Koser et al. described the oxidative 1,2-aryl migration of 1,1-disubstituted 
alkenes 83 to obtain α-arylated carbonyl compounds 84.[19,20] Very recently, Wirth et al. 
reported the enantioselective version of this transformation to obtain α-arylated carbonyl 
compounds 84 in up to 90% yield and with up to 94% ee (Scheme 2.7).[21] The authors 
used chiral hypervalent iodine(III) reagent 6a and generated in situ Koser type’s reagent.  
 
Scheme 2.7. Oxidative 1,2-aryl migration of 1,1-disubstituted alkenes 83 mediated by hypervalent iodine 
reagent. 
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 Ring contractions 
Ring contractions are important rearrangements in organic synthesis. Over the past 
30 years, ring contractions mediated by hypervalent iodine(III) reagents have been used 
frequently. A detailed discussion on the ring contractions of cycloalkenes and 
cycloalkanones can be found in a review published by Silva in 2006.[22] 
Silva et al. also reported the ring contraction of 1,2-dihydronaphthalenes 87 mediated by 
Koser’s reagent to generate indane derivatives 88 in moderate yield.[23] Depending on the 
solvent used, the indanes generated were bearing different acetals. Dimethyl acetal 
derivative 88a was obtained in methanol with a yield of 36% and in 2,2,2-trifluoroethanol, 
acetal 88b was synthesised in 73% yield (Scheme 2.8).[24]  
 
Scheme 2.8. Ring contraction of 1.,2-dihydronaphthalene derivatives 87 mediated by Koser’s reagent. 
With this method, the precursor 90 for the synthesis of ()-indatraline 91 was obtained in 
62% yield (Scheme 2.9). In 2013, Wirth et al. reported the stereoselective ring contraction 
of tetralone using hypervalent iodine 6b and triflic acid to activate the iodine reagent. The 
corresponding indane was obtained with 72% yield and 59% ee at -78 °C or 30% yield 
and 70% ee at -100 °C.[16] 
 
Scheme 2.9. Ring contraction of 1,2-dihydronaphthalene derivative 90 for the synthesis of ()-indatraline. 
Very recently (2016), Silva et al. reported the ring contraction of 1,2-dihydronaphthalenes 
87 to yield optically active 1-substituted indanes 88. Chiral hypervalent iodine 92 was 
prepared in situ from the corresponding iodoarene using m-CPBA and camphorsulfonic 
acid [(R)-CSA] (Figure 2.1). Different cyclic alkenes were investigated and the 
corresponding indanes 88 were isolated in moderate to good yields and with up to 78% 
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ee. Furthermore, the rearrangement occurred in 5 minutes compared to 14 hours in the 
previous works which render this method attractive to access indane derivatives.[25] 
 
Figure 2.1. Structure of chiral hypervalent iodine 92. 
In 2012, Silva et al. reported the ring contraction of 2,3-dihydrobenzoxepine 93 using 
Koser’s reagent. The rearrangement proceeded with 58% yield. The proposed mechanism 
is shown in Scheme 2.10. The reaction was initiated by the activation of the double bond 
with Koser’s reagent, generating a carbocation which can be trapped by the oxygen lone 
pair to generate intermediate 95. After ring opening of the four-membered ring, the 
iodonium species 96 underwent a ring contraction rearrangement leading to the 
corresponding protonated aldehyde 97. This aldehyde was easily reduced using sodium 
borohydride to yield alcohol 94.[26] 
 
Scheme 2.10. Ring contraction of 2,3-dihydrobenzoxepine 93 mediated by hypervalent iodine reagent. 
Florence Malmedy Introduction of oxidative rearrangements 
31 
 
 Ring expansions 
In 2005, Koser developed a ring expansion of alkylidenebenzocycloalkenes 98 using 
Koser’s reagent to form β-benzocycloalkenones 100 in up to 99% yield.[27] A possible 
mechanism involves the formation of cationic intermediates 99 followed by the aryl 
migration and attack of methanol to provide the corresponding ketal which can be 
hydrolysed with water to give the desired expanded ring 100 (Scheme 2.11). 
 
Scheme 2.11. Ring expansion of alkylidenebenzocycloalkenes 98 mediated by Koser’s reagent. 
The same year, Hara et al. reported the ring expansion of iodoalkyl cyclic ethers 101 
using (diacetoxyiodo)toluene 102 (Scheme 2.12). A plausible mechanism consists of the 
in situ oxidation of the iodine moiety followed by the attack of the oxygen lone pair to 
give intermediate 105. After ring opening by an acetoxy group, the desired expanded 
cyclic ethers 103 were obtained in good to excellent yields.[28] 
 
Scheme 2.12. Ring expansion of iodoalkyl cyclic ethers 101 mediated by hypervalent iodine reagent. 
Silva et al. published later on the ring expansion of 1-vinyl cycloalkanols of type 106. 
Depending on the reaction conditions, three different compounds 107, 108 and 109 were 
generated in moderate to good yields (Scheme 2.13).[29] 
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Scheme 2.13. Ring expansion of 1-vinylcycloalkanols derivatives 106 mediated by Koser’s reagent. 
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 Hofmann rearrangement 
The first Hofmann rearrangement mediated by hypervalent iodine(III) was reported by 
Loudon et al. in 1984. In this paper, the authors described the transformation of aliphatic 
amides into amines using PIFA with good to excellent yields.[30,31] 
Yanada et al. published in 2009 the tandem reaction on alkynylbenzylamides 110 to 
generate benzo-fused nitrogen heteroaromatic systems 111 (Scheme 2.14). This tandem 
transformation consists of the Hofmann type rearrangement of amides 110 to form the 
isocyanates 112 which can react with an alcohol to form intermediates 113. After 
activation of the triple bond with PtCl2, a ring cyclisation occurred leading to the 
formation of compounds 111 in up to 92% yield.[32] 
 
Scheme 2.14. Hofmann rearrangement of alkynylbenzylamides 110 into benzo-fused nitrogen heteroaromatic 
systems 111 mediated by DIB. 
Later on, Kalesse et al. synthesised urea 118 using this rearrangement. After generation 
and hydrolysis of the isocyanates 115, intermediates 116 were decarboxylated to form the 
corresponding amines 117 which reacted with the unreacted isocyanates 115 leading to 
the formation of ureas 118 in up to 60% yield (Scheme 2.15).[33] 
 
Scheme 2.15. Hofmann rearrangement of amides 104 into ureas 118 mediated by DIB. 
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Moriyama et al. reported the Hofmann rearrangement of imides 119 using an in situ 
oxidation of iodobenzene using m-chloroperbenzoic acid (m-CPBA). With this method, 
anthranilic acid derivatives 120 and a number of β- and γ-amino acids were successfully 
obtained in good yields (Scheme 2.16).[34] 
 
Scheme 2.16. Hofmann rearrangement of aromatic and aliphatic imides 119 mediated by hypervalent iodine 
reagent. 
The same year, Ochiai et al. reported the first catalytic Hofmann-type rearrangement on 
primary amides 114 using iodobenzene with m-CPBA as the stoichiometric oxidant, to 
generate hydrochloride salts 121 in up to 95% yield.[35] The mechanism pathway involves 
the reaction of the iodine(III) reagent 122 with the nitrogen atom of the amide 114 
followed by a 1,2-migration to form the corresponding isocyanate 115. After hydrolysis 
with water and decarboxylation, the desired amines were obtained as hydrochloride 
salts 121 (Scheme 2.17). 
 
Scheme 2.17. Catalytic Hofmann rearrangement of primary carboxamides 114 mediated by hypervalent iodine 
reagent. 
In 2012, Zhdankin also published the rearrangement of amides 114 to generate 
carbamates 123 using N-tosyliminobenzyliodinane [PhINTs] for the stoichiometric 
transformation.[36] Later on, the same group reported the catalytic version of this 
rearrangement using Oxone® to oxidise iodobenzene in situ.[37] In both methods, the 
carbamates 123 were formed in 70 to 98% yield (Scheme 2.18). 
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Scheme 2.18. Hofmann rearrangement of amides 114 into carbamates 123 mediated by hypervalent iodine 
reagent. 
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 Other rearrangement reactions 
Only a few rearrangements of tertiary alcohols to make α,β-unsaturated ketones have been 
reported to date. Vatèle published in 2008 the rearrangement of cyclic tertiary alcohols 
124 mediated by iodosylbenzene with a catalytic amount of TEMPO. Different catalysts 
were also tried and bismuth triflate was the best one for this specific transformation 
(Scheme 2.19).[38] 
 
Scheme 2.19. Oxidative rearrangement of tertiary alcohols 124 mediated by hypervalent iodine reagent. 
A year later, Ishihara et al. described a catalytic rearrangement of cyclic allylic alcohol 
126 with only 5 mol% of iodine(I) reagent 127, using Oxone® as the stoichiometric 
oxidant in the presence of a catalytic amount of tetrabutylammonium hydrogen sulfate. 
The corresponding α,β-unsaturated ketones 128 were obtained in moderate to good yields 
(Scheme 2.20).[39] 
 
Scheme 2.20. Oxidative rearrangement of tertiary alcohols 126 mediated by hypervalent iodine reagent. 
More recently, Canesi et al. used hypervalent iodine reagents to mediate a Wagner-
Meerwein-type rearrangement. This transformation usually consists of an acid-catalysed 
conversion of alcohols into olefins involving a 1,2-alkyl or aryl shift. In 2009, the group 
reported this rearrangement on phenol derivatives 129 (Scheme 2.21). The mechanism 
involves a dearomatisation of the phenol generating a phenoxenium ion 130 which can 
then be stabilised by a 1,2-migration to form ketones 131 in moderate yields.[40] The group 
also extended this method to homoallylic alcohols and the rearrangement proceeded 
through a 1,3-allyl shift with moderate yields (up to 61%). 
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Scheme 2.21. Oxidative 1,2-alkyl rearrangement of compounds 129 mediated by DIB. 
The same group showed, a few years later, that the chirality from a chiral alcohol could 
be transferred to generate a quaternary carbon centre with 95% ee.[41] 
Dearomatisation of phenols can also lead to a Prins–Pinacol type-transformation. Canesi 
et al. reported that phenols 132 were converted into spirodienones 134 when exposed to 
PhI(OAc)2 (Scheme 2.22). The phenoxonium ion 133 generated can be trapped by the 
olefin moiety. After ring contraction through migration and loss of the protecting group, 
the spiro compounds 134 were obtained in good yields (30-84%).[42]  
 
Scheme 2.22. Prins–Pinacol rearrangement to synthesise spirodienones 134. 
Finally, Khatri and Zhu reported the reaction of (diacetoxy)iodoarene 135 with 
(trimethyl)allylsilane in the presence of BF3•OEt2. The reaction proceeded through an 
iodonio-Claisen rearrangement generating ortho-allyliodoarenes 136 as the major 
products (Scheme 2.23).[43] However, the presence of an electron donating group in the 
meta-position was essential for the reaction to proceed with in good yield (59-93%). 
 
Scheme 2.23. Iodonio-Claisen rearrangement to synthesise ortho-allyliodoarenes. 
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 Summary 
Oxidative rearrangements mediated by hypervalent iodine(III) reagents are a versatile 
way to synthesise precursor for the formation of natural products or more complex 
molecules. These transformations can proceed via a 1,2-aryl migration, ring contraction, 
ring expansion, Hofmann type rearrangement. However, the number of asymmetric 
rearrangement transformations available in the literature is currently insufficient and 
leaves a lot to be accomplished. 
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 Introduction  
The synthesis of enantiomerically pure drugs has increased in the recent decades in the 
chemical industry. However, it is still challenging to obtain these compounds with high 
stereoselectivity. The role of stereoselectivity in the drug molecules’ interaction with the 
enzyme in the human body is thoroughly considered by drug developers.[1] Indeed, in 
many cases, one enantiomer is biologically more active than the other one or in extreme 
cases, the undesirable enantiomer is toxic and can induce some side effects.[2,3] Improving 
the asymmetric synthesis of those drug molecules would also reduce the total dose given 
to the patient or avoid the difficult step of separating the two enantiomers at the end of 
the total synthesis. This separation would also lead to a waste of half of the crude 
material.[1] 
In the 1970s, pharmaceutical industries were mainly focusing their research on the 
synthesis of racemates. However, with the improvement in chiral technologies in the late 
1990s, the percentage of chiral drugs increased from 25% to over 50% of the market in 
2000.[3] As a result of this, the concept of chiral-switch has been developed. This term 
describes drug molecules that have already been approved and marketed as racemates but 
are re-investigated as single enantiomers. An example of chiral-switch is ibuprofen 139 
(Figure 3.1).  
Ibuprofen 139, naproxen 140, or flurbiprofen 141 are examples of Non-Steroidal Anti-
Inflammatory Drugs (NSAIDs). Most of those NSAIDs are marketed as racemates with 
the exception of (S)-naproxen 140 and (S)-flunoxaprofen 142 (Figure 3.1).  
 
Figure 3.1. Structure of ibuprofen, (S)-naproxen, flurbiprofen, (S)-flunoxaprofen and ketoprofen. 
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NSAIDs are used for the treatment of inflammatory diseases such as rheumatoid or 
arthritis. They are also used as analgesics and anti-pyretics[4]. Their mechanism of action 
is to non-selectively inhibit the enzymes cyclooxygenase-1 (COX-1) and 
cyclooxygenase-2 (COX-2). These enzymes are responsible for the synthesis of 
prostaglandins from arachidonic acid after an external stimuli (inflammatory or 
physiological). Prostaglandins contribute to the pain, fever, or swelling resulting from the 
stimuli (Figure 3.2).[5,6] 
 
Figure 3.2. Schematic mechanism of inhibition of enzyme COX by profens. 
The (S)-enantiomer of those profens is usually the only active stereoisomer against the 
enzymes COX and therefore, the asymmetric synthesis of these drugs would be preferable 
to the racemic one.[7,8] So far, the chiral-switch protocol has been successfully applied for 
ibuprofen 139 and ketoprofen 143 in 1994 and 1998, respectively.[3] 
In the next section, the synthesis of these profens is described. 
 Previous synthesis of aryl-propionic acid 
3.1.1.1. Brown synthesis of ibuprofen 
In the 1960s, Boots Company Pure Drug Company (England) discovered ibuprofen and 
patented the so called Brown synthesis.[9] Ibuprofen was first introduced on the market as 
a racemate for the treatment of inflammation related to rheumatic disease in 1969. The 
Brown synthesis consists of six steps, shown in Scheme 3.1. After acylation of 
isobutylbenzene 144 via a Friedel-Craft reaction, the intermediate 146 was generated by 
addition of ethyl 2-chloroacetate in the presence of sodium ethoxide. The aldehyde 147, 
obtained after hydrolysis under acidic condition, was then converted to the corresponding 
oxime 148. After loss of water, the nitrile 149 formed was easily hydrolysed under acidic 
condition leading to the formation of ibuprofen 139. 
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Scheme 3.1. Brown synthesis of ibuprofen 139 (Boots PDC, 1962).[9] 
This synthesis uses a very classic methodology but it suffers from a low atom efficiency 
(40%) and necessitates six reaction steps. Therefore, it is not a very efficient route to 
produce ibuprofen. Indeed, the hydroxyl amine is introduced in the fourth step to make 
the oxime 148 which is then converted to the nitrile moiety and finally, to the 
corresponding carboxylic acid 139. Therefore, the hydroxylamine is added and then 
removed which renders this total synthesis inefficient. 
3.1.1.2. The Boots-Hoechst-Celanese synthesis of ibuprofen 
In 1991, a greener alternative to the brown synthesis was proposed by the Boots-Hoechst-
Celanese company. This strategy consists of only three catalytic steps and uses the same 
precursor, isobutylbenzene, as the starting point of this synthesis (Scheme 3.2).[10,11]  
In this sequence, isobutylbenzene 144 is first acylated using acetic anhydride and in the 
presence of hydrogen fluoride. After reduction of the ketone 145 to the corresponding 
alcohol 151 using hydrogen and Pd/C as catalyst, a subsequent carbonylation was 
performed with Pd(II) catalyst under CO atmosphere in concentrated HCl to yield 
ibuprofen 139. This method is considered as the green synthesis of ibuprofen as the 
aqueous salt waste could be reduced from 60% to just 1%. Furthermore, anhydrous 
hydrogen fluoride (HF) was used as the solvent in the first step and could be recycled 
without loss of efficiency. The main waste resulting from this method is acetic acid as 
by-product. However, the company developed a recycling method and, therefore, reached 
a total synthesis with almost no waste. 
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Scheme 3.2. Boots-Hoechst-Celanese synthesis of ibuprofen 139. 
3.1.1.3. General routes for the synthesis of aryl propionic acid 
In the last few decades, a number of approaches have been published for the synthesis of 
aryl-propionic acid 159 with high enantiomeric excess. A selection of strategies are 
outlined below and summarised in Scheme 3.3. 
The first strategy is the direct methylation of the corresponding phenylacetic acid 
derivatives 152.[12–14] In 2005, Ramachandran et al. reported a new catalytic route for the 
synthesis of naproxen in a solid–liquid biphasic system using chiral quaternary 
ammonium salts. With this method, naproxen was obtained with 56% ee (93% ee after 
recrystallisation).[15]  
Both, the second and third strategies involve the terminal introduction of a carboxylic 
acid moiety either by functionalisation or by oxidation. Styrene derivatives 153 can react 
under palladium catalysis with carbon monoxide and BNPPA [(S)-(+)-1,1'-binaphthyl-
2,2'-diyl hydrogen phosphate] as chiral ligand. Alper et al. obtained by this method the 
desired compounds in good yields (85-90%) and with moderate enantioselectivities.[16,17] 
Stille et al. yielded the same target molecules using Hydrogen, carbon monoxide and a 
complex of Pt(II) containing the chiral ligand (-)-BPPM [(2S,4S)-N-(tert-
butoxycarbonyl)-4-(diphenylphosphino)-2-[(diphenylphosphino)methyl]pyrrolidine] (up 
to 99% ee after recrystallisation).[18]  
The third method to synthesise these derivatives was developed by Slobedman et al. and 
consists of a Sharpless epoxidation on allylic alcohols 154 as the key step followed by a 
hydrogenolysis. However, no data on the enantioselectivity of this process was reported 
in the manuscript.[19]  
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Scheme 3.3. Synthetic approaches for 2-aryl propionic acid 159. 
The next possibility to generate the arylpropionic acid is to introduce the entire propionic 
moiety. This fourth strategy consists of the addition of an activated nucleophilic aryl 
group onto the Reformatsky reagent 156. Périchon et al. published the α-arylation of aryl 
halides with α-chloroesters 156 under nickel catalysis to form aryl-propionic esters in 
moderate to good yields (up to 87% yield).[20] Turner et al. reported in 1961 the reaction 
of 1-phenylethyl chloride with carbon dioxide in presence of magnesium to obtain 
2 phenylpropionic acid in 58% yield.[21] In 2015, Nakamura et al. described the first iron-
catalysed enantioselective cross-coupling reaction between aryl Grignard compounds 155 
and α-chloroalkanoates 156 in the presence of a chiral biphosphine ligand and the 
products were obtained in good yields and with up to 82% ee.[22]  
The fifth strategy presented by Piccolo et al. consists of a Friedel-Craft alkylation of the 
aryl ring 157. The aryl-propionate derivatives were obtained in moderate to good yield 
(40-84%) but the poor regioselectivity of this method renders this reaction less 
attractive.[23]  
The sixth strategy is the rearrangement of propiophenone derivatives. In 1987, Piccolo’s 
group proposed a zinc-catalysed rearrangement of chiral α-haloacetals 158 to obtain 
2-arylpropionic acid derivatives 159 with good enantioselectivities (up to 82% ee). 
However, this process is not an asymmetric synthesis as the chiral centre had to be 
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established prior to the reaction when synthesising the haloacetals from enantiomerically 
pure (S)-ethyl lactate and (S)-alanine.[24] The preparation of aryl propanoic acid 159 from 
propiophenone derivatives 29 and thallium(III) nitrate was described by MacKillop et al. 
in 31% yield.[25] They postulated that after the oxythallation of the enol 160, an oxidative 
rearrangement occurred through aryl migration and simultaneous reduction of 
thallium (III) to thallium (I). The authors also observed a competing reaction with the 
direct substitution of thallium (III) by methanol (Scheme 3.4). 
 
Scheme 3.4. Rearrangement of propiophenone derivatives 29 described by MacKillop et al.[25] 
Due to the price and toxicity of thallium salts, the industrial applications are limited and 
other polyvalent reagents were considered. Lead tetraacetate was therefore investigated 
by Yamauchi et al. for the rearrangement of propiophenone 29 in the presence of 
trimethylorthoformate. The desired rearranged product was obtained in good to excellent 
yields (73-96%).[26] 
Haruta et al. described the rearrangement of propiophenone 29 using the less toxic 
(diacetoxy)iodobenzene [PhI(OAc)2]. This method proceeded most likely through a 
similar reaction mechanism as with the thallium salt and the authors achieved the 
synthesis of 2-arylpropionates 163 in up to 88% yield. [27,28] The rearrangement reaction 
also proceeded with iodine, iodine monochloride and iodine trichloride in moderate to 
good yields.[29] 
3.1.1.4. Flow synthesis of ibuprofen 
Another interesting way of synthesising those 2-aryl-propionics acids 159 was 
demonstrated by McQuade et al. in 2009 for the synthesis of ibuprofen.[30] The group 
developed the first continuous-flow synthesis of ibuprofen using an efficient three-step 
process which required no purification. The synthetic route consists of a Friedel-Craft 
acylation on isobutylbenzene 144 followed by the rearrangement reaction mediated by 
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PhI(OAc)2 in HC(OMe)3 and the resulting propionate 163b was subsequently hydrolysed 
to yield ibuprofen 139. With this method, McQuade et al. were able to produce 540 mg/h 
of crude ibuprofen. 
In 2015, Jamison et al. improved the continuous-flow synthesis of ibuprofen while using 
quite a harsh reagent for a flow system (AlCl3). Their synthesis was similar to the one of 
McQuade’s group except that the migration reaction was mediated by iodine 
monochloride instead PhI(OAc)2. An overall yield of 83% was achieved for a 
three-minute synthesis and the full set up is shown in Figure 3.3. With this method, 
Jamison et al. were able to produce 8.09 g/h of ibuprofen in its salt form 167. 
 
Figure 3.3. Flow synthesis of ibuprofen developed by Jamison et al.[31] 
 Objectives 
In this chapter, the rearrangement of propiophenone derivatives 29 into 2-arylpropionates 
163 using hypervalent iodine(III) is described. In 1985, Haruta et al. explored this 
rearrangement using (diacetoxy)iodobenzene [PhI(OAc)2] as the oxidant and sulfuric acid 
as the activator for the reaction. This reaction was performed in trimethyl orthoformate 
[HC(OMe)3] instead of methanol to avoid the formation of the side product 165 (Scheme 
3.5).[27,28]  
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Scheme 3.5. Rearrangement of propiophenone derivatives 29 to 2-arylpropionates 163 by Haruta et al.[28] 
The aim of this project was to develop an enantioselective method for this particular 
rearrangement as 2-arylpropionates 163 are direct precursors of non-steroidal 
anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen or flurbiprofen. Indeed, 
(S)- or (R)-enantiomers have different biological activities and an asymmetric synthesis 
is desired over kinetic resolutions to separate the two enantiomers.  
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 Optimisation using 4-methoxypropiophenone 
In order to become familiar with the reaction, the results presented in Haruta’s paper were 
first reproduced using 4-methoxypropiophenone 29c. After an hour at room temperature, 
the desired product 163c was obtained in 82% yield (Scheme 3.6). 
 
Scheme 3.6. Rearrangement of 4-methoxypropiophenone into molecule 163c following Haruta’s method. 
The asymmetric transformation was then performed using Ishihara ester 6a as the chiral 
iodine(III) reagent and sulfuric acid as the activator at 0 °C. The desired product was 
obtained in 45% yield and with 14% ee (Scheme 3.7).  
 
Scheme 3.7. First attempt of stereoselective rearrangement of 4-methoxypropiophenone 29c using Ishihara 
ester 6a. 
In order to increase the enantioselectivity, trimethylsilyl trifluoromethanesulfonate 
[TMSOTf] was used to perform the reaction under milder conditions. The reaction was 
initially done using (diacetoxy)iodobenzene [PhI(OAc)2], producing the racemic product. 
The desired product 163c was formed in 82% yield but it also further reacted with the 
excess amount of PhI(OAc)2 to produce the diaryliodonium salt 168 in 11% yield 
(Scheme 3.8). The ester moiety was also cleaved during the work up to lead to the 
formation of the carboxylic acid derivative 168. Interestingly, only the rearranged product 
further reacted with DIB to give diaryliodonium salt 168. No diaryliodonium salt 
generated from propiophenone 29c was observed. A plausible explanation is the 
deactivation of the aryl ring by the acyl moiety on the aryl ring of propiophenone 29c. 
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Scheme 3.8. Rearrangement of 4-methoxypropiophenone 29c into molecule 163c and diaryliodonium salt 168. 
A crystal structure was obtained to confirm the structure of the diaryliodonium salt 168. 
(Figure 3.4). 
 
Figure 3.4. Crystals structure of iodonium salt 168. 
To prove that methyl 2-(4-methoxyphenyl)propionate 163c was an intermediate of the 
diaryliodonium salt 168, molecule 163c was reacted under the same reaction conditions 
except for the solvent that was replaced by dichloromethane (usual solvent used for the 
formation of diaryliodonium salts). The diaryliodonium salt 168 was obtained in 90% 
yield after 4 h at room temperature (Scheme 3.9). 
 
Scheme 3.9. Formation of diaryliodonium salt 168 from methyl 2-(4-methoxyphenyl)propionate 163c. 
To suppress the formation of the diaryliodonium salt 168, PhI(OAc)2 was used in a strictly 
stoichiometric amount and this salt 168 was only found in traces amount in the reaction 
mixture while the yield for the desired compound 163c remained the same (Scheme 3.10). 
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Scheme 3.10. Rearrangement of 4-methoxypropiophenone 29c into molecule 163c using TMSOTf. 
The asymmetric transformation was then carried out and the desired rearranged product 
163c was obtained in low yield with no improvement of enantioselectivity compared to 
the reaction with sulfuric acid (Scheme 3.11). 
 
Scheme 3.11. Asymmetric rearrangement of 4-methoxypropiophenone 29c using TMSOTf. 
Considering the fairly acidic property of the proton in the α-position of the ester, it was 
envisioned that the product 163c might racemise leading to lower enantioselectivity. To 
check this, a sample was taken after 1, 3, 5, and 20 h, worked up and the enantiomeric 
excess (ee) was measured by HPLC. No change of ee was observed overtime and 
therefore this hypothesis of racemisation was abandoned.  
The optimisation was not continued with 4-methoxypropiophenone 29c but instead with 
propiophenone 29a. In the case of propiophenone 29a, the addition of a slight excess of 
the iodine(III) reagent would not lead to the formation of diaryliodonium salt 168. Indeed, 
the phenyl ring of propiophenone is not activated anymore by the methoxy group and 
therefore, it is much less likely to react a second time with the iodine(III) reagent. 
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 Optimisation using propiophenone 
The rearrangement of propiophenone 29a was first performed using PhI(OAc)2 and two 
acids were compared. These acids were used to activate the iodine(III) reagent to make it 
more reactive. Both Lewis acid and BrØnsted acid gave full conversion into methyl-2-
phenylpropionate 163a and the product was isolated in 62% and 40% yield, respectively 
(Table 3.1). 
 
Table 3.1. Racemic rearrangement of propiophenone 29a into methyl-2-phenylpropionate163a. 
Entry Time [h] Acid (eq.) Yielda [%] 
1 4 TMSOTf (2) 62 (99) 
2 3 p-TsOH•H2O (2) 40 (99) 
a The yield reported are the isolated yields; the consumptions of starting 
material (called conversion in the text) are shown in brackets. 
With moderate results of the racemic version of this reaction and no trace of the 
corresponding diaryliodonium salt, the asymmetric transformation was performed using 
different conditions as shown in Table 3.2. The reaction was first investigated using 
Ishihara ester 6a as the iodine(III) reagent and two Lewis acids were compared. 
Surprisingly, the reaction did not lead to the formation of the desired product 163a under 
dry reaction conditions but resulted in complete degradation of starting material (Table 
3.2, Entries 1 and 2). When the reaction was performed with normal grade HC(OMe)3 
and without inert atmosphere, the desired product was observed with very good 
conversion and acceptable isolated yield considering the volatility of product 163a. 
However, the enantioselectivity remained low with 25% and 10% respectively (Table 3.2, 
Entries 3 and 4). 
To prove that water was involved in the reaction, dry HC(OMe)3 was used in combination 
with ten equivalents of water under nitrogen atmosphere. The desired product 163a was 
obtained with slightly lower conversion than in just normal grade HC(OMe)3 but the 
enantioselectivity increased to 33% (Table 3.2, Entries 4 and 5).  
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Table 3.2. Effect of the additives on the asymmetric rearrangement of propiophenone 29a into 
methyl-2-phenylpropionate 163a. 
Entry 
Temperature 
[°C] 
Time 
[h] 
Additives  
(eq.) 
Yielda 
[%] 
eeb 
[%] 
1c 0 24 TMSOTf (2) n.p. - 
2c 0 24 TfOH (2) n.p. - 
3 0 22 TMSOTf (2) 22 (84) 25 
4 0 16 TfOH (2) 36 (89) 10 
5c r.t. 24 TfOH (2), H2O (10) 34 (61) 33 
6 r.t. 24 H2SO4 (2) 44 (77) 23 
7 r.t. 24 p-TsOH•H2O (2) 48 (75) 13 
8c r.t. 24 TfOH (2), MeOH (3) (66) 33 
n.p. = no desired product; a The consumptions of starting material (called conversion in the 
text) are shown in brackets; b The major isomer was the (R)-isomer; c Dry HC(OMe)3 was 
used. 
For the simplicity of the reaction setup, normal grade HC(OMe)3 was used instead of the 
addition of water into dry HC(OMe)3. Two BrØnsted acids were also used to see their 
effect on the reaction’s conversion and selectivity. Sulfuric acid and p-TsOH•H2O worked 
similarly well with conversions of 77% and 75%, respectively. However, the ee remained 
very low with 23% and 13%, respectively (Table 3.2, Entries 6 and 7). 
The water present in the reaction could activate trimethylorthoformate in the presence of 
an acid to generate methyl formate and methanol. Therefore, if the water was directly 
replaced by dry methanol in dry HC(OMe)3, it should lead to similar result. Indeed, both 
reactions gave the desired product with roughly the same conversion and exactly the same 
enantioselectivity (Table 3.2, Entries 5 and 8). 
The effect of the solvent was then tested and the results are shown in Table 3.3. The 
reaction worked quite well in dichloromethane with 56% yield and 33% ee (Table 3.3, 
Entry 1). 2,2,2-Trifluoroethanol (TFE) is known to increase the enantioselectivity in the 
presence of hypervalent iodine(III).[32] Therefore, the reaction was also performed in a 
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mixture of dichloromethane and 2,2,2-trifluoroethanol (1:1). The conversion of the 
reaction was increased from 60% to 88% but the ee dropped to 22% (Table 3.3, Entries 1 
and 2).  
 
Table 3.3. Effect of the solvent on the asymmetric rearrangement of 
propiophenone into methyl-2-phenylpropionate. 
Entry 
Solvent  
(eq.) 
Time 
[h] 
Yielda 
[%] 
eeb 
[%] 
1 CH2Cl2 4 56 (60) 33 
2 CH2Cl2 / TFE (1:1) 5 64 (88) 22 
3 CH3CN 22 n.r. - 
4c, d CH2Cl2 / MeOH (3) 24 (17) - 
5d CH2Cl2 / MeOH (3) 24 n.r. - 
6c CH2Cl2 / MeOH (3) 24 54 (100) - 
7 CH2Cl2 / MeOH (10) 24 35e  
n.r. = no reaction; a The consumptions of starting material (called conversion in the 
text) are shown in brackets; b The major isomer was the (R)-isomer; c PhI(OAc)2 was 
used instead of Ishihara ester 6a; d No HC(OMe)3 was used; e α-OMe addition 
product 165a was obtained as the only product. 
Acetonitrile was also used as the solvent for this transformation but no product was 
observed and starting material was recovered. The reaction was also carried out using 
only three equivalents of methanol instead of trimethylorthoformate. With PhI(OAc)2, the 
desired product was only observed in 17% conversion while with the Ishihara ester 6a, 
no product 163a was formed and the starting material was fully recovered (Table 3.3, 
Entries 4 and 5). Finally, both methanol and trimethylorthoformate were used in 
combination and the product was obtained with full conversion using PhI(OAc)2. 
Unfortunately, with Ishihara ester 6a, no rearranged product 163a was observed and only 
the α-methoxy addition product (2-methoxy-1-phenylpropan-1-one 165a, (Figure 3.5)) 
was observed in 35% yield (Table 3.3, Entry 7). 
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Figure 3.5. Structure of the side product 2-methoxy-1-phenylpropan-1-one 165a. 
Different temperatures were then compared as shown in Table 3.4. When the reaction 
was performed at -20 °C using Ishihara ester 6a, the enantioselectivity increased to 40% 
(Table 3.4, Entry 3). The temperature was further lowered down to -48 °C, but this led 
only to the formation of (1,1-dimethoxypropyl)benzene with some starting material 
recovered (Table 3.4, Entry 4). 
 
Table 3.4. Effect of the temperature and the iodine(III) reagent on the asymmetric rearrangement of 
propiophenone into methyl-2-phenylpropionate 163a. 
Entry 
Iodine 
 (III) 
Temperature 
[°C] 
Time 
[h] 
Additives  
(eq.) 
Yielda 
[%] 
eeb 
[%] 
1 6a 0 22 TMSOTf (2) 22 (84) 25 
2 6a 0 16 TfOH (2) 36 (89) 10 
3 6a -20 24 TfOH (2) (96) 40 
4 6a -48 10 TfOH (2) n.p.c - 
5 6b -20 24 TfOH (2) 49 (91) 53 
6 6b -20 24 TMSOTf (2) 18 (39) 51 
7 6b -20 24 BF3•OEt2 (2) n.r. - 
8 169 0 23 TfOH (2) 69 (93) 15 
n.p. = no desired product; n.r. = no reaction; a The yields reported are the isolated yields and the 
consumptions of starting materials (called conversion in the text) are shown in brackets; b The major 
isomer was the (R)-isomer except for Entry 8 where the (S)-isomer was formed as the major isomer; 
c (1,1-Dimethoxypropyl)benzene was isolated as well as some starting material. 
Two other hypervalent iodine reagents were also investigated for this reaction in order to 
improve the enantioselectivity (Figure 3.6). 
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Figure 3.6. Structure of Ishihara amide 6b and (S)-(2-(1-(pyridin-2-yl)ethoxy)phenyl)-l3-
iodanediyl diacetate 169. 
The reaction was initially performed with Ishihara amide 6b using the same reaction 
conditions as previously with the Ishihara ester 6a. The desired product was obtained with 
very good conversion and a higher enantioselectivity of 53% (Table 3.4, Entry 5). The 
effect of the Lewis acid in combination with the Ishihara amide 6b was also investigated. 
The enantioselectivity was as good using TMSOTf (51% ee) but the conversion dropped 
to 39% (Table 3.4, Entry 6). When BF3•OEt2 was used, no reaction occurred and starting 
material was recovered (Table 3.4, Entry 7). 
During this research, the synthesis of a new chiral hypervalent iodine(III) reagent 169 
was achieved and will be described in Chapter 6. This new reagent is believed to induce 
more enantioselectivity because of the pyridine ring that could coordinate with the iodine 
centre and therefore block one side of the reagent. In this reaction, this positive effect was 
not significantly observed as the enantioselectivity remained very low (15% ee) while the 
conversion stayed as high as with the other iodine(III) reagents (Table 3.4, Entry 8). 
The volatility of methyl-2-phenylpropionate 163a rendered the analysis of this reaction 
difficult. Indeed, the isolated yield depended on how long the reaction mixture was left 
on the rotary evaporator before the yield was calculated. Therefore, those results have a 
great standard deviation. To overcome this problem, a substrate with a larger aryl ring 
system was used to form a product with a much lower volatility. Propionylnaphthalenes 
were chosen as they are easily accessible using Friedel-Craft reaction. 
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 Optimisation using propionylnaphthalene 
Propionylnaphthalene was synthesised using standard Friedel-Craft methodology.[33] 
Naphthalene was stirred together with aluminium chloride and propionyl chloride for 2 h 
at 35 °C. A mixture of 1-propionylnaphthalene 172 and 2-propionylnaphthalene 171 was 
obtained with a conversion determined by 1H NMR of 91% and 9%, respectively (Scheme 
3.12). However, the two compounds could not be fully separated by column 
chromatography but some pure fractions could be isolated. 
 
Scheme 3.12. Synthesis of 1-propionylnaphthalene and 2-propionylnaphthalene using Friedel-Craft method. 
Nevertheless, the rearrangement transformation was performed on the mixture of both 
1- and 2-propionylnaphthalenes (91:9 ratio by 1H NMR) and it resulted in complete 
conversion into their corresponding rearranged products 174a and 173a (Scheme 3.13).  
 
Scheme 3.13. Rearrangement of a mixture of 1-propionylnaphthalene and 2-
propionylnaphthalene into their corresponding methyl (R)-2-(naphthalen-1-
yl)propionate 174a and methyl (R)-2-(naphthalen-2-yl)propionate 173a. 
The rearrangement transformation was then performed on both pure 1- or 
2-propionylnaphthalene and the results are showed in Table 3.5. Both substrates gave the 
rearranged product in very good yields (87% and 83%) (Table 3.5, Entries 1 and 2). The 
reaction was then carried out using Ishihara ester 6a as the chiral iodine(III) reagent. 
Again, both transformations occurred with moderate yields and the same 
enantioselectivity (Table 3.5, Entries 3 and 4). 
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Table 3.5. Rearrangement of 1- or 2-propionylnaphthalene. 
Entry Substrate 
Iodine 
(III) 
Temperature 
[°C] 
Time 
[h] 
Yielda 
[%] 
eeb 
[%] 
1 171 PhI(OAc)2 r.t. 5 83 - 
2 172 PhI(OAc)2 r.t. 5 87 - 
3 171 6a -20 24 48 24 
4 172 6a -20 24 62 22 
a The yields reported are the isolated yields; b The major isomer was the (R)-isomer. 
As both substrates showed very similar reactivity and 1-propionylnaphthalene was 
synthesised in larger amount than 2-propionylnaphthalene, the optimisation was carried 
out using 1-propionylnaphthalene and results are shown in Table 3.6.  
First, the reaction was performed with Ishihara amide 6b to confirm that it was still the 
preeminent chiral iodine(III) reagent among the one used in this thesis to induce 
stereoselectivity. The reaction worked well and the desired product 174a was isolated in 
91% yield while the enantioselectivity increased to 46% ee (Table 3.5, Entry 4 and Table 
3.6, Entry 1).  
To elucidate if the reaction could be performed with a catalytic amount of Lewis acid, the 
reaction was carried out using the same reaction conditions with the amount of Lewis 
acid that was reduced to 0.2 equivalents. Unfortunately, this resulted in no reaction and 
the starting material was recovered (Table 3.6, Entry 2). This indicates that the Lewis acid 
is there to activate the iodine(III) species and not only to form an equilibrium between 
the ketone and the enol form. In the second case, a catalytic amount of acid should be 
sufficient. Another Lewis acid, BF3•OEt2, was also tested in this transformation but only 
starting materials were observed in the crude mixture (Table 3.6, Entry 3). 
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Table 3.6. Optimisation of rearrangement of 1-propionylnaphthalene. 
Entry 
Lewis Acid 
(eq.) 
R 
Temperature 
[°C] 
Yielda 
[%] 
eeb 
[%] 
1 TfOH (2) Me -20 91 46 
2 TfOH (0.2) Me -20 n.r. - 
3 BF3•OEt2 (2) Me -20 n.r. - 
4 TfOH (2) Et -20 70 62 
5 TfOH (2) iPr -20 22c - 
6 TfOH (2) Me r.t. 81 44 
7 TfOH (2) Me 40 40 40 
n.r. = no reaction; a The yields reported are the isolated yields; b The major isomer 
was the (R)-isomer; c No desired product formed and the yield reported is the yield 
for 2-isopropoxy-1-(naphthalen-1-yl)propan-1-one. 
The influence of the orthoformate’s alkyl chain was then investigated. Triethyl 
orthoformate allowed the reaction to be more selective with 62% ee while maintaining a 
high yield (Table 3.6, Entry 4). This higher enantioselectivity can be explained by the 
greater steric bulk around the migrating aryl group. To test this hypothesis, an even 
bulkier orthoformate was tested. However, the reaction with the tri-iso-propyl 
orthoformate did not lead to the desired rearranged product 174c. The iso-propyl group 
was added at the α-position of the ketone in 22% yield (Table 3.6, Entry 5). This might 
be due to the very large steric bulk of the iso-propyl moiety (Scheme 3.14). Indeed, the 
formation of the ketal 176 should be much more favoured in the case of the less bulky 
trimethyl or triethyl orthoformate than for the bulkier tri-iso-propyl orthoformate. If the 
equilibrium is shifted to the ketal form 176 (R = Me, Et), the presence of two oxygens 
will favour the rearranged transformation as they can stabilise the positive charge 
resulting from the aryl group’s migration. On the other hand, if the equilibrium is shifted 
towards the ketone form 175 (R = iPr), the free alcohol is more likely to attack the carbon 
in α-position in an SN2 manner to generate the α-alkoxylated product 177.  
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To verify this hypothesis, the iso-propyl ketal could be isolated prior to the rearrangement 
reaction. If the reaction occurs, this would imply that the ketal is a key intermediate in 
this transformation. However, if no rearranged product is observed, it does not disprove 
this theory as under the reaction conditions, the ketal 176 is in equilibrium with the ketone 
form 175. If the equilibrium is completely shifted to the left, no ketal 176 would remain 
in the reaction mixture and therefore no rearranged product 178 would be observed. 
 
Scheme 3.14. Equilibrium between ketone and ketal form to explain the selectivity for 
either the α-alkoxylated product or the rearranged product. 
When exposed to the reaction conditions, the dimethyl ketal derivative 179 equilibrated 
rapidly to the corresponding ketone 29a. Therefore, it was assumed that it would be the 
same for the iso-propyl ketal moiety. As the equilibrium is more shifted to the ketone 
form, no rearranged product would then be observed if this experiment was performed. 
 
Figure 3.7. Structure of dimethyl ketal derivative 179. 
Finally, the effect of the temperature on the selectivity was also investigated. At room 
temperature, the reaction worked similarly well than at -20 °C with 81% yield and 44% ee 
(Table 3.6, Entry 6). When the reaction was heated at 40 °C, the isolated yield for the 
desired product 174a dropped to 40% and many side products were observed in the crude 
1H NMR. However, the product 174a was still obtained with 40% ee. Therefore, the best 
reaction conditions are with Ishihara amide 6b, triethyl orthoformate and two equivalents 
of triflic acid at room temperature. However, trimethyl orthoformate was chosen to be 
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used for the reaction scope to ensure good conversion and chemical yield into the 
2-arylpropionate derivatives 163.  
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 Scope of the reaction 
 Influence of the alkyl chain 
The influence of the alkyl chain was investigated. The results are presented in Table 3.7. 
When butyrophenone 29d was used, the selectivity increased, to reach 63% ee (Table 3.7, 
Entry 2). This might be due to the slightly higher bulkiness of the ethyl group compared 
to the methyl. Therefore, if an iso-propyl group is used, the selectivity should also 
increase. Indeed, when the reaction was performed with isovalerophenone 29e, the 
selectivity increased to 73% ee (Table 3.7, Entry 3). Unfortunately, as the selectivity 
increased with the bulkiness of the alkyl chain, the reactivity and hence, the conversion 
dropped significantly.  
 
Table 3.7. Effect of the alkyl chain on the enantioselectivity of the rearrangement reaction. 
Entry Substrate Product 
Temperature 
[°C] 
Yielda 
[%] 
eeb 
[%] 
1 
  
-20 
49 
(91) 
53 
2 
  
-20 56 63 
3 
  
-20 31 73 
4 r.t. 31 68 
5c 
  
r.t. 31 35 
a The yields reported are the isolated yields and the consumptions of starting material (called conversion in the 
text) is shown in brackets; b The major isomer was the (R)-isomer; c HC(OEt)3 was used instead of HC(OMe)3. 
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The reaction with isovalerophenone 29e was also performed at room temperature to check 
on another substrate that the temperature did not have a big impact on the selectivity. The 
enantioselectivity dropped only by 5% and confirmed the relatively small impact of 
temperature on the rearrangement (Table 3.7, Entry 4). The reaction was also carried out 
with triethyl orthoformate as it was beneficial for the rearrangement of 
1-propionylnaphthalene (Table 3.6, Entry 4). However, with isovalerophenone as 
substrate, the enantioselectivity dropped to 35% ee (Table 3.7, Entry 5).  
The reaction was also carried out with cyclopropyl(phenyl)methanone 29g. In the racemic 
reaction, the substrate rearranged after ring opening of the cyclopropane moiety to give 
molecule 181 in 65% yield (Scheme 3.15).  
 
Scheme 3.15. Racemic rearrangement of cyclopropyl(phenyl)methanone 29g.  
Unfortunately, the asymmetric rearrangement did not occur and stopped at the ring 
opening stage with almost quantitative yield (Scheme 3.16). 
 
Scheme 3.16. Attempt of asymmetric rearrangement of cyclopropyl(phenyl)methanone 29g. 
 Influence of the substituent on the aryl group 
The influence of the electron density of the aromatic ring was then studied and the results 
are listed in Table 3.8 and Table 3.9. Most substrates were commercially available but a 
number of them were quite expensive. Therefore, prior to the rearrangement 
transformation, a few of them were synthesised following known procedures.  
2-Bromopropiophenone was synthesised from the corresponding benzaldehyde 182 via 
addition of ethyl magnesium bromide to give the alcohol 183 in 77% yield. The alcohol 
was subsequently oxidised with pyridinium chlorochromate (PCC) to the ketone 29h in 
96% yield (Scheme 3.17)[34]. 
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Scheme 3.17. Synthesis of 2-bromopropiophenone 29h from 2-bromobenzaldehyde 182. 
3-Nitropropiophenone 29i was easily prepared by nitration of commercially available 
propiophenone 29a using fuming nitric acid (Scheme 3.18).[35] 
 
Scheme 3.18. Nitration of propiophenone to synthesise 3-nitropropiophenone 29i. 
Finally, 4-iso-butylpropiophenone 29b and 6-methoxy-2-propionylnaphthalene 29j were 
synthesised via a Friedel-Craft reaction between propionyl chloride 166 and 
iso-butylbenzene 144 or 2-methoxynaphthalene 184, respectively. Both reactions gave 
the desired products in good yields (Scheme 3.19). 
 
Scheme 3.19. Friedel-Craft reaction to prepare a) 4-iso-butylpropiophenone 29b and b) 6-
methoxy-2-propionylnaphthalene 29j. 
The effect of the electron density of the aryl group was first shown on propiophenone 
derivatives with an electron-rich aryl moiety and the results are listed in Table 3.8. The 
rearranged products are obtained in very good yield with all the alkyl chain substituted 
aromatic compounds (Table 3.8, Entries 2-4). The reaction worked similarly well with 
4-methoxypropiophenone 29c with 80% yield but surprisingly did not work with 
6-methoxy-2-propionylnaphthalene 29j (Table 3.8, Entries 5 and 6). Only trace amount 
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of the desired product could be observed in the crude 1H NMR for the racemic reaction 
and no product was formed in the asymmetric transformation.  
 
Table 3.8. Rearrangement of propiophenone derivatives with electron-rich aryl group. 
Entry Substrate Product 
T 
[°C] 
Yielda 
[%] 
eeb 
[%] 
1 
  
-20 49 (62) 53 
2 
  
r.t. 79 (86) 46 
3 
  
r.t. 87 (91) 44 
4 
  
r.t. 72 (94) 35 
5c 
  
r.t. 80 (82) 27 
6c 
 
 
r.t. (Traces) - 
a The yields reported are the isolated yields for the asymmetric transformation and the yields for the racemic 
reaction are shown in brackets; b The major isomer was the (R)-isomer; c Only one equivalent of iodine(III) 
reagent was used. 
The trend for the yield can be explained by the fact that the more electron-rich the aryl 
ring is, the faster the migration of the aryl group is. Indeed, the positive charge of the 
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phenonium ion 185 generated is more stabilised than with electron-poor aromatic 
moieties (Figure 3.8).  
 
Figure 3.8. Stabilisation of the phenonium ion 185 by the methoxy group on the aromatic ring. 
The slightly lower yield for the 4-methoxypropiophenone 29c could be due to the lower 
amount of Ishihara amide 6b used in this reaction (1.0 equivalent instead of 
1.2 equivalents) to avoid as much as possible the formation of the diaryliodonium salt 
(see Scheme 3.8). However, this substrate might still overreact to form the corresponding 
diaryliodonium salt, therefore lowering the isolated yield of the desired product.  
The enantioselectivity seems to follow the opposite trend. This may be due to the fact that 
the reaction rate is faster for the more electron-rich aromatic ring and therefore, the 
interaction with the chiral auxiliary is not strong enough to induce high selectivity. 
The results for the rearrangement of propiophenone derivatives 29 with an 
electron-deficient aromatic moiety are shown in Table 3.9. The enantioselectivity does 
not seem to be affected by the substituent. Indeed, for all the compounds for which 
enantioselectivity could be measured, the enantiomeric excess was very similar with 44 to 
46% ee (Table 3.9, Entries 1, 3 and 4). However the yield of this reaction is highly 
dependent on the electron withdrawing group. The yield decreased when a bromine was 
in the para position compared to a fluorine (28% and 50%, repectively; Table 3.9, 
Entries 1 and 2). The position on the aromatic ring is also important. While the para and 
meta substituents gave poor yields (28% and 14%), the ortho substituted product 163h 
was obtained in moderate yield (46%) (Table 3.9, Entries 2-4). When a trifluoromethyl 
substituent was in the meta position of the aryl ring, the desired rearranged product 163p 
could only be obtained in trace amounts and the α-ethoxylated product 186 was isolated 
as the major product in 13% yield. Finally, the rearrangement of 
meta-nitro-propiophenone 29i mediated with the Ishihara amide 6b did not occur and the 
starting material was fully recovered from the reaction mixture. However, in its racemic 
version, substrate 29i reacted with PhI(OAc)2 to give the desired rearranged product 163i 
in 75% yield. 
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Table 3.9. Rearrangement of propiophenone derivatives with electron-poor aryl group. 
Entry Substrate Product 
T 
[°C] 
Yielda 
[%] 
eeb 
[%] 
1 
  
-20 50 (92) 45 
2 
  
r.t. 28 (76) -d 
3 
  
r.t. 14 (98) 46 
4 
  
r.t. 46 (79)  44 
5c 
 
 
+ 
 
r.t. 
Traces 
(73) 
- 
13 (23) -d 
6 
  
r.t. n.r. (75) - 
a The yields reported are the isolated yields for the asymmetric transformation and the yield for the 
racemic reaction are shown in brackets; b The major isomer was the (R)-isomer; c HC(OEt)3 was 
used instead of HC(OMe)3; d The enantiomeric excess could not be determined as the enantiomers 
could not be separated by HPLC but all products showed some negative optical rotation values. 
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The rearrangement reaction was also performed with compound 188, which contains a 
heteroaromatic ring. The substrate was synthesised from picolinonitrile 187 and ethyl 
magnesium bromide in 97% yield via a standard Grignard addition (Scheme 3.20).  
 
Scheme 3.20. Synthesis of 1-(pyridin-2-yl)propan-1-one 188 from picolinonitrile.  
The propionyl group was placed in the ortho-position to determine if there could be a 
coordination of the nitrogen atom of the pyridine ring with the hypervalent iodine reagent 
to induce a greater stereoselectivity.  
During the rearrangement reaction, no desired product 189 was formed but the starting 
material was fully converted into another product (Scheme 3.21). After purification by 
column chromatography, only a small amount of starting material could be isolated back. 
This is surprising as no starting material was observed in crude 1H NMR. This suggested 
that the product was not stable on silica.  
 
Scheme 3.21. Attempt of rearrangement of 1-(pyridin-2-yl)propan-1-one 188. 
The reaction was repeated and a number of experiments were done to determine the 
structure. A shift downfield of the aromatic protons was observed in the 1H NMR and the 
signals for the ethyl group were shifted upfield. The shift downfield of the four aromatic 
protons suggested that the nitrogen atom of the pyridine ring was either protonated or 
coordinated to iodine or a triflate ion. If the pyridine’s nitrogen was coordinating to 
PhI(OAc)2, the ratio between the protons from the pyridine ring and the proton from the 
phenyl ring of PhI(OAc)2 should be the same. This was not the case as the ratio was of 
1:1.8. Therefore it is believed that the phenyl signals are those from iodobenzene and 
have nothing to do with this main unknown product. To prove further this theory, a third 
of the sample was subjected to vacuum. Under these conditions, iodobenzene should 
evaporate and the main product would remain. A 1H NMR of that sample showed the 
disappearance of iodobenzene as expected. 
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The second option was a possible coordination to the triflate ion. To verify this 
hypothesis, a basic work up was performed using an aqueous sodium bicarbonate solution 
and the organic compound was extracted with dichloromethane. If the triflate ion is 
present, a 19F NMR should show a peak for the crude fraction but not for the fraction with 
the basic work up as the triflate ion would then be trapped in the aqueous layer. Indeed, 
for the fraction from the high vacuum, a peak at -78.3 ppm could be observed, indicating 
the presence of a triflate ion. On the other hand, only traces of the triflate ion peak was 
observed by 19F NMR after basic work up. This suggested that the triflate ion was 
coordinating to the pyridine’s nitrogen in the original mixture. 
The other point to discuss on the structure is the shift upfield of the ethyl group peaks. 
This means that the ketone is probably not present and it was confirmed by 13C NMR that 
no carbonyl peak is part of the molecule. The other peak that is seen in the crude 1H NMR 
is a peak at 3.15 ppm integrating for 6 protons. This suggests that the ketone is protected 
as a dimethyl ketal moiety. The chemical shifts were compared with similar compounds 
and matched those found in the literature.[36] The proposed structure of this product is 
shown in Figure 3.9. 
 
Figure 3.9. Proposed structure from the rearrangement reaction of 1-(pyridin-2-yl)propan-1-one 188. 
To check if this transformation needed the presence of hypervalent iodine to occur, the 
reaction was repeated again but in the absence of PhI(OAc)2. In the crude 
1H NMR, the 
same product was observed as the major product. This suggests that the hypervalent 
iodine did not interact at all with substrate 188 under these conditions. 
 Substrates with other functional groups 
The rearrangement was also performed on other substrates to verify if other functional 
groups in the molecule were tolerated. The reaction was first carried out on 
dibenzoylmethane 191. The expected products were either the mono-rearranged product 
192 or the double rearranged product 192’ (Scheme 3.22). 
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Scheme 3.22. Expected products from the rearrangement of dibenzoylmethane 190. 
However, the reaction did not work as expected and no rearranged product was observed. 
Instead, the cleavage of the molecule was noted as ethylbenzoate 193 was formed in 
81% yield as well as 2-ethoxy-1-phenylethan-1-one 194 (43% yield) and 2,2-diethoxy-1-
phenylethan-1-one 195 (39% yield) (Scheme 3.23).  
 
Scheme 3.23. Attempt of rearrangement on dibenzoylmethane 190. 
The mechanism for this cleavage is not obvious. In 1987, Moriarty et al. proposed a 
plausible mechanism for the transformation of dibenzoylmethane 190 into phenylglyoxal 
203 and benzoic acid 202 using pentafluoroiodobenzene bis(trifluoroacetate) 197[37] 
(Scheme 3.24).  
 
Scheme 3.24. Mechanism for the cleavage of dibenzoylmethane 191 proposed by Moriarty et al. using 
pentafluoroiodobenzene bis(trifluoroacetate) 197[37].  
After the formation of the enol 196, the substrate reacted with the hypervalent iodine 197 
reagent to form the intermediate 198. Water was added to the molecule leading to the 
reduction of 197 to its corresponding iodine(I). Intermediate 199 reacted with a second 
equivalent of iodine(III) reagent 197 and intermediate 200 was generated. In the presence 
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of water, an equilibrium between 200 and 201 was proposed to finally produce benzoic 
acid 202 and phenylglyoxal 203.  
A similar activation of the ketone by the iodine(III) reagent could be used in this specific 
case. However, if the mechanism was exactly the same, no mono ethoxy product 194 
would be observed and only the protected aldehyde 195 would be isolated with 
ethylbenzoate. Therefore, a slightly different mechanism is proposed. As suggested by 
Moriarty, the iodine(III) can activate one of the ketones while ethanol (generated from 
triethyl orthoformate) attacked the other carbonyl group. As shown in Scheme 3.25, ethyl 
benzoate and intermediate 204 are the products of this addition. A second molecule of 
ethanol can react with compound 204 to generate the mono-α-ethoxylated product 194. 
Then, with the excess amount of iodine(III) reagent, this mono-α-ethoxylated product 194 
was further oxidised using another equivalent of iodine(III) reagent to yield 195.  
 
Scheme 3.25. Plausible mechanism for the formation of products 193, 194 and 195. 
To prove that compound 194 was the precursor for molecule 195, the reaction was 
performed with the isolated molecule 194 under the same reaction condition (Scheme 
3.26). The expected product 195 was obtained in 82% yield supporting the second part of 
the mechanism showed in Scheme 3.25. 
 
Scheme 3.26. α-Ethoxylation of 2-ethoxy-1-phenylethan-1-one 194. 
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The reaction was then carried out with ethyl benzoylacetate 205 to evaluate if the ester 
would survive under the reaction conditions. The ester remained in the final product 
however, no rearrangement product was observed and only product 206 was isolated in 
56% yield (Scheme 3.27). 
 
Scheme 3.27. Attempt of rearrangement on ethyl benzoylacetate 205. 
The same outcome was observed in the reaction of benzoylacetonitrile 207 and the 
α-ethoxylated product 208 was isolated in 42% yield (Scheme 3.28). 
 
Scheme 3.28. Attempt of rearrangement on benzoylacetonitrile 207. 
tert-Butyl group is usually quite good in migration reactions as it can stabilise the positive 
charge formed. However, in this particular migration reaction, no desired product was 
observed and only the product 210 was isolated in 73% yield (Scheme 3.29). 
 
Scheme 3.29. Attempt of rearrangement on 2,2,6,6-tetramethyl-3,5-heptanedione 209. 
The results above show that this reaction only works when an aryl group is present next 
to the ketone. Also, if an electron withdrawing group is present in α-position of the ketone, 
no rearranged product is formed and only the α-ethoxylated product can be isolated. 
Another aryl group in the α-position of the carbonyl may induce better stereoselectivity 
due to the higher bulkiness of the phenyl group compare to a methyl group. 
Substrate 212 was synthesised via a Friedel-Craft reaction from toluene and phenylacetyl 
chloride 211 in 75% yield. 
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Scheme 3.30. Synthesis of 2-phenyl-1-(p-tolyl)ethan-1-one 212 via Friedel-Craft reaction. 
The rearrangement transformation was then carried out using PhI(OAc)2 under the 
general reaction conditions (Table 3.10, Entry 1). The desired product 213a was isolated 
as the major product in 70% yield. However, this was not the only compound isolated as 
compound 214a and compound 215a were also obtained in 10% yield each.  
 
Table 3.10. Rearrangement of 2-phenyl-1-(p-tolyl)ethan-1-one 212. 
Entry 
Iodine(III) 
reagent 
R 
213 214 215 
Yielda 
[%] 
ee  
[%] 
Yielda 
[%] 
ee  
[%] 
Yielda 
[%] 
ee 
[%] 
1 PhI(OAc)2 Me 70 - 10 - 10 - 
2 6b Me 62 25 11 7 4 5 
3 PhI(OAc)2 Et 54 - - - - - 
a The yields reported are the isolated yields. 
A plausible mechanism for the formation of these two products is provided in Scheme 
3.31. The ketone 212 is in equilibrium with the enol intermediate 216 under the acidic 
condition of the reaction. This enol 216 can then react with the iodine(III) reagent to 
obtain intermediate 217 with the iodine in α-position of the ketone. The p-tolyl group can 
then migrate to generate the product 213. However, the intermediate 217 can also react 
with methanol in a nucleophilic substitution to obtain compound 214. Enol 216 can react 
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slightly differently as the mesomeric form suggests also a partially negative charge in the 
para-position of the phenyl ring. After addition of the hypervalent iodine reagent, 
intermediate 218 would then be generated. After a reductive elimination process, the 
methoxy group is added in para-position on the phenyl ring. Then this intermediate 219 
can undergo the rearrangement reaction in the same way as compound 213 to generate 
product 215.  
 
Scheme 3.31. Possible mechanism for the formation of product 213, 214, 215 with a) rearrangement reaction; 
b) direct addition; c) reductive elimination. 
The asymmetric reaction was then performed with the Ishihara amide 6b as the iodine(III) 
reagent. The reaction worked in similar manner as for the racemic version with isolated 
yield of 62%, 11% and 4% for product 213a, 214a and 215a, respectively. Despite the 
relatively good overall yield, the enantioselectivities obtained for the different 
compounds were quite low with 25%, 7% and 5% ee, respectively. Two explanations can 
be proposed for these low stereoselectivities. The orientation of the phenyl moiety was 
unable to sterically inhibit one side of the molecule when the iodine(III) was added onto 
the molecule. The second possibility is the acidic character of the proton in α-position of 
the carbonyl group. The products were maybe racemising during the purification and the 
analyses. Therefore, the enantioselectivities showed in Table 3.10 (Entry 2) would be 
erroneous.  
The same reaction was also performed with triethyl orthoformate to see if the p-ethoxy 
product 215b would also be formed in this case. Only the product 213b was isolated in a 
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slightly lower yield (54%). However, this reaction was not very clean and the formation 
of the two other products cannot be excluded.  
 Formation of quaternary carbon centre 
The asymmetric synthesis of quaternary centres still remains challenging. Therefore, 
substrate 220 was synthesised in order to check if these reaction conditions would allow 
the easy synthesis of molecules containing a chiral quaternary carbon. Substrate 220 was 
prepared by the methylation of compound 212 using methyl iodide as the methylating 
agent and sodium hydride as the base. Compound 220 was obtained in 80% yield (Scheme 
3.32). 
 
Scheme 3.32. Synthesis of 2-phenyl-1-(p-tolyl)propan-1-one 220. 
The reaction was then carried out under the general racemic conditions but unfortunately, 
after two days of reaction, no product 221 was observed by 1H NMR and the starting 
material 220 was fully recovered (Scheme 3.33). 
 
Scheme 3.33. Attempt of rearrangement reaction on 2-phenyl-1-(p-tolyl)propan-1-one 220. 
In conclusion, the rearrangement transformation was shown to work quite well in the 
presence of relatively electron rich systems while the yields dropped quite drastically with 
electron withdrawing substituents. The reaction also has some limitations. If an electron 
withdrawing group is present in α-position of the carbonyl, the migration reaction does 
not occur. Instead, the product from the nucleophilic substitution is always observed. The 
migration does not work with an alkyl chain such as a tert-butyl group. Finally, the 
reaction conditions do not allow the formation of a quaternary centre. 
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 Mechanistic studies 
When Haruta et al. investigated this reaction in the racemic manner, they also proposed 
the mechanism shown in Scheme 3.34.[28] Under acidic conditions, the propiophenone 
derivative is in equilibrium with its enol form 160. It can then react with PhI(OAc)2 to 
give intermediate 222. After the formation of the ketal on the ketone, the aryl group can 
migrate. As the iodine is connected to an sp3 carbon, it is an excellent leaving group and 
therefore the intermediate 224 is obtained. The positive charge is then trapped by another 
methoxy group and after hydrolysis, the final methyl ester product 163 is formed.  
 
Scheme 3.34. Mechanism proposed by Haruta et al. in 1985.[28] 
In order to improve the enantioselectivity, it would be interesting to know at which stage 
of the mechanism the stereochemistry is induced and if the stereoselectivity is changing 
over the reaction time. The first possibility is that the formation of the enol is selective. 
The second possibility would be the addition of the iodine onto the enol and the third 
option is the migration of the aryl group. Each point will be discussed in the section 
below.  
 Origin of the stereoselectivity 
If the formation of the enol is at the origin of the selectivity, each enol ((E) and (Z)) might 
give the opposite enantiomer 222 in the presence of a chiral iodine(III) reagent. However 
both enol might not behave in a similar way towards the iodine(III) reagent and therefore 
the other two possibilities to induce the stereoselectivity were first explored.  
Recently, Legault et al. obtained much higher enantioselectivities using enol ether as 
precursor for the α-oxytosylation of propiophenone.[38–40] The authors believed that the 
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enol ether prevents the formation of the O-bonded intermediate after addition of the 
hypervalent iodine reagent, and that only the C-bonded intermediate is generated, leading 
to higher enantioselectivities. This approach was investigated for this rearrangement 
reaction. Acetylated propiophenone 226 was easily synthesised using lithium 
diisopropylamide (LDA) and acetic anhydride in 52% yield (Scheme 3.35). 
 
Scheme 3.35. Acetylation of propiophenone 29a. 
The rearrangement reaction was performed using the optimised conditions and with 
PhI(OAc)2. No rearranged product was observed and only the α-methoxylated product 
165a was isolated in 57% yield. The remaining starting material was recovered. This 
result suggested that the rearrangement did not occur as the formation of the ketal moiety 
was not possible (see section 3.6.2 below). 
 
Scheme 3.36. Attempt of rearrangement on substrate 226. 
A more labile protecting group (TMS) was therefore used to render possible the formation 
of the hemiketal/ketal and therefore favoured the migration pathway. The protected 
(Z)-enolate 227 was synthesised (Scheme 3.37). 
 
Scheme 3.37. Synthesis of vinyl silyl ether (Z)-227 from propiophenone.  
Vinyl silyl ether (Z)-227 was then used for the rearrangement reaction (Scheme 3.38). 
Under the best reaction conditions found in section 3.4, the rearranged product 163a was 
only observed in trace amount while the main product synthesised was again the addition 
of the methoxy at the α-position of the ketone.  
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Scheme 3.38. Attempt of rearrangement transformation on vinyl silyl ether (Z)-227.  
The main product of the reaction shown in Scheme 3.38 was the α-methoxylated 
propiophenone 165a. This compound is the result of the direct nucleophilic substitution 
of the iodine by a methoxy group. As this process is an SN2 reaction, it would involve 
complete inversion of configuration and therefore, the enantioselectivity observed should 
be the opposite of the one due to the addition of the iodine(III) reagent onto the double 
bond. In other words, if some enantiomeric excess is observed in the molecule 165a in 
the presence of a chiral iodine(III) reagent, the reaction of hypervalent iodine and the enol 
would be the determining step for the stereochemistry in the final product. 
The reaction was carried out with vinyl silyl ether compound (Z)-227 and Ishihara amide 
6b using the optimised conditions (Scheme 3.39). Again, the rearranged product 163a 
was isolated only in very small amount (4%) and the main product of the reaction 
remained 165a with 80% yield. Surprisingly, the enantiomeric excess of compound 165a 
was of 78% ee which is much higher than the rearranged product 163a (47% ee).  
 
Scheme 3.39. Asymmetric transformation of vinyl silyl ether (Z)-227. 
This means that the addition of the iodine on the double bond of the enol is rather selective 
but unfortunately, this selectivity is much smaller in the final product of the 
rearrangement reaction. One explanation would be the racemisation of the final product 
between its formation and the analyses by HPLC. However, it was shown with 
4-methoxypropiophenone 29c that the product was not racemising over time as the 
enantiomeric excess was the same after 1, 3, 5 and 20 h. Therefore, the intermediate might 
be racemising before the migration occurs. The enolisation of intermediate 222 would 
lead to enol 222a. However, this process is not so favoured and might be difficult. On the 
other hand, hypervalent iodine reagent are excellent leaving group when bonded to an sp3 
carbon. Therefore, it is plausible to generate the cationic species 222b. As the carbon 
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centre is now sp2-hybridised, it is planar and the stereochemistry induced during the 
addition of the iodine reagent is lost, leading to racemisation. Depending on the rate of 
this cleavage compare to the migration reaction, a partial racemisation could be observed. 
 
Scheme 3.40. Possible mechanism leading to racemisation of intermediate 222. 
Both products 163a and 165a are believed to be synthesised from the same precursor 
(R)-223. The rearranged product would be obtained after an antiperiplanar migration of 
the phenyl group to generate the (R)-isomer (pathway a). On the other hand, the 
methoxylated product would yield the (S)-isomer (pathway b). Both pathways proceed 
with inversion of configuration at the stereogenic centre. However, due to the Cahn–
Ingold–Prelog priority rules, the final absolute configuration is opposite. 
 
Figure 3.10. Structure of intermediate 223a and possible mechanism to explain the stereochemistry of the 
products. 
 Trimethyl orthoformate vs methanol 
Trimethyl orthoformate under acidic conditions and with traces of water forms methanol 
and methyl formate 232 (Scheme 3.41). Therefore, is it necessary to use trimethyl 
orthoformate as the solvent of the reaction or could methanol be used instead? 
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Scheme 3.41. Reaction of trimethyl orthoformate with water under acidic conditions. 
When the rearrangement reaction of propiophenone was performed with methanol 
(3 equivalents) and in absence of orthoformate, no conversion into desired rearranged 
product was observed. The same reaction was also carried out with a mixture of methanol 
(3 equivalents) and trimethyl orthoformate (3 equivalents) and the rearranged product 
was obtained in 54% yield. However, if the amount of methanol was increased to 
10 equivalents, the α-methoxylated product 165a was observed in 35% yield (Table 3.3, 
Entries 4, 6 and 7). 
The first experiment shows the importance of the trimethyl orthoformate in this reaction 
as it seems to be necessary for the formation of the ketal intermediate. This key molecule 
is probably essential for the migration step to occur. Indeed, when no trimethyl 
orthoformate is present and therefore no ketal intermediate is formed, no rearranged 
product is observed and only the α-methoxylated product was present in the crude 
1H NMR. The formation of the hemiketal instead of the ketal cannot be excluded from 
the mechanism pathway as the ketal formation is quite slow compared to the excellent 
leaving ability of the iodine moiety. However, the hemiketal would still help for the 
migration step to occur. 
The second and the third experiments show the importance of the amount of methanol 
present in the reaction mixture compared to trimethyl orthoformate. When only three 
equivalents of methanol were used, the rearranged product was the only isolated product 
of the reaction. However, with ten equivalents of methanol, no rearrangement occurred 
and only the α-methoxylated product was formed.  
The reaction was also performed using the isolated dimethyl ketal propiophenone 179 
(Scheme 3.43). This substrate was synthesised from propiophenone using a published 
method in 75% yield (Scheme 3.42).[36] 
Florence Malmedy Rearrangement of propiophenone derivatives 
83 
  
 
Scheme 3.42. Synthesis of (1,1-dimethoxypropyl)benzene 179. 
The rearrangement proceeded similarly well than with propiophenone and the conversion 
(87%) and the enantioselectivity (46% ee) were similar (Scheme 3.43). This result would 
then suggest a rapid interconversion of the ketone 29a with the ketal/hemiketal under the 
reaction conditions. Indeed, the enol form is needed for the addition of the hypervalent 
iodine reagent but the ketal/hemiketal intermediate is also required for the migration step 
to occur. 
 
Scheme 3.43. Rearrangement reaction of (1,1-dimethoxypropyl)benzene 179. 
To verify if the ketone and the ketal forms interchange in solution, the same reaction was 
performed on the isolated ketal 179 but in absence of the iodine(III) reagent. Crude 
1H NMR data were measured NMR data showed a mixture of the ketone 29a, a small 
amount of the ketal 179 as well as the hemiketal form.  
In conclusion, the mechanism proposed by Haruta et al. in 1985 is relatively in agreement 
with the experiments done in this section. However, the equilibrium of every intermediate 
with the corresponding ketone/ketal/hemiketal forms has to be taken into account. The 
stereoselective step of the mechanism is the addition of the iodine(III) reagent onto the 
substrate but unfortunately the migration pathway does not seem as stereoselective as the 
methoxylation by direct substitution of the iodine(III) moiety by methanol. 
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 Hydrolysis 
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are present on the market either in 
their carboxylic acid form or as their corresponding salts. Therefore, the methyl ester of 
molecule 163b needs to be hydrolysed to the corresponding carboxylic acid 139. 
To avoid racemisation during the hydrolysis, the reaction was first performed under acidic 
conditions with trifluoroacetic acid in dichloromethane in the presence of water. 
Unfortunately, no reaction occurred and the methyl ester was recovered after the reaction.  
The use of a week base (Na2CO3) was also not sufficient to hydrolyse the ester. Therefore, 
a stronger base was employed (NaOH) in tetrahydrofuran and methanol. Ibuprofen 139 
was isolated in excellent yield and with 22% ee (Scheme 3.44).  
 
Scheme 3.44. Hydrolysis of compound 163b to generate ibuprofen. 
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 Towards catalytic transformations  
Finally, it would be really interesting to perform this reaction catalytically to increase the 
atom efficiency. The catalytic transformation was investigated using PhI(OAc)2 as the in 
situ synthesised hypervalent iodine reagent. The results are showed in Table 3.11. A 
well-known oxidant for the formation of PhI(OAc)2 from iodobenzene is sodium 
perborate tetrahydrate (NaBO3•4H2O). However, this oxidant requires the presence of 
small quantities of acetic acid to work. Therefore, ten equivalents of acetic acid were 
added to the reaction mixture.  
The reaction was carried out with sodium perborate tetrahydrate, trimethyl orthoformate, 
acetic acid in dichloromethane but no product formation was observed and the starting 
material was recovered (Table 3.11, Entry 1). The same reaction was also performed 
using trimethyl orthoformate as the solvent of the reaction instead of dichloromethane but 
again no reaction occurred (Table 3.11, Entry 2).  
 
Table 3.11. Attempts of catalytic rearrangement of propiophenone. 
Entry Oxidant (eq.) Additives (eq.) Solvent Results 
1 NaBO3•4H2O (10) 
AcOH (10) 
HC(OMe)3 (10) 
CH2Cl2 n.r. 
2 NaBO3•4H2O (10) AcOH (10)  HC(OMe)3 n.r. 
2 m-CPBA (2) MeOH (8) CH3CN n.r. 
3 m-CPBA (2) HC(OMe)3 (10) CH3CN n.r. 
4 m-CPBA (2) HC(OMe)3 (10) CH2Cl2 n.r. 
5 m-CPBA (2) 
HC(OMe)3 (10) 
TMSOTf (1) 
CH3CN 100% conv.a 
n.r. = no reaction; a propiophenone dimethyl acetal 179 was the main product of the reaction. 
Another oxidant used in catalytic transformations involving iodine reagents is 
m-chloroperbenzoic acid (m-CPBA). The reaction was carried out using two different 
solvents (dichloromethane and acetonitrile) and in presence of either trimethyl 
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orthoformate or methanol but in all cases, only starting material was observed in the crude 
1H NMR. Only in the case when some TMSOTf was added, the reaction went to 
completion. However, the crude mixture showed many unwanted products and the main 
product was not the desired rearranged product 163a. Instead, propiophenone dimethyl 
acetal 179 was the major product.  
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 Conclusions and outlook 
The stereoselective rearrangement of propiophenone derivatives mediated by hypervalent 
iodine(III) reagent was described in this chapter. 2-Arylpropionate derivatives 163 were 
synthesised in moderate to good yields with moderate enantioselectivities using Ishihara 
amide 6b in the presence of TfOH in trimethyl orthoformate. The hydrolysis of compound 
163b into ibuprofen 139 was successfully achieved using sodium hydroxide. Further 
investigations to improve the enantioselectivity or to develop a catalytic method are still 
necessary to make this route attractive to synthesise NSAIDs in a larger scale. 
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 Introduction about the functionalisation of carbon-carbon 
double bonds 
The functionalisation of alkenes is a very important reaction in synthetic chemistry as it 
allows quick access to more complex molecules. Hypervalent iodine(III) reagents are well 
known to activate carbon-carbon double bonds to promote their reaction with a 
nucleophile. As the iodine reagent is then connected to an sp3 carbon centre, it is an 
excellent leaving group and therefore, a second nucleophile can displace the iodine(III), 
reducing it to iodine(I). A broad variety of nucleophiles can be used and a brief summary 
of enantioselective functionalisation is presented below. 
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 Dioxygenation 
In 1997, Wirth et al. developed the first enantioselective oxidation of styrene 235 
mediated by a hypervalent iodine reagent. Different reagents 237 were investigated and 
the bisoxytosylated product 236 was obtained in moderate to good yield and with up to 
21% ee.[1] A year later, their chiral iodine(III) reagent 238a was further functionalised to 
yield product 236 with an improved enantioselectivity of 53%.[2] This stereoselectivity 
was further enhanced by changing the substituent on the aryl ring of the reagent 238b 
(65% ee) (Scheme 4.1).[3] 
 
Scheme 4.1. Bisoxytosylation of styrene 235. 
Fujita et al. reported in 2007 an enantioselective intramolecular oxygenation of but-3-enyl 
carboxylates 239 mediated by chiral hypervalent iodine(III) reagents 241a and 241b. The 
corresponding tetrahydrofuran derivatives were obtained in up to 73% yield and with up 
to 64% ee (Scheme 4.2).[4] 
 
Scheme 4.2. Enantioselective intramolecular oxygenation of but-3-enyl carboxylates 239. 
In 2010, the same group developed the first endo-selective oxylactonisation, generating 
an unexpected 6-membered ring with high regioselectivities and high enantioselectivities 
(up to 97% ee) (Scheme 4.3).[5]  
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Scheme 4.3. Endo-selective oxylactonisation of ortho-alk-1-enylbenzoate 242. 
The proposed mechanism for this transformation is shown in Scheme 4.4. The activation 
of the (diacetoxyiodo)arene by BF3•OEt2 and electrophilic addition onto the double bond 
leads to intermediate 244. This intermediate 244 can react in two different ways to give 
intermediates 245 or 246, followed by a second nucleophilic substitution to obtain the 
desired product 247. As both nucleophilic additions proceed with inversion of 
configuration, only the syn-product is formed. Furthermore, the first nucleophilic addition 
is proposed to take place at the benzylic position where a positive charge can be 
delocalised, leading to the preferred intermediate 246. After the addition of the internal 
carboxylic acid, the iodine moiety is displaced, leading to the desired product 247. 
 
Scheme 4.4. Plausible mechanism for the endo-selective oxylactonisation. 
Li et al. reported the diastereoselective acetoxylation of alkenes 248 using PhI(OAc)2 and 
BF3•OEt2 to activate the iodine reagent. They demonstrated that the syn- or anti-products 
249 were obtained selectively depending on the presence of water. This reaction was also 
performed on a larger scale (5 g) without loss of yield or selectivity (Scheme 4.5).[6]  
 
Scheme 4.5. Diastereoselective diacetoxylation of alkenes 248. 
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A plausible mechanism to explain the selectivity is shown in Scheme 4.6. After activation 
of PhI(OAc)2 by BF3•OEt2, electrophilic attack onto the alkene 248 occurred and 
intermediate 250 was generated. In the absence of water, acetic acid can act as the 
nucleophile and yield the anti-249 in the presence of acetic anhydride. However, when 
water was added to the reaction mixture, it reacted with the carbocation to form 
intermediate 251. The intermediate was then ring-opened with the addition of an acetate 
to yield hydroxylated compounds 252 and 252’. After acetylation using acetic anhydride, 
the desired syn-249 was obtained. 
 
Scheme 4.6. Plausible mechanism for the diastereoselective diacetoxylation of alkenes 248. 
In 2011, Fujita et al. published the enantioselective Prevost and Woodward reaction on 
styrene derivatives 253 (Scheme 4.7). It was found that by changing the solvent mixture 
and therefore the nature of the nucleophile, either the syn- or the anti-product 254 was 
obtained in moderate to good yields and with up to 96% ee. This is a nice example of 
switchover of stereochemistry in a reaction.[7] 
 
Scheme 4.7. Enantioselective Prevost and Woodward reaction. 
Very recently, Muñiz et al. reported the enantioselective diacetoxylation of styrene 
derivatives using iodine reagent 255 (Figure 4.1). The catalyst (20 mol%) was oxidised 
in situ with Selectfluor® and activated with TMSOTf. The hydroxyacetates obtained were 
then fully acetylated using acetic anhydride. The corresponding diacetoxylated products 
were obtained in good yields (55 to 92%) and with up to 96% ee.[8] 
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Figure 4.1. Structure of iodoarene 255. 
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 Oxyamination 
In 2012, Farid and Wirth developed the first highly enantioselective oxyamination of 
alkenes 256 mediated by a hypervalent iodine(III) reagent. The corresponding isoureas 
258a were synthesised in good yields (60-71%) and with up to 99% ee (Scheme 4.8).[9] 
Michael et al. studied in 2008 the effect of the Lewis acid and the urea substituents on the 
formation of either the oxyamination product 258a or the diamination compound 258b.[10] 
They showed that under strong acidic conditions, product 258a was formed as the major 
product due to the better nucleophilicity of the oxygen. These oxyaminated products are 
direct precursors to unnatural amino acids. 
 
Scheme 4.8. Enantioselective oxyamination mediated by hypervalent iodine reagents. 
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 Diamination 
Muñiz et al. reported the first enantioselective intermolecular diamination on styrene 
derivatives 259 using hypervalent iodine(III) reagent in 2011. Chiral Ishihara ester 6a or 
reagent 261 were used together with mesitylamine to yield diaminated products 260a in 
up to 86% yield and with up to 95% ee (Scheme 4.9).[11] In 2013, they developed dinuclear 
iodine(III) reagents and used them for the diamination of a variety of alkenes. It was found 
that using a binaphthyl dinuclear iodine(III) reagent 262 was leading to the formation of 
optically active diamine products 260b (14% ee) and 260c (32% ee).[12] 
 
Scheme 4.9. Diamination of styrene derivatives 259.  
A year later (2014), Wirth et al. published the intramolecular enantioselective 
diamination of alkenes, leading to bicyclic products 264 in moderate to good yields and 
with up to 94% ee.[13] The synthesis of a novel hypervalent iodine(III) reagent 265 bearing 
a pyridine moiety was developed. Pyridine is known to coordinate with hypervalent 
iodine reagents and its proximity with the stereogenic centre should allow good 
stereoselectivity.[14,15] This reaction was also performed catalytically using catalyst 266 
sodium perborate tetrahydrate as the internal oxidant. The reaction worked similarly well 
with up to 72% yield and with up to 86% ee (Scheme 4.10).  
 
Scheme 4.10. Intramolecular enantioselective diamination of alkenes 263. 
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 Halogenation 
In 2002, Wirth et al. reported the asymmetric iodolactonisation of unsaturated carboxylic 
acid 267 using iodine monochloride in the presence of a chiral amine. Amine 269 gave 
the best enantioselectivity with up to 49% ee. With this method, the iodolactates 268 were 
isolated in around 80% yield (Scheme 4.11).[16] 
 
Scheme 4.11. Asymmetric iodolactonisation of 267 mediated by ICl. 
A few years later, Lupton performed the dibromination of styrene derivatives 270 using 
chiral hypervalent iodine reagent 272 in the presence of pyridine hydrobromide. The 
desired product 271 was obtained in 82% yield but poor enantioselectivity was observed 
(3% ee). Changing the temperature or the solvent did not improved the selectivity of this 
transformation (Scheme 4.12).[17] 
 
Scheme 4.12. Attempt of asymmetric dibromination of styrene derivatives 270. 
In 2011, Nicolaou described the first enantioselective dichlorination of allylic alcohols 
273 using dichloroiodoarene 275 in the presence of (DHQ)2PHAL 276 as a chiral catalyst. 
Various trans-cinnamyl alcohols were successfully dichlorinated in moderate to good 
yield (35-90%) and with up to 85% ee (Scheme 4.13).[18]  
 
Scheme 4.13. Dichlorination of allylic alcohols 273. 
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In 2013, Nevado et al. reported the first intramolecular, regio- and enantioselective 
aminofluorination of alkenes 277 induced by chiral hypervalent iodine 279. Products 278 
were obtained in good to excellent yields and with up to 88% ee (Scheme 4.14). It was 
also found that p-xylene difluoride could be employed for the racemic aminofluorination 
of a range of styrene derivatives.[19] 
 
Scheme 4.14. Enantioselective aminofluorination of alkenes 277. 
Kita et al. published a year later the first catalytic aminofluorination of alkenes 277 using 
iodoarene 280 as a catalyst with a stoichiometric amount of m-CPBA in the presence of 
a fluorine source (hydrogen fluoride pyridine or 46% aqueous hydrofluoric acid).[20] 
Aminofluorinated compounds 278 were obtained in moderate yields (60-65%) and with 
up to 70% ee. 
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 Conclusion 
In conclusion, hypervalent iodine reagents are powerful tools for the asymmetric 
difunctionalisation of carbon-carbon double bonds. They can be used either as chiral 
reagents or as racemates in the presence of a chiral auxiliary. More recently, a few groups 
have developed enantioselective catalytic functionalisation of alkenes. These are quite 
promising tools for the organic synthesis of natural products and drugs. 
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 Introduction 
Functionalisation of alkenes is usually a key step in the synthesis of more complex 
molecules such as natural products.[1–5] Electrophilic iodine(III) species can activate 
unsaturated compounds to functionalise them. After the first attack of the iodine(III) onto 
the double bond, a first nucleophile can add from the opposite side of the double bond to 
form the intermediate 283. Due to the high leaving group ability of the iodine(III) species 
when bonded to an sp3 carbon, the reaction proceeds with the addition of a second 
nucleophile (the same or different to the first one) to afford the difunctionalised product 
284 (Scheme 5.1). 
  
Scheme 5.1. Schematic interaction of hypervalent iodine with alkene 281. 
Furthermore, if the alkene such as 285 contains a nucleophile (e.g. alcohol, amine, thiol, 
carboxylic acid…), an intramolecular nucleophilic attack can occur, leading to the 
products as shown in Scheme 5.2. Two products can be formed during this reaction, the 
exo- and the endo-cyclised products 286 and 287. This selectivity will depend on the 
substrate and usually the Baldwin’s rules can be applied to predict it (Scheme 5.2).[6] 
 
Scheme 5.2. Exo- and endo-selectivity for the intramolecular nucleophilic attack onto the activated alkene 285. 
The double addition of nucleophiles onto the double bond can generate two new 
stereocentres. It is therefore of great interest to use chiral iodine(III) reagents to generate 
the desired products stereoselectively. 
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 Objectives 
The aim of this project is to synthesise lactone derivatives 291 using hypervalent 
iodine(III) reagents, as shown in Scheme 5.3. These molecules are highly functionalised 
and can be used as precursor for further transformations, such as intramolecular cascade 
reactions, to generate natural products or drugs.  
 
Scheme 5.3. General scheme for the cyclisation of compounds 290 using hypervalent iodine(III) reagent.  
These lactone derivatives 291 with two chiral centres will be prepared via an 
intramolecular cyclisation using hypervalent iodine reagents to activate the double bond. 
Furthermore, the use of chiral hypervalent iodine could induce some stereoselectivity in 
the resulting lactones. 
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 Results and discussion 
 Optimisation of the reaction conditions on dimethyl malonate 
derivative 297 
Substrate 297 was chosen for the optimisation of the reaction conditions. It contains an 
alkene and an alkyne functionality and two ester moieties that can act as the internal 
nucleophiles for the cyclisation. Compound 297 was easily prepared from dimethyl 
malonate 292 by two alkylation steps. The first one was performed using sodium hydride 
and allyl bromide 293 to install the allyl moiety. Both mono- and bis-alkylated products 
294 and 295 were generated in 50% and 20% yield, respectively (Scheme 5.4).  
 
Scheme 5.4. Synthesis of mono- and di-alkylated compounds 294 and 295. 
Mono-alkylated malonate 294 was then treated again with sodium hydride but in the 
presence of propargyl bromide 296. The desired propargylated product 297 was obtained 
in 64% yield (Scheme 5.5). 
 
Scheme 5.5. Addition of propargyl bromide onto malonate derivative 294. 
Different conditions were investigated to optimise the cyclisation reaction of malonate 
derivative 297 as shown in Table 5.1. The reaction was initially performed using only the 
iodine reagent at -20 °C. Both PhI(OAc)2 and I(OAc)3 did not mediate any cyclisation 
after 3 days of reaction and the starting material was fully recovered (Table 5.1, Entries 1 
and 2).  
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Table 5.1. Effect of the additives on the cyclisation of malonate derivative 297. 
Entry 
Iodine(III) Additives T Yielda [%] d.r. 
(eq.) (eq.) [°C] 298x 299 298 
1 DIB (1) - -20 to r.t. n.r.b - - 
2 I(OAc)3 (1) - -20 n.r. - - 
3 DIB (1) BF3•OEt2 (2) -20 a: 16 (54) Traces 10:1d 
4 DIB (1.2) BF3•OEt2 (2) -20 a: (60) Traces 10:1d 
5 DIB (1.2) BF3•OEt2 (2) -20 a: 15 (61)b Traces 10:1d 
6 DIB (1.2) BF3•OEt2 (2) 0 a: 48 45 6:1d 
7 DIB (1.2) BF3•OEt2 (2) r.t. a: (100)c n.d. 2:3d 
8 Koser (1.2) BF3•OEt2 (2) -20 b: 20 (49) - - 
9 PIFA (1.5) BF3•OEt2 (2) -20 n.p. - - 
10 DIB (1.2) BF3•OEt2 (3) -20 a: (83) - 5:1d 
11 DIB (1.2) 
BF3•OEt2 (3) 
AcOH (12.5) 
-20 a: 58 (85) 6 11:1d 
12 DIB (1.2) 
BF3•OEt2 (2) 
AcOH (12.5) 
-20 a: 24 (100) 32 8:1d 
13 DIB (1.2) 
BF3•OEt2 (2) 
H2O (0.01) 
-20 b: 39 (57) - 5:1 
n.r. = no reaction; starting material could be recovered. n.p. = no product could be isolated due to 
complete degradation. a Yields reported are the isolated yields. The consumptions of starting materials 
measured by 1H NMR (called conversion in the text) are shown in brackets. b The reaction was stirred 
for 3 days. c Full consumptions of the starting material was observed but much more degradation was 
observed.d d.r. is given as trans:cis ratio. 
It was suspected that the iodine reagent alone was not reactive enough, therefore, a Lewis 
acid was added to activate it. BF3•OEt2 was chosen and a cyclised product could be 
observed and isolated in 16% yield (Table 5.1, Entry 3). A ratio of 10:1 between the two 
diastereomers was measured in the crude 1H NMR. In order to determine whether the 
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5-exo or the 6-endo cyclised product was formed (Figure 5.1), 2D NMR spectra were 
recorded.  
 
Figure 5.1. 5- and 6-membered ring structure of product 298a. 
On the spectrum (Figure 5.2), HC is interacting in the space with HA, HB, HD and HE which 
indicates that HC is attached to the carbon bearing the OAc moiety or CH2OAc group. 
Furthermore, on the zoom picture of this experiment (Figure 5.3), only HA is interacting 
with HE. This suggests that there could be a 1,3-diaxial interaction between these two 
protons and therefore, a six membered-ring lactone would fit better the NOESY results. 
Indeed, if it was the 5-membered lactone that was obtained, protons HA and HB should 
interact the same way towards HD and HE as the carbon bearing HA and HB should freely 
rotate. As only HA and HE are interacting in the space (1,3-diaxial interaction), this also 
means that those two protons are in axial position and HB and HD are in equatorial position 
of the chair-like conformation.  
 
Figure 5.2. NOESY spectra of molecule 298a. 
HC HA HB HD HE 
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Figure 5.3. Zoom of the NOESY spectra of molecule 298a. 
However, the infrared spectra show two absorption peaks at 1776 and 1736 cm-1. The 
peak at 1736 cm-1 is most likely the C=O stretch of the methyl ester and the acetate. On 
the other hand, the peak at 1776 cm-1 is very characteristic of a 5-membered ring lactone 
which usually appears around 1770 cm-1 while the absorbance band for a 6-membered 
ring lactone is in the region of 1735 cm-1[7]. This result is in disagreement with the 
NOESY experiment. It is also unclear why HC is interacting with all the four other protons 
around it.  
In order to unambiguously determine the exact structure of the lactone, a crystal structure 
would be ideal. Fortunately, the oily product slowly crystallised over two years’ time at 
room temperature on the bench and the X-Ray crystal structure (Figure 5.4) finally 
established that it was the 5-membered ring lactone that was formed during the reaction. 
The crystal structure also revealed the relative stereochemistry of the major diastereomer, 
with the methyl ester and the CH2-acetate trans to each other. 
 
Figure 5.4. Crystal structure of lactone 298a. 
HA 
HB 
HD HE 
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A possible explanation for the interaction, in the NOESY spectrum, only between HE and 
HA (and not HB) might be due to a blocked conformation of the CH2-acetate moiety. 
An excess of the iodine reagent was then used to try to improve the conversion. However, 
this did not make a big difference with only an increase of 4% conversion and the 
diastereomeric ratio remained unchanged (Table 5.1, Entry 4). The yield was not 
improved by stirring the reaction for three days at room temperature and also the 
selectivity remained the same (Table 5.1, Entry 5). 
The effect of the temperature on the conversion and the selectivity was then studied. 
Increasing the temperature to 0 °C improved the conversion to 100% and the cyclised 
product 298a was isolated in 48% yield. However, the formation of a major side product 
was observed. After isolation and characterisation, it was found that a competing 
oxidation of the triple bond was occurring and in addition, the oxidised compound 299 
was isolated in 45% yield (Table 5.1, Entry 6). The selectivity also started to drop with a 
diastereomeric ratio of 6:1 being observed. When the reaction was warmed up to room 
temperature, considerable degradation was observed and products could not be isolated. 
The selectivity decreased even further with a diastereomeric ratio of approximately 2:3 
(Table 5.1, Entry 7).  
Two other iodine reagents were then compared with PhI(OAc)2. Koser’s reagent gave the 
cyclised product 298b (R = OH) in 20% yield. The selectivity could not be determined 
by 1H NMR as the peaks were overlapping (Table 5.1, Entry 8). Using PIFA together 
with BF3•OEt2 led to complete degradation to unidentifiable products (Table 5.1, 
Entry 9).  
Increasing the amount of BF3•OEt2 to 3 equivalents led to a better conversion (83%), but 
the selectivity dropped to a diastereomeric ratio of 5:1 (Table 5.1, Entry 10). The addition 
of an excess of nucleophile could also help to improve conversion of the starting material 
into the cyclised product 298a. Therefore, additional acetic acid was added to the reaction 
mixture and the cyclised product was isolated in 58% yield with slightly improved 
diastereomeric ratio of 11:1 (Table 5.1, Entry 11). As the increased amount of Lewis acid 
was detrimental for the selectivity, the reaction was also performed with only two 
equivalents of BF3•OEt2. The starting material was fully converted but surprisingly, it 
also led to much more formation of side product 299 as well as one other uncharacterised 
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side product. Furthermore, the selectivity decreased to a ratio of 8:1 (Table 5.1, Entry 12). 
Finally, it has to be noted than in the presence of water (1 mol%), the cyclisation still 
proceeded but with a lower conversion. Only product 298b was isolated in 39% yield and 
with a diastereomeric ratio of 5:1 (Table 5.1, Entry 13). 
The effect of the solvent was also studied and the results are shown in Table 5.2. When 
the reaction was performed in acetonitrile, no product was isolated due to complete 
degradation of the reaction mixture into uncharacterised products. The addition of acetic 
acid did not lead to a cleaner reaction (Table 5.2, Entries 2 and 3).  
 
Table 5.2. Effect of the solvent on the cyclisation of malonate derivative 297. 
Entry Solvent 
Additives 
(eq.) 
Yielda 
[%] 
d.r. 
1 CH2Cl2 BF3•OEt2 (2) 16 (54) 10:1b 
2 CH3CN BF3•OEt2 (2) n.p. - 
3 CH3CN 
BF3•OEt2 (2) 
AcOH (12.5) 
n.p. - 
4 
CH2Cl2 
/TFE (5:1) 
BF3•OEt2 (2) n.p. - 
n.p. = no product could be isolated due to complete degradation. a Yields 
reported are the isolated yields. The consumptions of starting material 
measured by 1H NMR (called conversion in the text) is shown in brackets.         
b Trans:Cis ratio 
2,2,2-Trifluorethanol (TFE) is known to coordinate to the iodine reagent and in several 
cases, has led to increased selectivity.[8] However, when a mixture of dichloromethane 
and TFE (5:1) was used as the solvent, complete degradation of the starting material was 
observed (Table 5.2, Entry 4).  
In order to further optimise the reaction time of the cyclisation, the reaction was 
monitored by 1H NMR analysis. The cyclisation was directly performed in deuterated 
chloroform to allow for a direct measurement. The sample was taken from the reaction 
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mixture and the results over time are shown in Table 5.3. The conversion kept increasing 
with the reaction time to reach 83% conversion.  
 
Table 5.3. Evolution of the ratio between 298a and 298b over time. 
Entry 
Time 
[h] 
Conversiona 
[%] 
298a/298b 
ratio 
1 0.5 30 1:4 
2 1 35 1:1.7 
3 2 37.5 1:1.7 
4 3 48 2:1 
5 24 59 2.3:1 
6 48 61 1.3:1 
7 53 83 1:1 
a Consumptions of starting material (called conversion in the text) 
was measured by 1H NMR. 
Surprisingly, the product 298b was observed in large quantities in every fraction 
collected. This means that even trace amounts of water present in the bottle of deuterated 
chloroform (brand new) was enough to induce the addition of a hydroxyl group instead 
of the acetoxy moiety. The ratio between 298a and 298b was changing with the reaction 
time and no trend can be clearly observed. Therefore, depending on the time the reaction 
was stopped, product 298a or product 298b would be the major product of the reaction. 
The isolated yield and the conversion measured in the crude 1H NMR were quite different 
and therefore, different hypotheses have been considered. The first one is the 
decomposition of the product when exposed to silica during the purification by column 
chromatography. This hypothesis was rapidly rejected. Indeed, the crude mixture and 
silica were stirred in a mixture of hexane and ethyl acetate for an hour, then filtered and 
analysed by 1H NMR. The same proportion of product was found as previously observed 
and no loss of material was measured. The same experiment was also performed but using 
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basic alumina and the same outcome confirmed that the product was completely stable 
under the purification conditions. 
It was then considered that the lower yield would be due to a loss of product during the 
work up. Again, different methods were compared with basic, neutral or acidic work up. 
All methods led to an acceptable crude mass and similar crude 1H NMR spectra were 
measured with no significant changes for the diastereomeric ratio. Therefore, it can be 
stated that the problem was not coming from the work up itself. 
The last possibility for the lower yield is the potential volatility of the products formed. 
This was confirmed by exposing the samples to high vacuum and measuring the mass 
before and after the process. Therefore, after the discovery, no sample was dried under 
high vacuum to avoid evaporation of the product mixture. 
 Optimisation on ethyl 2-cyanoacetate derivatives 
The cyclisation reaction was also performed on ethyl 2-cyanoacetate derivative 302 and 
different iodine reagents were again used to confirm that DIB was still the reagent of 
choice. First, the substrate was synthesised from ethyl 2-cyanoacetate in the presence of 
sodium hydride and 2.2 equivalents of allyl bromide. The mono- and di-alkylated 
products 301 and 302 were obtained in 22% and 76% yield, respectively (Scheme 5.6). 
 
Scheme 5.6. Synthesis of mono- and di-alkylated ethyl 2-cyanoacetate 301 and 302. 
The cyclisation reaction was then performed using di-alkylated substrate 302 in the 
presence of DIB and BF3•OEt2. The expected cyclised product 303a with the acetoxy 
group addition was isolated in 43% yield but the diastereomeric ratio was only 3:1 (Table 
5.4, Entry 1). Another Lewis acid (TMSOTf) was used for direct comparison. The 
cyclisation occurred with lower yield but no acetoxy group was added onto the double 
bond. Instead, the triflate anion from the Lewis acid reacted as the nucleophile to lead to 
product 303c (Table 5.4, Entry 2). The addition of TFE resulted again in complete 
degradation of the starting material to unknown compounds (Table 5.4, Entry 3).  
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Changing the iodine(III) reagent did not improve the isolated yield of the cyclised product 
303 or the selectivity. Iodosylbenzene and Koser’s reagent both mediated the addition of 
a hydroxyl group onto the double bond in 37% and 21% yield, respectively (Table 5.4, 
Entries 4 and 5). Finally, the use of PIFA resulted in complete degradation into unknown 
products. 
 
Table 5.4. Optimisation of the cyclisation of 302. 
Entry 
Iodine(III) 
(eq.) 
Additives 
(eq.) 
Yielda (303x) 
[%] 
d.r. 
1 DIB (1.2) BF3•OEt2 (2) a: 43 3:1 
2 DIB (1.2) TMSOTf (2) c: 28 n.d. 
3 DIB (1.2) 
TMSOTf (2) 
TFE 
n.p. - 
4 PhI=O (1) BF3•OEt2 (2) b: 37 n.d. 
5 Koser (1.5) BF3•OEt2 (2) b: 21 2:1 
6 PIFA (1.5) BF3•OEt2 (2) n.p. - 
n.d. = not determined due to the overlapping of the peaks in 1H NMR. n.p. = no desired product 
and degradation into unknown products was observed. a The yields reported are the isolated yields. 
From both substrate optimisations, the best reaction conditions were using PhI(OAc)2 in 
the presence of BF3•OEt2 and acetic acid. The resulting mixture was stirred in 
dichloromethane for 20 hours at -20 °C. These conditions were used for the scope of the 
reaction presented in the next section. 
 Scope of the reaction 
The cyclisation of malonate derivatives was performed using the best reaction conditions 
found above. The mono-allylated dimethyl malonate 294 was reacted with DIB to give 
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compound 304 in 61% yield (Scheme 5.7). The diastereomeric ratio determined in the 
crude 1H NMR was very low with 1.3:1.  
 
Scheme 5.7. Cyclisation of mono-allyl dimethyl malonate 294. 
The cyclisation also worked for the di-allylated substrate 295. As two carbon-carbon 
double bonds and two esters were present in the molecule, it was in principle possible to 
obtain the double cyclised spiro compound 305 by increasing the amount of iodine(III) 
reagent. Product 305 was isolated in 15% yield as the major product (Scheme 5.8). 
 
Scheme 5.8. Double cyclisation of substrate 305. 
If there is an addition of a carboxylic acid through the double bond, the cyclisation 
reaction should occur more easily if it is synthesised and isolated prior to the reaction. 
For this, malonate derivative 297 was treated with sodium hydroxide in methanol and the 
mono-hydrolysed malonate 306 was isolated in 96% yield. The cyclisation was then 
performed using the best conditions found during the optimisation. Two different cyclised 
product were formed during the reaction, one with the addition of a hydroxyl group onto 
the double bond (298b, 13%) and the other one with an acetoxy moiety (298a, 28% yield) 
(Scheme 5.9). 
 
Scheme 5.9. Selective hydrolysis followed by cyclisation mediated by DIB. 
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If a loss of methyl cation from the ester is assumed in the mechanism, di-tert-butyl 
malonate derivatives should provide better yields as the tert-butyl cation is a better 
leaving group. Indeed, it is more stabilised and also generates isobutene, by loss of a 
proton, which can be liberated as a gas. The synthesis of the compounds 308 and 309 was 
the same as for the previous substrates. The first alkylation was performed on di-tert-
butyl malonate 307 with allyl bromide to form compound 308. This crude mixture was 
used directly after a work up for the second alkylation using propargyl bromide. The 
resulting product 309 was obtained in 68% yield over the two steps (Scheme 5.10). 
 
Scheme 5.10. Synthesis of malonate derivatives 308 and 309. 
Substrate 309 gave the desired cyclised product 310 in moderate conversion (58%) and 
with moderate selectivity (d.r. = 4:1) (Scheme 5.11). The yield of the reaction remained 
the same as the one for the methyl ester substrate. However, the selectivity dropped 
drastically from 11:1 to 4:1 (d.r.).  
 
Scheme 5.11. Cyclisation of malonate derivative 309. 
Finally, the mono-allylated di-tert-butyl malonate 308 was also submitted to the same 
reaction conditions and led to the cyclised product 311 in good yield (70%) but with 
moderate selectivity of 4:1 (Scheme 5.12). The stereochemistry of the major isomer (cis) 
was determined by NOESY experiment on the isolated mixture (d.r. = 1.2:1) (see 
experimental section). 
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Scheme 5.12. Cyclisation of malonate derivative 308. 
 Asymmetric cyclisation 
As mentioned in the introduction, there are two chiral centres in this highly functionalised 
product 298a. Therefore, it would be of great interest to use a chiral hypervalent iodine 
reagent to mediate the cyclisation through a stereoselective addition across the double 
bond. The reaction was performed under the best reaction conditions, simply replacing 
PhI(OAc)2 with the Ishihara ester 6a (Scheme 5.13). Unfortunately this reaction did not 
lead to the desired product. No further investigation was performed on the asymmetric 
version of the cyclisation.  
 
Scheme 5.13. Attempt of asymmetric cyclisation of malonate derivative 297. 
 Hydrolysis of the acetate moiety 
In order to further functionalise the molecule, it would also be interesting to selectively 
hydrolyse the acetate group as the liberated alcohol could then be used as a nucleophile. 
This was easily done using potassium carbonate (1.5 equivalents) in methanol in only 
5 minutes reaction time. The hydrolysis was directly combined with the cyclisation 
reaction and the alcohol 312 was obtained in 41% yield over the two steps. However, the 
diastereoselectivity dropped drastically during the hydrolysis step to a diastereomeric 
ratio of 2:1 (Scheme 5.14). This decrease in the diastereomeric ratio might be due to the 
presence of the base which can potentially deprotonate in α-position of the acetate moiety, 
leading to a possible epimerisation. 
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Scheme 5.14. Cyclisation of malonate derivative 297, followed by the hydrolysis of the acetate moiety. 
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 Conclusion and outlook 
Malonate derivatives were successfully cyclised into their corresponding highly 
functionalised lactones with moderate to good diastereoselectivities. Furthermore, the 
5-membered ring structure was confirmed by X-Ray crystallography. Using other 
functional groups for R1 and R2 would also lead to a bigger library of valuable compounds 
for further functionalisation. 
 
Scheme 5.15. General scheme for the cyclisation of compounds 290 using hypervalent iodine(III) reagent.  
It would also be of great interest to further investigate the asymmetric version of this 
cyclisation to produce chiral precursors for many transformations. Finally, the use of a 
catalytic amount of iodine reagent would render this reaction more atom efficient and 
therefore more attractive. 
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 Introduction and objectives 
Hypervalent iodine reagents are largely used to replace transition-state metals in similar 
transformations. As mentioned in the introduction, they are highly electrophilic at the 
iodine centre and excellent leaving groups when bonded to an sp3 carbon. In order to 
enhance this electrophilicity further, an electron deficient iodoarene can be used.  
Use of a pyridine ring rather than a benzene ring, should improve the electrophilicity at 
the iodine centre. Indeed, the lone pair of the nitrogen is not able to increase the electron 
density of the π-electron system on the aromatic ring due to its geometry. Furthermore, 
the electron withdrawing ability of the electronegative nitrogen atom renders the aromatic 
ring more electron deficient. Therefore, the iodine atom would be more electrophilic.  
The first type of new iodine reagent that will be discussed in this chapter is represented 
in Figure 6.1. The reactivity of this non-chiral iodine(III) reagent 315 can be directly 
compared with PhI(OAc)2 to determine whether it is beneficial for the reactivity to have 
an electron poor aromatic system bonded to the iodine centre.  
 
Figure 6.1. Structure of new hypervalent iodine(III) 315. 
Lactate-based iodine(III) reagents such as 6 are well known reagents for stereoselective 
transformations. The conformational flexibility of these reagents can render the 
interaction of the oxygen or nitrogen atom with the iodine centre weaker. In the case of 
iodine(III) 33c, a strong interaction between the iodine atom and the methoxy group was 
observed (Figure 6.2).[1]  
 
Figure 6.2. Structure of different chiral hypervalent iodine(III) reagents. 
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Pyridine has the advantage that the lone pair of the nitrogen atom can coordinate with the 
iodine centre and this interaction has been reported in various publications.[2–4] If a chiral 
centre was present in the iodine(III) reagent, it would be possible to induce some 
stereoselectivity, which should be enhanced by the coordination of the pyridine ring with 
the iodine atom. In 2014, Wirth et al. designed a new iodine(III) reagent 265 with a similar 
backbone to compound 33c but bearing a pyridine moiety. With this reagent, diamination 
cyclised products could be obtained with up to 94% ee.[5]  
In this section, another pyridine-based iodine(III) reagent 316 is described and its 
reactivity and ability to induce stereoselectivity is determined. The most notable 
difference between reagent 265 and 316 is the number of atoms between the iodine centre 
and the nitrogen atom of the pyridine moiety. Comparison of these two hypervalent iodine 
reagents would reveal if the number of atoms between the iodine and the coordinating 
nitrogen is important with regards to the induction of stereoselectivity (Figure 6.3). 
 
Figure 6.3. Structure of iodine(III) reagent (S)-316. 
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 Oxidation of iodopyridine 
 4-Iodopyridine 
In order to oxidise 4-iodopyridine 317, a classical method with sodium perborate 
tetrahydrate was used. However, no oxidation occurred and the starting material was fully 
recovered (Scheme 6.1).  
 
Scheme 6.1. Attempt for the oxidation of 4-iodopyridine using NaBO3•4H2O. 
Another approach was then investigated to yield the (diacetoxy)iodopyridine compound 
315. First, it was proposed that the (dichloro)iodoarene 318 could be generated in situ 
from 4-iodopyridine in the presence of hypochlorous acid and hydrochloric acid. Under 
these acidic conditions, it was assumed that the pyridine moiety would then be protonated 
with chloride as plausible counter ion. Compound 318 would then be hydrolysed under 
basic condition using sodium hydroxide to obtain intermediate 319 which would be 
acetylated with acetic acid. However, no traces of oxidised iodine reagent 315 was 
observed in the crude mixture. Therefore, the first step of this sequence maybe did not 
give the (dichloro)iodopyridine derivative 318 making this route inefficient for the 
synthesis of (diacetoxy)iodopyridine 315 (Scheme 6.2). 
 
Scheme 6.2. Attempt for the oxidation of 4-iodopyridine using HClO. 
It was suspected that an oxidant may also react with the nitrogen atom. Therefore, the 
pyridine moiety was methylated prior to the oxidation. The N-methylated product 320 
was synthesised following a known procedure.[6] After reaction with iodomethane in 
tetrahydrofuran, the desired product was observed with 53% conversion.  
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Table 6.1. Methylation of 4-iodopyridine. 
Entry MeI (eq.) Solvent Yielda [%] 
1 2 THF (53) 
2 31 - 95 (100) 
a The yield reported is the isolated yield, the consumptions of starting 
materials (called conversion in the text) are shown in brackets. 
In order to improve the conversion of this transformation, iodomethane was used in a 
larger amount and the reaction was stirred in neat iodomethane overnight. Product 320 
was isolated in 95% yield. 
The oxidation of compound 320 was first attempted using m-CPBA and acetic acid in a 
mixture of dichloromethane and 2,2,2-trifluoroethanol (TFE). After evaporation of the 
solvent, which was red coloured, a new compound 321 was formed with 28% conversion 
(Table 6.2, Entry 1). However, this product was not the desired oxidised hypervalent 
iodine reagent. Elucidation of this unknown species is described below. 
Other oxidants were also investigated for the oxidation of 4-iodopyridinium 
derivative 320. Oxone®, Selectfluor®, peracetic acid and fuming nitric acid in 
trifluoroacetic anhydride did not yield any new product as judged by the crude 1H NMR 
(Table 6.2, Entries 2-5). However, a similar red-coloured solvent was evaporated after 
the reaction. Xenon difluoride is known to oxidise iodoarenes to their corresponding 
difluoroiodoarene. However, in this case, the reaction with xenon difluoride did not lead 
to any oxidised product (Table 6.2, Entry 6). Due to the possible instability of the 
generated hypervalent iodine reagent, the in situ generation of the hypervalent iodine 
moiety and its direct use for the α-fluorination of a ketone (propiophenone) was also 
investigated. However, no fluorination reaction occurred and the starting materials were 
recovered, suggesting no formation of the desired oxidised species. 
The same unknown product 321 was observed in 86% conversion when compound 320 
was treated with sodium perborate tetrahydrate at room temperature (Table 6.2, Entry 7). 
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Finally, an iodine(V) reagent, NaIO4 was used to oxidise molecule 320. However, no 
product was observed with this method (Table 6.2, Entry 8). 
 
Table 6.2. Optimisation of the oxidant for the oxidation of compound 320. 
Entry Oxidant (eq.) Solvent 
Time 
[h] 
Conversiona 
[%] 
1 m-CPBA (1) 
CH2Cl2/TFE (1:1) 
+ AcOH (12 eq.) 
5 28 
2 Oxone® (1) CHCl3/AcOH (1:1) 5 n.r. 
3 Selectfluor® (5) CH3CN/AcOH (3.2:1) 5 n.r. 
4 Peracetic acid - 24 n.r. 
5 TFAA (6), HNO3 (2) - 96 n.r. 
6 XeF2 (1) CH2Cl2 24 n.r. 
7 NaBO3•4H2O (10) AcOH 5 86 
8b 
NaIO4 (1), 
AcONa•H2O (2.2) 
AcOH/Ac2O (10:1) 2 n.r. 
n.r. = no reaction; a Consumptions of starting materials (called conversion in the text) were measured in the 
crude 1H NMR. b The reaction was stirred at reflux instead of room temperature. 
The red colour of the evaporated solution in each reaction could be due to some iodine I2 
in solution. In the crude 1H NMR, a high field shift of the two doublets of the aromatic 
protons (7.62 and 6.11 ppm) indicates a possible bond with an electron donating group 
such as an oxygen- or nitrogen- containing moiety instead of the iodine. The pyridine was 
still methylated as indicated by a peak at 3.62 ppm. This signal was also shifted high field 
compared to that of the starting material 320. The tendency to have a lower chemical shift 
compared to the iodopyridinium species 320 is not the right one for a hypervalent iodine 
compound. Usually, these reagents are shifted downfield when they are oxidised. 
13C NMR data also confirmed the presence of a carbonyl peak in the structure and only 
two aromatic carbon shifts were observed. The proposed structure for this compound is 
1-methylpyridin-4(1H)-one 321. A plausible mechanism for the formation of this 
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compound is shown in Scheme 6.3. First, an acetate moiety is added onto the pyridinium 
ring via an SNAr pathway. Indeed, the para position of the nitrogen atom is now much 
more electrophilic as the pyridine is methylated and therefore, positively charged. After 
the cleavage of the iodide anion, assisted by the nitrogen lone pair, the acetate moiety 323 
can be deprotected by a nucleophile (water, acetic acid…) to liberate the intermediate 
321’ which is a mesomeric form of compound 321. 
 
Scheme 6.3. Plausible mechanism for the formation of 1-methylpyridin-4(1H)-one 321 from compound 320.  
However, some parts of the mechanism are still not very clear and not in accordance with 
the experimental observation. First, there is the question of which is the first nucleophile 
for the SNAr reaction. It can be either the oxidant or the acetic acid. However, if only the 
acetic acid acts as the nucleophile, the reaction should proceed for all the reactions where 
acetic acid was present. Second, the red colour of the distillate suggested the formation 
of iodine I2. This suggests that the iodide I
- has been oxidised during the reaction. 
In order to better understand the mechanism of this reaction and especially why sodium 
perborate tetrahydrate is much more reactive than other oxidants, the reactivity of this 
reagent was investigated. Sodium perborate tetrahydrate is actually a disodium salt of a 
1,4-diboratetroxane dianion 324 surrounded by 6 molecules of water as shown in 1961 
by Hansson (Figure 6.4).[7]  
 
Figure 6.4. Structure of sodium perborate tetrahydrate as disodium salt of a 1,4.-diboratetroxane dianion 324. 
In the presence of acetic acid, sodium perborate reacts slightly differently to generate the 
more reactive peracetoxyboron species, by a sequence of equilibria and reactions as 
shown in Scheme 6.4.[8] McKillop and Sanderson reported that this species was probably 
more reactive than peracetic acid. 
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Scheme 6.4. Mechanism for the formation of peracetoxyboron species from the reaction of sodium perborate 
and acetic acid. 
The peracetoxyboron species can probably be present in solution as intermediate 330 
which is a good nucleophile. Therefore, it can add onto the aryl ring of molecule 320 via 
an SNAr to yield intermediate 331. The free iodide I
-
 can then cleave off the iodine 
attached to the ring, generating iodine I2. The formation of iodine would explain the red 
coloured distillate observed after the reaction. Then, the cleavage of iodine leads to the 
desired product 321 after elimination of the acetate moiety (Scheme 6.5).  
 
Scheme 6.5. Second plausible mechanism for the formation of product 321 using sodium perborate. 
This mechanism still does not explain why the reaction works with m-CPBA but not with 
peracetic acid. However, it is maybe a first step in the understanding of the reaction 
mechanism, especially concerning sodium perborate. 
The best results for the formation of compound 321 were obtained with sodium perborate 
tetrahydrate. In order to see if the formation of this product 321 can be avoided, different 
temperatures and reaction times were investigated. The results are combined in Table 6.3. 
Increasing the temperature to 55 °C led to a very low conversion of 24% to product 321 
(Table 6.3, Entry 2). The reaction time was then modified to show the evolution of the 
conversion into product 321 and to check if other products were formed, depending on 
the reaction time. The conversion increased over time to get to its maximum after 5 hours 
(86%) before decreasing drastically to 17% after 65 hours of reaction. 
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Table 6.3. Effect of the temperature and the reaction time on the formation of product 321. 
Entry 
T 
[°C] 
Time 
[h] 
Conversiona 
[%] 
1 r.t. 5 86 
2 55 5 24 
3 r.t. 1 56 
4 r.t. 3 51 
5 r.t. 65 17 
a Consumptions of starting materials (called 
conversion in the text) were measured by 1H NMR. 
The effect of the counter ion was also investigated. Therefore, 4-iodopyridine was 
methylated using dimethylsulfate to obtain the iodopyridinium derivative 332 in 
83% yield (Scheme 6.6). 
 
Scheme 6.6. N-methylation of 4-iodopyridine with dimethylsulfate. 
Compound 332 was then treated with two different oxidants, sodium perborate 
tetrahydrate and peracetic acid. Again, no hypervalent iodine reagent was observed but 
the same product 321 was obtained in 35% conversion with sodium perborate. A similar 
red-coloured solution was again evaporated, which suggests the formation of iodine. 
However, no product was formed with peracetic acid and the starting material was 
completely recovered (Scheme 6.7).  
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Scheme 6.7. Oxidation of compound 332. 
Finally, hypervalent iodine reagent can also be synthesised by ligand exchange of an 
iodoarene with another hypervalent iodine reagent such as Koser’s reagent 
[PhI(OH)OTs]. The reaction of compound 320 with one equivalent of Koser’s reagent 
led to a simple counter ion exchange to yield molecule 333 in 95% yield (Scheme 6.8). 
The addition of a second equivalent of Koser’s reagent did not change the course of the 
reaction. 
 
Scheme 6.8. Reaction of compound 320 with Koser’s reagent. 
The fact that the pyridine was methylated completely changed the electronic properties 
of the iodoarene substrate and this was detrimental for the oxidation of the iodoarene to 
a hypervalent iodine reagent.  
 3-Iodopyridine 
In order to understand slightly better the mechanism for the formation of compound 321 
and the role that the nitrogen atom plays in this reaction, molecule 335 was synthesised. 
The same procedure was used to methylate 3-iodopyridine and the corresponding product 
335 was obtained in 91% yield (Scheme 6.9). 
 
Scheme 6.9. N-methylation of 3-iodopyridine. 
The oxidation reaction was then performed using the best conditions used for the 
4-iodopyridinium derivative 320. However, no reaction occurred and the starting material 
335 was recovered. Fuming nitric acid in trifluoroacetic anhydride also did not mediate 
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the oxidation of the iodine to the desired hypervalent iodine compound 336 (Scheme 
6.10). 
 
Scheme 6.10. Attempt for the oxidation of molecule 335 with sodium perborate. 
The product of an SNAr was not observed which was expected. Indeed, the 
ipso-substitution cannot occur in this case as the carbon centre is in the meta-position to 
the positively charged nitrogen atom. Furthermore, by methylating the nitrogen atom of 
the pyridine, the electron properties of the iodoarene are changed. Therefore, the 
oxidation reaction was performed directly with 3-iodopyridine using m-CPBA. Only the 
pyridine N-oxide 337 was observed in the crude mixture and was isolated in 80% yield 
(Scheme 6.11).  
A second equivalent of m-CPBA was then added to further oxidise the pyridine N-oxide 
derivative 337 to the corresponding hypervalent iodine reagent. Acetic acid was also 
added after stirring the reaction overnight in order to yield (diacetoxy)iodoarene 
derivative. However, the desired product was not observed in the crude mixture as no 
acetate peak was present in the 1H NMR data. Nonetheless, the m-CPBA was reduced to 
its corresponding carboxylic acid (confirmed by mass spectrometry, and NMR data). This 
means that something else was oxidised and therefore, the iodosoarene derivative 338 
was proposed as the product of the oxidation reaction. In the mass spectra, the molecular 
peak of compound 338 was not found but the hypervalent bond is usually cleaved under 
the ionisation conditions and therefore, it is not surprising that only an m/z value 
corresponding to the iodine(I) derivative 337 was observed in the MS data. 
 
Scheme 6.11. Oxidation of 3-iodopyridine with m-CPBA. 
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It was also possible to yield the same product 338 directly from 3-iodopyridine 334 by 
adding 2.5 equivalents of m-CPBA. However, this reaction led to much more degradation 
and formation of other unidentified products. 
The easiest way to confirm that compound 338 was an iodine(III) reagent was to use this 
reagent in a reaction where hypervalent is commonly employed to mediate the 
transformation. The diacetoxylation of styrene was chosen. Pyridine N-oxide 337 was 
oxidised in situ using m-CPBA, prior to the addition of styrene (Scheme 6.12). No desired 
mono- or diacetoxylated product was observed in the crude mixture. However, compound 
338 was fully recovered and traces amount of the epoxide 340 was generated. This is 
probably due to the slight excess of m-CPBA which reacted directly with styrene. 
Therefore, there is no clear evidence for the formation of any hypervalent iodine reagent. 
 
Scheme 6.12. Attempt of diacetoxylation of styrene 339 mediated by reagent 338. 
 Conclusion 
The electronic properties of the iodoarene were completely changed when a pyridine ring 
was used compared to a phenyl group. In the case of the 4-iodopyridine, no oxidation 
occurred in the presence of a classical oxidant (NaBO3•4H2O) to generate hypervalent 
iodine reagents. However, 3-iodopyridine was selectively oxidised to the pyridine 
N-oxide derivative 337 using 1.1 equivalent of m-CPBA and was further oxidised using 
another 1.1 equivalent of the same oxidant.  
This change in reactivity compared to iodobenzene was even stronger with the methylated 
pyridine derivatives. While the 3-iodopyridinium compound 335 did not lead to any 
products in the presence of sodium perborate tetrahydrate, the 4-iodopyridinium 
derivatives showed the formation of product 321 after cleavage of the iodide, which was 
oxidised to I2. 
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Due to the change of electron density induced by methylation, the iodine centre would no 
longer be electrophilic and therefore, this type of reagent would probably not be more 
efficient that the parent iodobenzene and other hypervalent iodine derivatives.  
Another strategy was then considered. As the pyridine cannot be the centre core of the 
reagent, it might be interesting to install this aryl system on the side chain of an iodoarene, 
which would lead to a possible coordination with the iodine centre and therefore, to some 
selectivity. This strategy is explained in the next section. 
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 Synthesis of a new chiral hypervalent iodine(III) reagent 
 Synthesis 
The proposed synthesis of the new iodine(III) reagent 316 looked straightforward with a 
Mitsunobu reaction between 2-iodophenol and the corresponding alcohol 342, followed 
by the oxidation of the iodoarene 344 to the iodine(III) reagent 316.  
Prior to the Mitsunobu reaction, the alcohol (rac)-342 was synthesised by reduction of 
2-acetylpyridine 341 using sodium borohydride. The desired product was obtained in 
98% yield (Scheme 6.13). 
 
Scheme 6.13. Reduction of 2-acetylpyridine 341. 
The Mitsunobu was then performed with (rac)-342 and 2-iodophenol 343 using standard 
conditions and the corresponding product (rac)-344 was synthesised in 68% yield 
(Scheme 6.14). An excess of the pyridine derivatives was used to increase the conversion 
and to avoid that any 2-iodophenol remained in the reaction mixture. Indeed, 
2-iodophenol had the same Rf in the TLC (thin layer chromatography) as 344 and any 
leftover would render the purification difficult. 
 
Scheme 6.14. Mitsunobu reaction on iodophenol with (rac)-342 for the synthesis of compound (rac)-344. 
With this encouraging result, the chiral iodoarene reagent (S)-344 was synthesised using 
the same methodology. The (R)-342 substrate, which is commercially available, was used 
together with 2-iodophenol in the Mitsunobu reaction and the desired product (S)-344 
was obtained in 86% yield and with 91% ee (Table 6.4, Entry 1). As the Mitsunobu 
reaction proceeds with an inversion of configuration, the (S)-isomer was assumed to be 
the major product of the reaction. However, the enantioselectivity in the final product was 
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not very high. Therefore, the reaction was performed at lower temperature (0 °C) to see 
if there would be an improvement in the enantioselectivity. The reaction proceeded 
similarly well with 85% yield but the enantioselectivity remained unchanged with 91% ee 
(Table 6.4, Entry 2).  
 
Table 6.4. Effect of the temperature on the enantioselectivity of the Mitsunobu reaction. 
Entry 
Temperature 
[°C] 
Time 
[h] 
Yielda 
[%] 
ee 
[%] 
1 r.t. 18 86 91 
2 0 46 85 91 
a The yields reported are the isolated yields. 
In order to understand the reason of this low selectivity, a few experiment were 
undertaken. The first one was to check if the product (S)-344 was racemising over time. 
The enantiomeric excess of the iodoarene was measured again after two weeks of storage 
at room temperature and under air but no change in the ee was observed (still 91% ee). 
The second option was that the starting material was not as pure as stated on the bottle of 
the commercially available (R)-342. Therefore, the enantioselectivity was checked by 
HPLC and it was only of 85% ee (97% written on the bottle). The higher 
enantioselectivity of the product compared to the one of the starting material was not 
obvious to understand. A kinetic study was performed to see if one of the enantiomers 
(S)-342 or (R)-342 was reacting faster than the other one, therefore explaining the slightly 
higher selectivity of the product. The Mitsunobu reaction was performed with 
1.1 equivalents of the pyridine moiety 342 and different samples were taken at several 
stages of the reaction. Each time, the sample was passed through a silica plug to remove 
any triphenylphosphine oxide and the solvent was evaporated. The enantioselectivity was 
then measured by HPLC for each sample and the consumptions of starting material was 
also measured by 1H NMR. All the results are summarised in the graph below (Figure 
6.5). 
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Figure 6.5. Evolution of the consumptions of starting material (called conversion in the text) and the 
enantioselectivity during the Mitsunobu reaction. 
In this graph, the enantioselectivity is pretty constant at around 90% ee until 8 hours of 
reactions. However, the selectivity dropped to 86% ee after 26 h of reaction. However, 
this decrease in selectivity could be attributed to the experimental error of the 
measurement by HPLC. Concerning the conversion, the reaction was quite fast as after 
only 2 hours, the desired product was observed with 85% conversion. Full conversion 
into the desired product was measured in the crude NMR. The pyridine reagent 342 was 
used in slight excess (1.1 equivalents) which mean that a maximum of 90% conversion 
can be due to the (R)-isomer. The slightly higher enantioselectivity observed in the 
product 344 compared to the one of the starting material 342 can maybe be due to an 
asymmetric amplification[9] but an experimental error of the instrument cannot be 
excluded. 
The next step to synthesise this novel iodine(III) reagent was to oxidise the iodoarene (S)-
344. A well-known oxidant for this transformation is sodium perborate tetrahydrate. 
However, for this iodoarene substrate, the desired product 316 was only formed in 
40% conversion (Table 6.5, Entry 1). Selectfluor® was used instead in a mixture of 
acetonitrile and acetic acid and the desired product was obtained in 92% yield (Table 6.5, 
Entry 2). 
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Table 6.5. Oxidation of iodoarene (S)-344. 
Entry 
Oxidant 
(eq.) 
Solvent 
Temperature 
[°C] 
Time 
[h] 
Yielda 
[%] 
1 NaBO3•4H2O AcOH 45 7 (40) 
2 Selectfluor® CH3CN/AcOH (3.2:1) r.t. 24 92 (100) 
a The yields reported are the isolated yields; the consumptions of starting materials measured by 1H NMR 
(called conversion in the text) are shown in brackets. 
The enantiopurity of the iodine(III) reagent was assumed to be of 91% (the same as the 
iodoarene (S)-344). This induces some limitations for enantioselective transformations, 
however, the reagent could still be tested in different known reactions to verify its 
efficiency. If the reagent shows promising results, the enantiopurity of the reagent could 
be improved by using a starting material with a higher enantiomeric excess. This alcohol 
can be synthesised by the selective reduction of 2-acetylpyridine using, for example, a 
chiral rhodium[10] or iron[11] catalyst. 
As iodine(III) reagent 316 is a solid compound, recrystallisation was attempted in order 
to see if there was any interaction in the solid state between the nitrogen atom of the 
pyridine moiety and the iodine centre. This was successfully performed on (rac)-316 by 
dissolving it in dichloromethane and overlaying it with hexane for a slow evaporation. 
The crystal structure is shown in Figure 6.6. In each elementary cell, two molecules of 
(R)-316 and two molecules of (S)-316 were crystallised together.  
 
Figure 6.6. Crystal structure of (rac)-316.  
Florence Malmedy Synthesis of new hypervalent iodine(III) reagents 
139 
 
In this crystal structure, the nitrogen atom of the pyridine moiety is not interacting with 
the iodine centre. This observation in the solid state suggested that the reagent may not 
be efficient for inducing an enantioselective reaction. However, compound 316 may 
behave differently in solution than in its crystal form. The reactivity and the selectivity of 
this new reagent (S)-316 was investigated in different typical reactions, usually mediated 
by hypervalent iodine reagents. The results are described in the section below. 
 Evaluation of the reactivity and the selectivity of reagent (S)-316 
The first transformation investigated with hypervalent iodine (S)-316 was the 
rearrangement of propiophenone 29a described in chapter 3. As mentioned in this chapter, 
the 1,2-aryl migration proceeded well with 90% conversion and 69% isolated yield. 
However, the selectivity was low with only 15% ee (Scheme 6.15). Furthermore, this 
iodine(III) reagent mediated the reaction with a much lower selectivity than the Ishihara 
amide 6b. The same reaction was also performed at 0 °C to improve the 
enantioselectivity. However, product 163a was obtained in similar yield 
(87% conversion, 65% yield) and with 14% ee. This demonstrates the low impact of the 
temperature on the selectivity of this migration reaction. 
 
Scheme 6.15. Rearrangement of propiophenone 29a using iodine(III) reagent (S)-316. 
Wirth et al. described the rearrangement of chalcone derivatives 345 into compounds 
346.[12] With the Ishihara amide 6b as the iodine(III) reagent and TMSOTf as the 
activating agent, the rearranged product 346 was obtained in 80% yield and with 86% ee. 
With reagent (S)-316, the same product 346 was isolated in the same yield (80%). 
However, the selectivity induced by the reagent (S)-316 was much lower with 26% ee 
(Scheme 6.16). 
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Scheme 6.16. Rearrangement of chalcone 345 using iodine(III) reagent (S)-316. 
Very recently, the enantioselective rearrangement of 1,1-disubstituted alkenes was 
described by Wirth et al.[13] Substrate 347 was investigated and the corresponding 
α-arylated ketones 348 was obtained in 87% yield and with 94% ee. The catalytic 
transformation is currently under optimisation and catalyst (S)-344 was considered for 
the mediation of the migration. With m-CPBA as the internal oxidant and p-TsOH•H2O 
to activate the iodine(III) compound generated in situ, the α-arylated ketone 348 was 
obtained in 23% conversion and with 6% ee. However, ketone 348 was not the major 
product but instead, product 349 was observed in 55% conversion. Nevertheless, the 
selectivity induced by catalyst (S)-344 was very poor compared to other iodine catalysts 
which could mediate the rearrangement with up to 75% ee (Scheme 6.17). 
 
Scheme 6.17. Catalytic rearrangement mediated by iodoarene (S)-344. 
The oxidation of thioanisole was also studied using iodine(III) reagent (S)-316. Following 
Koser’s method,[14] (methylsulfinyl)benzene 351 was successfully synthesised in 90% 
yield using chiral reagent (S)-316 (Table 6.6, Entry 2). However, product 351 was 
obtained as a racemate.  
In order to improve the selectivity, the temperature was lowered down to -78 °C. At this 
temperature, the reaction should be slower and therefore, chiral reagent (S)-316 would 
have more time to interact with the substrate and induce some chirality in the product 
generated. The reaction proceeded similarly well and the desired oxidised product 351 
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was obtained in 94% yield but the selectivity was almost none (2% ee) (Table 6.6, 
Entry 3).  
 
Table 6.6. Oxidation of thioanisole 350 using iodine(III) reagent 316. 
Entry Iodine(III) 
Temperature 
[°C] 
Time 
[h] 
Yielda 
[%] 
ee 
[%] 
1 (rac)-316 r.t. 2 93 - 
2 (S)-316 r.t. 2 90 0 
3 (S)-316 -78 1 94 2 (R) 
a The yields reported are the isolated yields.  
The α-oxytosylation of propiophenone was also performed using iodine(III) reagent 
(S)-316. Substrate 227 was used instead of propiophenone as it had previously shown 
better enantioselectivity.[15] Following the procedure published by Legault et al., the 
reaction of the vinyl acetate derivative 227 with reagent (S)-316 in the presence of 
p-TsOH•H2O proceeded with moderate yield (63% yield). However, the 
enantioselectivity induced by the chiral reagent was low (6% ee) (Scheme 6.18). 
 
Scheme 6.18. α-Oxytosylation of compound 227 using iodine(III) reagent (S)-316. 
Legault et al. also described the catalytic oxytosylation of substrate 227 using a 
lactate-based iodoarene, m-CPBA as the internal oxidant and p-TsOH•H2O to activate the 
in situ generated iodine(III) reagent.[16,17] Under these conditions, the α-oxytosylated 
ketone 30a was obtained in 49% yield and with 83% ee.[17] The reaction was directly 
compared with the novel iodine(III) reagent using iodoarene (S)-344 and the same 
reaction conditions described by Legault et al. The corresponding α-oxytosylated ketone 
30a was isolated in higher yield (69%) but with low enantioselectivity (7% ee) (Scheme 
6.19). 
Florence Malmedy Synthesis of new hypervalent iodine(III) reagents 
142 
 
 
Scheme 6.19. Catalytic α-oxytosylation of 227 using iodoarene (S)-344. 
Finally, the diacetoxylation of styrene was investigated using reagent (S)-344 and 
following the method described by Muñiz et al. in 2016.[18] The iodoarene (S)-344 was 
first oxidised in situ using peracetic acid in acetic acid to generate the iodine(III) reagent 
which was activated with triflic acid. This was then followed by the addition of styrene 
to obtain a dioxygenated intermediate which was then fully acetoxylated with acetic 
anhydride to yield diacetoxylated product 352 in 37% yield. However, the iodine reagent 
316 did not induce any stereoselectivity for this transformation (Scheme 6.20).  
 
Scheme 6.20. Diacetoxylation of styrene 339 using iodoarene 344. 
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 Conclusion and future work 
The oxidation of 3- and 4-iodopyridine to hypervalent iodine reagent was attempted. 
However, no desired product was observed in the crude mixture. The oxidation of 
3-iodopyridine led to the formation of 3-iodopyridine N-oxide 337, while the 
4-iodopyridinium derivative 320 yielded product 321 after cleavage of the carbon-iodine 
bond. 
Another approach was then considered and the synthesis of a novel chiral iodine(III) 
reagent (S)-316 was described. Its reactivity and selectivity was investigated. The reagent 
mediated transformations in similar yield to those described in the literature. However, 
the enantioselectivity remained low. This trend might be explained by the lack of 
interaction between the nitrogen atom of the pyridine moiety and the hypervalent iodine 
centre, as observed in the crystal structure. Indeed, without this interaction, the chain can 
freely rotate which means that no high enantioselectivity can be obtained.  
Modifications to the chain such as its length, the nature of the heteroatoms and their 
position in the chain, and also production of a C2-symmetric reagent could improve the 
selectivity of this pyridine-based reagent whilst maintaining a good reactivity. Another 
possibility is to install a CF3 moiety in the para position of the iodine centre such as in 
compound 353. The hypervalent iodine reagent generated should be more electrophilic 
and therefore, more reactive (Figure 6.7).  
 
Figure 6.7. Structure of hypervalent iodine reagent 353. 
Florence Malmedy Synthesis of new hypervalent iodine(III) reagents 
144 
 
 References 
[1] U. H. Hirt, M. F. H. Schuster, A. N. French, O. G. Wiest, T. Wirth, Eur. J. Org. 
Chem. 2001, 1569–1579. 
[2] T. Suefuji, M. Shiro, K. Yamaguchi, M. Ochiai, Heterocycles 2006, 67, 391–397. 
[3] T. P. Pell, S. A. Couchman, S. Ibrahim, D. J. D. Wilson, B. J. Smith, P. J. Barnard, 
J. L. Dutton, Inorg. Chem. 2012, 51, 13034–13040. 
[4] V. V. Grushin, T. M. Shcherbina, T. P. Tolstaya, J. Organomet. Chem. 1985, 292, 
105–117. 
[5] P. Mizar, A. Laverny, M. El-Sherbini, U. Farid, M. Brown, F. Malmedy, T. Wirth, 
Chem. Eur. J. 2014, 20, 9910–9913. 
[6] A. K. Y. Lam, C. Li, G. Khairallah, B. B. Kirk, S. J. Blanksby, A. J. Trevitt, U. 
Wille, R. A. J. O’Hair, G. da Silva, Phys. Chem. Chem. Phys. 2012, 14, 2417–
2426. 
[7] A. Hansson, Acta Chem. Scand. 1961, 15, 934–935. 
[8] A. McKillop, W. R. Sanderson, Tetrahedron 1995, 51, 6145–6166. 
[9] C. Girard, H. B. Kagan, Angew. Chem. Int. Ed. 1998, 37, 2922–2959. 
[10] H. Yang, N. Huo, P. Yang, H. Pei, H. Lv, X. Zhang, Org. Lett. 2015, 17, 4144–
4147. 
[11] R. Bigler, A. Mezzetti, Org. Process Res. Dev. 2016, 20, 253–261. 
[12] U. Farid, F. Malmedy, R. Claveau, L. Albers, T. Wirth, Angew. Chem. Int. Ed. 
2013, 52, 7018–7022. 
[13] M. Brown, R. Kumar, J. Rehbein, T. Wirth, Chem. Eur. J. 2016, 22, 4030–4035. 
[14] D. G. Ray, G. F. Koser, J. Am. Chem. Soc. 1990, 112, 5672–5673. 
[15] B. Basdevant, C. Y. Legault, J. Org. Chem. 2015, 80, 6897–6902. 
[16] A.-A. Guilbault, B. Basdevant, V. Wanie, C. Y. Legault, J. Org. Chem. 2012, 77, 
11283–11295. 
[17] B. Basdevant, C. Y. Legault, Org. Lett. 2015, 17, 4918–4921. 
Florence Malmedy Synthesis of new hypervalent iodine(III) reagents 
145 
 
[18] S. Haubenreisser, T. H. Wöste, C. Martínez, K. Ishihara, K. Muñiz, Angew. Chem. 
Int. Ed. 2016, 55, 413–417. 
Florence Malmedy Experimental Part 
146 
 
  
 Experimental Part 
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 General considerations 
The reactions were performed using standard laboratory equipment. All air sensitive 
reactions were carried out under argon or nitrogen atmosphere using oven dried 
glassware. All reaction were stirred using a stirrer plate and a magnetic stirrer bar and 
heating if necessary over a hotplate with a temperature probe control and an adapted 
heating block.  
Lower temperatures were obtained using ice/water bath (0 °C), liquid 
nitrogen/acetonitrile bath (-40 °C), dry ice/acetone bath (-78 °C) or using a chiller 
(0 to -20 °C). 
Büchi B-461, B-481 or B-490 were used for solvent evaporations (reduced pressure up to 
15 mbar) and a high vacuum instruments was used to further dry the products except 
when the compounds were volatile.  
A Büchi GKR-50 Kugelrohr distillation instrument was employed for Kugelrohr 
distillations.  
Dry diethyl ether, tetrahydrofuran, toluene and acetonitrile were collected from a solvent 
purification system (SPS) from the company M BRAUN (MB SPS-800). Dry 
dichloromethane was distilled over calcium hydride under nitrogen atmosphere. Other 
dry solvents and chemicals were purchased from Sigma Aldrich, Alfa Aesar, Acros 
Organic, FluoroChem or TCI UK and were used without further purification. 
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 Chromatographic Methods 
 Thin-layer chromatography (TLC) 
All reactions were monitored by thin-layer chromatography (TLC) which was performed 
on precoated aluminium sheets of Merck silica gel 60 F254 (0.20 m) and visualised by 
UV radiation (254 nm) or/and by staining with ceric ammonium molybdate solution 
(235 mL distilled H2O, 12 g ammonium molybdate, 0.5 g ceric ammonium molybdate, 
15 mL concentrated sulfuric acid), potassium permanganate solution (1.5 g KMnO4, 10 g 
K2CO3, 1.25 mL 10% NaOH, 200 mL distilled H2O) or iodine. 
 Column Chromatography 
7.2.2.1. Manual column chromatography 
Manual column chromatography was performed using silica gel 60 (Merck, 
230-400 mesh) under increased pressure (Flash Chromatography) or as gravitational 
column chromatography. The solvents used for the purification are indicated in the text 
and were purchased from Fisher Scientific as laboratory grade.  
7.2.2.2. Automated column chromatography (Biotage) 
Automated column chromatography was performed on a Biotage® Isolera Four using 
some Biotage® cartridges SNAP Ultra 10 g, SNAP Ultra 25 g, SNAP Ultra 50 g, SNAP 
Ultra 100 g, Telos® 12 g and Telos® 20 g. The solvents used for the purification are 
indicated in the text and were purchased from Fisher Scientific as laboratory grade.  
 High Pressure Liquid Chromatography (HPLC) 
The HPLC measurements were carried out on a Shimadzu instrument. The different 
modules were SIL-10ADVP (auto injector), LC-10ATVP (liquid chromatograph), 
FCV-10ALVP (pump), DGU-14A (degasser), CTO-10ASVP (column oven), 
SCL-10AVP (system controller) and SPD-M10A (diode array detector). The solvents 
used were hexane and 2-propanol and were bought from Fischer scientific as HPLC 
grade. The chiral columns used for the separation of the enantiomers were Daicel 
Chiralcel OD-H (0.46 cm Ø x 25 cm), Daicel Chiralcel OJ (0.46 cm Ø x 25 cm), Daicel 
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Chiralcel OB-H (0.46 cm Ø x 25 cm), YMC Chiral Amylose-C S-5µm (0.46 cm Ø x 
25 cm) and Regis® Pirkle Covalent (R,R) Whelk-O 1 (0.46 cm Ø x 25 cm).  
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 Physical Data 
 1H NMR Spectroscopy 
1H NMR spectra were measured on Bruker DPX 500 (500 MHz), Bruker DPX 400 
(400 MHz), Bruker DPX 300 (300 MHz) and Bruker DPX 250 (250 MHz) instruments. 
The chemical shifts δ are given in ppm downfield of tetramethylsilane (δ = 0 ppm). 
Compounds and crude reaction mixtures were dissolved in either deuterated chloroform, 
deuterated methanol or deuterated dimethylsulfoxide. Coupling constants (J) are given in 
Hertz. The multiplicity of signals is designated: s = singlet, d = doublet, t = triplet, q = 
quartet, quin = quintet, sept = septet, dt = doublet of triplet, td = triplet of doublet, bs = 
broad singlet, m = multiplet. Residual solvent peaks are 7.26 ppm for chloroform, 
3.31 ppm for methanol and 2.54 ppm for dimethylsulfoxide. 
 13C NMR Spectroscopy 
13C NMR spectra were measured on Bruker DPX 500 (125 MHz), Bruker DPX 400 
(100 MHz) and Bruker DPX 300 (75 MHz) instruments. The chemical shifts δ are given 
in ppm downfield of tetramethylsilane (δ = 0 ppm). Compounds and crude reaction 
mixtures were dissolved in either deuterated chloroform, deuterated methanol or 
deuterated dimethylsulfoxide. Coupling constants (J) with fluorine are given in Hertz. 
The multiplicity of signals is designated: d = doublet, q = quartet. Residual solvent peaks 
are 77.16 ppm for chloroform, 49.00 ppm for methanol, 39.52 ppm for dimethylsulfoxide.  
 19F NMR Spectroscopy 
19F NMR spectra were measured on Jeol Eclipse 300 (283 MHz) instrument. The 
chemical shifts δ are given in ppm. 
 Mass Spectrometry 
Mass spectrometric measurements were performed by the EPSRC Mass Spectrometry 
Service Centre, Swansea University or by R. Jenkins/R. Hick/S. Waller at Cardiff 
University. Ions were generated by the atmospheric pressure chemical ionisation (APCI), 
Electrospray (ES) or Electron Ionisation (EI). Mass fragments usually are in atomic mass 
units per elementary charges (m/z) with relative abundance of ion in percentage (%). The 
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high resolution mass spectrometry (HRMS) for most of the compounds was carried out 
at EPSRC Mass Spectrometry Service Centre, Swansea University. The molecular ion 
peak values quoted for either molecular ion [M]+, molecular ion plus hydrogen [M+H]+, 
molecular ion plus ammonium ion [M+NH4]
+ or molecular ion plus sodium [M+Na]+.  
 IR Spectroscopy 
IR spectra were recorded on a Shimadzu IR Affinity-1S instrument. Wavenumbers are 
quoted in cm-1. All compounds were measured neat directly on the crystal of the IR 
machine. 
 Melting Points 
Melting points were measured using a Gallenkamp variable heater with samples in open 
capillary tubes.  
 Optical Rotation 
Optical rotation were measured with a SCHMIDT and HAENSCH UniPol L polarimeter 
at 20 °C in a cuvette of 50 mm length with a sodium light (589.30 nm). HPLC grade 
chloroform was used to prepare the solution and the concentration is indicated in the data 
section. 
 X-Ray Crystallography 
Single-crystal XRD data were collected on an Agilent SuperNova Dual Atlas 
diffractometer with a mirror monochromator (using either Cu (= 1.5418 Å) or Mo 
( = 0.7107 Å) radiation), equipped with an Oxford cryosystems cooling instrument. 
Crystal structures were solved and refined using SHELX. Non-hydrogen atoms were 
refined with anisotropic displacement parameters. Hydrogen atoms were inserted in 
idealised positions, and a riding model was used with Uiso set at 1.2 or 1.5 times the value 
of Ueq for the atom to which they are bonded. 
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 Experimental data 
 Synthesis of common iodine(III) reagents 
(Diacetoxyiodo)benzene DIB 
 
To a solution of iodobenzene (2.75 mL, 25.4 mmol) in acetic acid (250 mL), sodium 
perborate tetrahydrate (37.7 g, 254 mmol) was added over 15 minutes. The resulting 
mixture was then heated at 50 °C for 3 h. After removing the acetic acid under vacuum, 
water (100 mL) was added. The organic phase was extracted with CHCl3 (3 x 100 mL), 
dried over MgSO4 and concentrated under vacuum. Hexane (30 mL) was added to 
precipitate the pure product as a white powder (90% yield, 7.09 g, 24.5 mmol).  
The spectroscopic data are in agreement with literature.[1] m.p. = 161 - 164 °C (lit.[1] 
162 - 163 °C) 1H NMR (300 MHz, CDCl3): δ = 8.10 – 8.08 (m, 2H, H-Ar), 7.61 – 7.58 
(m, 1H, H-Ar), 7.54 – 7.47 (m, 2H, H-Ar), 2.01 (s, 6H, 2 CH3) ppm. 
 [Bis(trifluoroacetoxy)iodo]benzene PIFA 
 
To a solution of iodobenzene (2.0 mL, 17.9 mmol) in trifluoroacetic acid (20 mL), 
Oxone® (11.0 g, 17.9 mmol) was added. The resulting mixture was stirred at room 
temperature for 3 h. The solvent was then evaporated and chloroform (20 mL) was added. 
The resulting precipitate was filtered and the filtrate was concentrated under vacuum. 
After recrystallisation (5 mL TFA + 50 mL petroleum ether), the desired product was 
obtained as a yellow crystalline compound (21% yield, 1.61 g, 3.72 mmol).  
The spectroscopic data are in agreement with literature.[2] m.p. = 115 - 118 °C (lit.[2] 
118 - 120 °C) 1H NMR (400 MHz, CDCl3): δ = 7.18 (dd, J = 8.5, 1.0 Hz, 2H, H-Ar), 
6.62 (tt, J = 7.5, 1.1 Hz, 1H, H-Ar), 7.18 (tt, J = 8.0, 1.5 Hz, 2H, H-Ar) ppm. 
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Koser’s reagent 
 
To a stirred solution of iodobenzene (1.1 mL, 9.8 mmol) in CH2Cl2 (9 mL) and 
2,2,2-trifluoroethanol (9 mL), m-CPBA (2.2 g, 9.8 mmol) and p-TsOH•H2O (1.9 g, 
9.8 mmol) were successively added. The resulting solution was stirred at room 
temperature for 40 minutes and concentrated under a stream of air. Then, Et2O (15 mL) 
was added to the remaining residue and the precipitate was filtered off and dried under 
vacuum to give the desired product as a colourless solid (90% yield, 3.47 g, 8.8 mmol). 
The spectroscopic data are in agreement with literature.[3] m.p. = 126 - 128 °C (lit.[3] 
132 - 135 °C); 1H NMR (400 MHz, CD3OD): δ = 8.38 (d, J = 7.7 Hz, 2H, H-Ar), 7.86 
(t, J = 7.5 Hz, 1H, H-Ar), 7.74 – 7.69 (m, 4H, H-Ar), 7.25 (d, J = 8.0 Hz, 2H, H-Ar), 2.39 
(s, 3H, CH3) ppm. 
2-Iodoresorcinol 
 
Resorcinol (5.0 g, 45.4 mmol) and iodine (12.3 g, 48.4 mmol) were dissolved in H2O 
(32 mL) and cooled down to 0 °C. Sodium bicarbonate (4.23 g, 50.3 mmol) was added 
slowly with vigorous stirring. After 30 minutes, the brown slurry mixture was extracted 
with EtOAc (3 x 40 mL). The combined organic layers were washed with sat. aq. sodium 
thiosulfate solution (100 mL) and brine (100 mL), dried over MgSO4 and concentrated 
under vacuum. The resulting solid was triturated with cold CHCl3 (20 mL, -10 °C) and 
left to crystallise at -10 °C. The pale brown crystals were filtered, washed with cold CHCl3 
and dried under vacuum (53% yield, 5.63 g, 23.8 mmol).  
The spectroscopic data are in agreement with literature.[4] m.p. = 106 - 107 °C (lit.[5] 
105 - 108 °C); 1H NMR (400 MHz, CDCl3): δ = 7.18 (t, J = 8.1 Hz, 1H, H-Ar), 6.62 (d, 
J = 8.1 Hz, 2H, H-Ar), 5.27 (s, 2H, OH) ppm. 
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Dimethyl 2,2'-((2-iodo-1,3-phenylene)bis(oxy))(2R,2'R)-dipropionate 354 
 
2-iodoresorcinol (4.79 g, 20.3 mmol), triphenylphosphine (13.3 g, 50.8 mmol) and methyl 
(S)-(-)-lactate (4.85 mL, 50.8 mmol) were dissolved in dry THF (100 mL) under N2 and 
wrapped in aluminium foil. The reaction was cooled at 0 °C and DIAD (10.0 mL, 
50.8 mmol) was added dropwise. After 1 h at 0 °C, the mixture was warmed up to room 
temperature and stirred overnight. The solvent was removed under vacuum and Et2O 
(100 mL) was added. The triphenylphosphine oxide, which precipitated, was removed by 
filtration and the filtrate was evaporated under vacuum. The product was obtained after 
column chromatography (0 to 20% EtOAc in hexane) as a white solid (84% yield, 6.96 g, 
17.1 mmol).  
The spectroscopic data are in agreement with literature.[6] m.p. = 75 - 76 °C; 1H NMR 
(400 MHz, CDCl3): δ = 7.14 (t, J = 8.3 Hz, 1H, H-Ar), 6.37 (d, J = 8.3 Hz, 2H, H-Ar), 
4.76 (q, J = 6.8 Hz, 2H, 2 CHCH3), 3.75 (s, 6H, 2 OCH3), 1.70 (d, J = 6.8 Hz, 6H, 
2 CHCH3) ppm; [𝛂]𝐃
𝟐𝟎 = -20.0 (c = 1.0, CHCl3) (lit.
[7] [α]D
20 = -21.0 (c = 1.2, CHCl3)).  
Dimethyl-2,2'-((2-(diacetoxy-λ3-iodanyl)-1,3-phenylene)bis(oxy))(2R,2'R)-
dipropionate 6a 
 
Dimethyl 2,2'-((2-iodo-1,3-phenylene)bis(oxy))(2R,2'R)-dipropionate 354 (408 mg, 
1.00 mmol) and Selectfluor® (1.77 g, 5.00 mmol) were dissolved in CH3CN (32 mL) and 
glacial acetic acid (10 mL) under N2. After 5 h, the solvents were removed under vacuum 
and the resulting oil was diluted with CH2Cl2 (50 mL) and H2O (50 mL). The aqueous 
phase was extracted with CH2Cl2 (2 x 50 mL). The combined organic layers were dried 
over MgSO4 and concentrated under vacuum. The resulting yellow oil was used without 
further purification. (94% yield, 505 mg, 0.963 mmol).  
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The spectroscopic data are in agreement with literature.[6] 1H NMR (400 MHz, CDCl3): 
δ = 7.40 (t, J = 8.4 Hz, 1H, H-Ar), 6.57 (d, J = 8.4 Hz, 2H, H-Ar), 4.87 (q, J = 6.8 Hz, 
2H, 2 CHCH3), 3.76 (s, 6H, 2 OCH3), 1.98 (s, 6H, 2 OC(O)CH3), 1.68 (d, J = 6.8 Hz, 6H, 
2 CHCH3).  
(2R,2'R)-2,2'-((2-Iodo-1,3-phenylene)bis(oxy))dipropionic acid 355 
 
Dimethyl 2,2'-((2-iodo-1,3-phenylene)bis(oxy))(2R,2'R)-dipropionate 354 (4.0 g, 
9.8 mmol) was dissolved in a mixture of THF (50 mL) and MeOH (50 mL). After cooling 
at 0 °C, 2 N NaOH (50 mL) was added slowly and the resulting solution was stirred at 
room temperature overnight. The reaction was quenched with 1 N HCl (120 mL) at 0 °C, 
extracted with EtOAc (3 x 100 mL), dried over MgSO4 and concentrated under vacuum. 
The resulting white solid was used without further purification (99% yield, 3.7 g, 
9.7 mmol). 
The spectroscopic data are in agreement with literature.[6] 1H NMR (400 MHz, 
DMSO-d6): δ = 7.21 (t, J = 8.3 Hz, 1H, H-Ar), 6.42 (d, J = 8.4 Hz, 2H, H-Ar), 4.85 (q, 
J = 6.7 Hz, 2H, 2 CHCH3), 1.54 (d, J = 6.8 Hz, 6H, 2 CHCH3) ppm.  
 (2R,2'R)-2,2'-((2-Iodo-1,3-phenylene)bis(oxy))bis(N-mesitylpropanamide) 25 
 
(2R,2'R)-2,2'-((2-iodo-1,3-phenylene)bis(oxy))dipropionic acid 355 (3.57 g, 9.39 mmol) 
and SOCl2 (10.2 mL, 141 mmol) were refluxed for 1.5 h. The solvent was co-evaporated 
with benzene (3 x 5 mL) and the resulting brown oil was placed under N2 atmosphere and 
then dissolved in dry CH2Cl2 (50 mL). The reaction was cooled at 0 °C, 
2,4,6-trimethylaniline (3.96 mL, 28.2 mmol) was added dropwise and the reaction was 
stirred at room temperature overnight. The solution was cooled to 0 °C, quenched with 
1 N HCl (20 mL), extracted with CH2Cl2 (3 x 50 mL), dried over MgSO4 and concentrated 
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under vacuum. The pure product 25 was obtained after column chromatography (0 to 10% 
EtOAc in CHCl3) as a pale yellow solid (81% yield, 4.67 g, 7.61 mmol).  
The spectroscopic data are in agreement with literature.[6] m.p. = 230 - 232 °C; 1H NMR 
(400 MHz, CDCl3): δ = 8.01 (s, 2H, 2 NH), 7.35 (t, J = 8.3 Hz, 1H, H-Ar), 6.91 (s, 4H, 
H-Ar), 6.64 (d, J = 8.4 Hz, 2H, H-Ar), 5.01 (q, J = 6.7 Hz, 2H, 2 CHCH3), 2.27 (s, 6H, 
2 CH3), 2.15 (s, 12H, 4 CH3), 1.78 (d, J = 6.7 Hz, 6H, 2 CHCH3) ppm; [𝛂]𝐃
𝟐𝟎 = -121.0 
(c = 1.01, CHCl3). 
(2,6-bis(((R)-1-(mesitylamino)-1-oxopropan-2-yl)oxy)phenyl)-λ3-iodanediyl 
diacetate 6b 
 
(2R,2'R)-2,2'-((2-Iodo-1,3-phenylene)bis(oxy))bis(N-mesitylpropanamide) 25 (618 mg, 
1.00 mmol) and Selectfluor® (1.77 g, 5.00 mmol) were dissolved in CH3CN (32 mL) and 
glacial acetic acid (10 mL) under N2. After 5 h, the solvents were removed under vacuum 
and the resulting solid was diluted with CH2Cl2 (50 mL) and H2O (50 mL). The aqueous 
phase was extracted with CH2Cl2 (2 x 50 mL). The combined organic layers were dried 
over MgSO4 and concentrated under vacuum. The resulting yellow solid was used 
without further purification. (90% yield, 657 mg, 0.897 mmol).  
The spectroscopic data are in agreement with literature.[6] m.p. = 117 - 120 °C (lit.[8] 
118 - 120 °C); 1H NMR (400 MHz, CDCl3): δ = 8.35 (s, 2H, 2 NH), 7.57 (t, J = 8.4 Hz, 
1H, H-Ar), 6.93 (d, J = 8.5 Hz, 2H, H-Ar), 6.79 (s, 4 H, H-Ar), 5.15 (q, J = 6.7 Hz, 2H, 
2 CHCH3), 2.21 (s, 6H, 2 CH3), 2.10 (bs, 12H, 4 CH3), 1.88 (d, J = 6.7 Hz, 6H, 2 CHCH3), 
1.49 (s, 6H, 2 OC(O)CH3) ppm; [𝛂]𝐃
𝟐𝟎 = -80.0 (c = 1.0, CHCl3). 
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 Rearrangement of propiophenone derivatives 
7.4.2.1. Synthesis of substrates 
1-(4-Isobutylphenyl)propan-1-one 29b 
 
The product 29b was synthesised using a known procedure.[9] To a suspension of AlCl3 
(1.29 g, 9.68 mmol) in dry CH2Cl2 under N2, propionyl chloride (910 µL, 10.4 mmol) was 
slowly added at 0 °C. After stirring for 20 minutes, iso-butylbenzene (1.17 mL, 
7.45 mmol) was added dropwise and the resulting solution was stirred at room 
temperature for 2 h. The mixture was poured into a solution of crunched ice and 
concentrated HCl (2.5 mL) and left to warm up to room temperature. The reaction mixture 
was extracted with CH2Cl2 (2 x 30 mL), washed with sat. aq. NaHCO3 solution (20 mL), 
water (30 mL), dried over MgSO4 and concentrated under vacuum. The pure product was 
obtained after purification by column chromatography (0 to 10% EtOAc in hexane) as a 
colourless oil (74% yield, 1.05 g, 5.52 mmol).  
The spectroscopic data are in agreement with literature.[9] Colourless oil; 1H NMR 
(400 MHz, CDCl3): δ = 7.89 – 7.87 (m, 2H, H-Ar), 7.23 – 7.21 (m, 2H, H-Ar), 2.99 (q, 
J = 7.3 Hz, 2H, CH2CH3), 2.52 (d, J = 7.2 Hz, 2H, CH2CH(CH3)2), 1.93 – 1.84 (m, 1H, 
CH2CH(CH3)2), 1.22 (t, J = 7.3 Hz, 3H, CH2CH3), 0.90 (d, J = 6.6 Hz, 6H, 
CH2CH(CH3)2) ppm; 13C NMR (125 MHz, CDCl3): δ = 200.7 (C=O), 147.4 (CAr), 134.9 
(CAr), 129.4 (2 CArH), 128.1 (2 CArH), 45.5 (CH2CH(CH3)2), 31.8 (CH2CH3), 30.2 
(CH2CH(CH3)2), 22.5 (CH2CH(CH3)2), 8.5 (CH2CH3) ppm; IR (neat): 2955, 1682, 1607, 
1460, 1225, 1180, 951, 783 cm-1; HRMS (NSI): [M+H]+ calc. 191.1430, found 191.1426 
[C13H19O]
+.  
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1-(2-Bromophenyl)propan-1-ol 183 
 
The product 183 was synthesised using a known procedure.[10] To a solution of 
2-bromobenzaldehyde 182 (234 µL, 2.00 mmol) in dry Et2O (10 mL) at -10 °C, a solution 
of ethyl magnesium bromide in Et2O (3.34 mL, 3 M, 10.0 mmol) was added. The resulting 
solution was stirred at -10 °C for 3 h, then quenched with sat. aq. NH4Cl solution (20 mL) 
and the organic phase was extracted with EtOAc (3 x 30 mL), dried over MgSO4 and 
concentrated under vacuum. 1-(2-Bromophenyl)propan-1-ol 183 was obtained as a 
colourless oil and used without further purification (77% yield, 332 mg, 1.54 mmol). 
The spectroscopic data are in agreement with literature.[11] 1H NMR (300 MHz, CDCl3): 
δ = 7.56 – 7.50 (m, 2H, H-Ar), 7.33 (td, J = 7.6, 0.9 Hz, 1H, H-Ar), 7.12 (td, J = 7.7, 
1.7 Hz, 1H, H-Ar), 5.03 – 5.00 (m, 1H, CHOH), 2.01 (bs, 1H, OH), 1.88 – 1.66 (m, 2H, 
CHCH2CH3), 1.01 (t, J = 7.4 Hz, 3H, CHCH2CH3) ppm.  
1-(2-Bromophenyl)propan-1-one 29h 
 
The product 29h was synthesised using a known procedure.[10] To a suspension of 
pyridinium chlorochromate (PCC; 500 mg, 2.32 mmol) and silica gel (500 mg) in dry 
CH2Cl2 (2 mL), a solution of 1-(2-bromophenyl)propan-1-ol 183 (332 mg, 1.54 mmol) in 
dry CH2Cl2 (3 mL) was added dropwise. After 3 h at room temperature, the reaction 
mixture was filtered through a silica plug, washing the silica with CH2Cl2 (200 mL). The 
solvent was removed under vacuum and the desired product was obtained as a pale yellow 
oil which was used without further purification (96% yield, 316 mg, 1.48 mmol). 
The 1H NMR spectrum is in agreement with literature.[12] 1H NMR (400 MHz, CDCl3): 
δ = 7.61 – 7.59 (m, 1H, H-Ar), 7.37 – 7.35 (m, 2H, H-Ar), 7.30 – 7.27 (m, 1H, H-Ar), 
2.93 (q, J = 7.3 Hz, 2H, CH2), 1.21 (t, J = 7.2 Hz, 3H, CH3) ppm; 13C NMR (125 MHz, 
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CDCl3): δ = 205.1 (C=O), 142.2 (CAr), 133.7 (CArH), 131.4 (CArH), 128.3 (CArH), 127.5 
(CArH), 118.7 (CAr), 36.2 (CH2), 8.2 (CH3) ppm; IR (neat): 2978, 1699, 1587, 1427, 1213, 
748 cm-1; HRMS (NSI): [M+H]+ calc. 212.9910, found 212.9912 [C9H10OBr]
+. 
1-(3-Nitrophenyl)propan-1-one 29i 
 
The product 29i was synthesised using a known procedure.[13] Fuming nitric acid 
(9.7 mL) was added at -45 °C to propiophenone (1.00 mL, 7.45 mmol) and the resulting 
solution was stirred for 1 h at -45 °C. Crunched ice was added and the resulting green 
mixture was left to warm up to room temperature. The organic phase was extracted with 
Et2O (2 x 30 mL), washed with water (20 mL), aq. 2 N NaOH solution (30 mL), brine, 
dried over MgSO4 and concentrated under vacuum. EtOH (4 mL) was added to the crude 
solid and the solution was kept at -15 °C for 1 h. The pure product was obtained, after 
filtration, as pale yellow crystals (52% yield, 700 mg, 3.91 mmol). 
m.p. = 95 - 97 °C; 1H NMR (400 MHz, CDCl3): δ = 8.77 (t, J = 1.9 Hz, 1H, H-Ar), 8.41 
(ddd, J = 8.2, 2.2, 1.0 Hz, 1H, H-Ar), 8.32 – 8.27 (m, 1H, H-Ar), 7.68 (t, J = 8.0 Hz, 1H, 
H-Ar), 3.07 (q, J = 7.2 Hz, 2H, CH2), 1.26 (t, J = 7.2 Hz, 3H, CH3) ppm; 13C NMR 
(125 MHz, CDCl3): δ = 198.5 (C=O), 148.7 (CAr), 138.3 (CAr), 133.6 (CArH), 130.0 
(CArH), 127.3 (CArH), 123.0 (CArH), 32.3 (CH2), 8.1 (CH3) ppm; IR (neat): 2988, 1687, 
1526, 1346, 1213, 1096, 732, 675 cm-1; HRMS (NSI): [M+H]+ calc. 180.0655, found 
180.0655 [C9H10O3N]
+.  
1-(6-Methoxynaphthalen-2-yl)propan-1-one 29j 
 
To a solution of propionyl chloride (1.20 mL, 13.6 mmol) and AlCl3 (1.88 g, 14.0 mmol) 
in dry CH2Cl2 (4 mL), a solution of 2-methoxynaphthalene (2.37 g, 15.0 mmol) in dry 
CH2Cl2 (6 mL) was added via syringe pump (6 mL/h) at room temperature. The resulting 
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mixture was stirred for 20 h, then quenched with crunched ice. The organic phase was 
extracted with CH2Cl2 (3 x 25 mL), dried over MgSO4 and concentrated under vacuum. 
After column chromatography (0 to 10% EtOAc in hexane), the desired product was 
obtained as a white solid (79% yield, 2.55 g, 11.9 mmol). 
The spectroscopic data are in agreement with literature.[9] m.p. = 105 - 107 °C (lit.[9] 
109 °C); 1H NMR (400 MHz, CDCl3): δ = 8.40 (s, 1H, H-Ar), 8.01 (dd, J = 8.6, 1.7 Hz, 
1H, H-Ar), 7.84 (d, J = 9.0 Hz, 1H, H-Ar), 7.76 (d, J = 8.7 Hz, 1H, H-Ar), 7.20 (dd, 
J = 8.9, 2.5 Hz, 1H, H-Ar), 7.14 (d, J = 2.4 Hz, 1H, H-Ar), 3.94 (s, 3H, OCH3), 3.11 (q, 
J = 7.3 Hz, 2H, CH2), 1.27 (t, J = 7.3 Hz, 3H, CH3) ppm; 13C NMR (125 MHz, CDCl3): 
δ = 200.6 (C=O), 159.8 (CAr – OMe), 137.3 (CAr), 132.5 (CAr), 131.2 (CArH), 129.5 
(CArH), 128.0 (CAr), 127.2 (CArH), 124.8 (CArH), 119.8 (CArH), 105.9 (CArH), 55.5 
(OCH3), 31.8 (CH), 8.6 (CH3) ppm; IR (neat): 1678, 1620, 1481, 1350, 1265, 1022, 
821 cm-1; HRMS (ESI): [M+H]+ calc. 215.1067, found 215.1065 [C14H15O]
+. 
Synthesis of 1-Propionylnaphthalene and 2-Propionylnaphthalene 
To a solution of propionyl chloride (2.46 mL, 28.1 mmol) and AlCl3 (3.85 g, 28.9 mmol) 
in dry CH2Cl2 (8 mL), a solution of naphthalene (3.95 g, 30.8 mmol) in dry CH2Cl2 (8 mL) 
was added via syringe pump (0.2 mL/min) at 35 °C. The resulting mixture was stirred for 
an additional hour. The reaction was quenched at 0 °C with 3 N HCl (30 mL). The organic 
phase was extracted with CH2Cl2 (3 x 50 mL), dried over MgSO4 and concentrated under 
vacuum. Crude 1H NMR showed full conversion into the two products with a ratio of 
91:9 (1-naphthyl: 2-naphthyl). After column chromatography (100% hexane), the two 
propionylnaphthalenes could not be fully separated but some pure fractions were isolated. 
2-Propionylnaphthalene 171 
 
The spectroscopic data are in agreement with literature.[14] White solid; m.p. = 62 - 64 °C 
(Lit.[15] 64 - 65 °C); 1H NMR (400 MHz, CDCl3): δ = 8.48 (s, 1H, H-Ar), 8.05 (dd, 
J = 8.2, 1.7 Hz, 1H, H-Ar), 7.97 (d, J = 8.0 Hz, 1H, H-Ar), 7.89 (t, J = 8.4 Hz, 2H, H-Ar), 
7.62-7.53 (m, 2H, H-Ar), 3.15 (q, J = 7.2 Hz, 2H, CH2), 1.29 (t, J = 7.2 Hz, 3H, CH3) 
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ppm; 13C NMR (125 MHz, CDCl3): δ = 200.9 (C=O), 135.7 (CAr), 134.5 (CAr), 132.8 
(CArH), 129.7 (CArH), 129.6 (CArH), 128.5 (CArH), 128.4 (CArH), 127.9 (CArH), 126.9 
(CArH), 124.1 (CArH), 32.0 (CH2), 8.6 (CH3) ppm; IR (neat): 2974, 1678, 1373, 1276, 
1188, 1126, 798 cm-1; HRMS (ESI): [M+H]+ calc. 185.0961, found 185.0961 
[C13H13O]
+. 
1-Propionylnaphthalene 172 
 
The spectroscopic data are in agreement with literature.[16] Pale yellow oil; 1H NMR 
(400 MHz, CDCl3): δ = 8.56 (d, J = 8.5 Hz, 1H, H-Ar), 7.98 (d, J = 8.2 Hz, 1H, H-Ar), 
7.87 – 7.84 (m, 2H, H-Ar), 7.61 – 7.48 (m, 3H, H-Ar), 3.09 (q, J = 7.3 Hz, 2H, CH2), 1.29 
(t, J = 7.3 Hz, 3H, CH3) ppm; 13C NMR (125 MHz, CDCl3): δ = 205.4 (C=O), 136.5 
(CAr), 134.1 (CAr), 132.4 (CArH), 130.3 (CAr), 128.5 (CArH), 127.9 (CArH), 127.2 (CArH), 
126.5 (CArH), 126.0 (CArH), 124.5 (CArH), 35.6 (CH2), 8.8 (CH3) ppm; IR (neat): 2974, 
2934, 1678, 1508, 1230, 1176, 1111, 794 cm-1; HRMS (ESI): [M+H]+ calc. 185.0961, 
found 185.0958 [C13H13O]
+. 
1-(Pyridin-2-yl)propan-1-one 189 
 
The product 189 was synthesised using a known procedure.[17] To a solution of 
2-cyanopyridine (0.92 mL, 9.6 mmol) in dry Et2O (15 mL) at -20 °C, a solution of ethyl 
magnesium bromide (3.84 mL, 3 M, 11.5 mmol) was slowly added. After the addition, 
the reaction mixture was stirred at that temperature for 1 h and then gradually warmed up 
to room temperature over 3 h. The reaction was quenched with 2 N HCl (5 mL) and stirred 
for additional 15 minutes. The two layers were separated, the aqueous phase was 
neutralised to pH = 8 using 2 N NaOH. The organic phase was extracted with CH2Cl2 
(3 x 10 mL), washed with water, brine, dried over MgSO4 and concentrated under 
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vacuum. The pure product was obtained after distillation (0.1 mbar, 80 °C) as a colourless 
oil (97% yield, 1.25 g, 9.26 mmol).  
The spectroscopic data are in agreement with literature.[17] 1H NMR (400 MHz, CDCl3): 
δ = 8.69 – 8.63 (m, 1H, H-Ar), 8.03 (d, J = 7.9 Hz, 1H, H-Ar), 7.82 (t, J = 7.7 Hz, 1H, 
H-Ar), 7.48 – 7.41 (m, 1H, H-Ar), 3.23 (q, J = 7.3 Hz, 2H, CH2), 1.21 (t, J = 7.3 Hz, 3H, 
CH3) ppm; 13C NMR (125 MHz, CDCl3): δ = 202.7 (C=O), 153.6 (CAr), 149.0 (CArH), 
136.9 (CArH), 127.1 (CArH), 121.8 (CArH), 31.2 (CH2), 8.1 (CH3) ppm; IR (neat): 2976, 
1697, 1584, 4356, 1223, 995, 760 cm-1; HRMS (EI): [M]+ calc. 135.0684, found 
135.0681 [C8H9NO]
+
. 
2-Phenyl-1-(p-tolyl)ethan-1-one 212 
 
To a solution of phenyl acetyl chloride (0.86 mL, 6.5 mmol) and AlCl3 (0.86 g, 6.5 mmol) 
in dry CH2Cl2 (10 mL), toluene (0.76 mL, 7.1 mmol) was added dropwise at 0 °C. The 
resulting mixture was stirred at room temperature for 16 h. The reaction was quenched 
with crunched ice and the organic phase was extracted with CH2Cl2 (3 x 25 mL), dried 
over MgSO4 and concentrated under vacuum. After column chromatography (0 to 10% 
EtOAc in hexane), the pure product 212 was obtained as white crystals (75% yield, 1.02 
g, 4.78 mmol). 
The spectroscopic data are in agreement with literature.[18] m.p. = 102 - 105 °C (lit.[18] 
104 - 105 °C); 1H NMR (400 MHz, CDCl3): δ = 7.92 (d, J = 8.2 Hz, 2H, H-Ar), 
7.34 – 7.30 (m, 2H, H-Ar), 7.27 – 7.24 (m, 5H, H-Ar), 4.26 (s, 2H, CH2), 2.40 (s, 3H, 
CH3) ppm; 13C NMR (125 MHz, CDCl3): δ = 197.4 (C=O), 144.1 (CAr), 135.0 (CAr), 
134.4 (CAr), 129.6 (2 CArH), 129.5 (2 CArH), 128.9 (2 CArH), 128.8 (2 CArH), 127.0 
(CArH), 45.6 (CH2), 21.8 (CH3) ppm; IR (neat): 2982, 2904, 1678, 1604, 1334, 
1168 cm-1; HRMS (NSI): [M+H]+ calc. 211.1117, found 211.1114 [C15H15O]
+. 
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2-Phenyl-1-(p-tolyl)propan-1-one 220 
 
To a suspension of NaH (18 mg, 0.77 mmol) in dry THF (30 mL) at 0 °C, a solution of 
2-phenyl-1-(p-tolyl)ethan-1-one 212 (154 mg, 0.734 mmol) in dry THF (30 mL) was 
added over 30 minutes using a dropping funnel. The reaction was warmed up to room 
temperature, iodomethane (100 µL, 1.60 mmol) was added and the resulting mixture was 
stirred for 2 h. After quenching the reaction with water (50 mL), the organic phase was 
extracted with Et2O (3 x 50 mL), dried over MgSO4 and concentrated under vacuum. 
After purification by column chromatography (0 to 10% EtOAc in hexane) the pure 
product 220 was obtained as a colourless oil (80% yield, 132 mg, 0.587 mmol). 
The spectroscopic data are in agreement with literature.[19] 1H NMR (400 MHz, CDCl3): 
δ = 7.47 – 7.44 (m, 2H, H-Ar), 7.37 – 7.33 (m, 2H, H-Ar), 7.30 – 7.28 (m, 1H, H-Ar), 
3.16 (s, 6H, 2 OCH3), 1.91 (q, J = 7.5 Hz, 2H, CH2), 0.59 (t, J = 7.5 Hz, 3H, CH3) ppm; 
13C NMR (125 MHz, CDCl3): δ = 200.1 (C=O), 143.6 (CAr), 141.9 (CAr), 134.2 (CAr), 
129.3 (2 CArH), 129.1 (2 CArH), 129.0 (2 CArH), 127.9 (2 CArH), 126.9 (CArH), 47.9 (CH), 
21.7 (CH3), 19.6 (CH3) ppm; HRMS (APCI): [M+H]
+ calc. 225.1274, found 225.1269 
[C16H17O]
+
. 
7.4.2.2. Rearrangement reaction 
General procedure GP1 for the racemic synthesis of compounds 163 
To a solution of propiophenone derivative 29 (0.609 mmol) and PhI(OAc)2 (235 mg, 
0.731 mmol) in HC(OMe)3 (1.5 mL), TfOH (220 µL, 1.22 mmol) was added dropwise. 
The resulting mixture was stirred at room temperature for 5 h, quenched with water 
(1 mL), extracted with Et2O (3 x 2 mL), dried over a Telos
® phase separator and the 
solvent was removed under reduced pressure. After column chromatography (0 to 10% 
EtOAc in hexane), the corresponding pure product 163 was obtained. 
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General procedure GP2 for the asymmetric synthesis of compounds 163 using 
Ishihara ester reagent 
To a solution of propiophenone derivative 29 (0.609 mmol) and Ishihara ester 6a 
(385 mg, 0.731 mmol) in HC(OMe)3 (1.5 mL), TMSOTf or TfOH (1.22 mmol) was added 
dropwise at the desired temperature. The resulting mixture was stirred at the temperature 
and for the time mentioned in Chapter 3, quenched with water (1 mL), extracted with 
Et2O (3 x 2 mL), dried over a Telos
® phase separator and the solvent was removed under 
reduced pressure. After column chromatography (0 to 10% Et2O in hexane), the 
corresponding pure product 163 was obtained. 
General procedure GP3 for the asymmetric synthesis of compounds 163 using 
Ishihara amide reagent. 
To a solution of propiophenone derivative 29 (0.305 mmol) and Ishihara amide (267 mg, 
0.365 mmol) in HC(OMe)3 (1.5 mL), TfOH (0.609 mmol) was added dropwise at the 
temperature mentioned in Chapter 3. The resulting mixture was stirred at that temperature 
for 24-48 h, quenched with water (1 mL), extracted with CH2Cl2 (3 x 2 mL), dried over a 
Telos® phase separator and the solvent was removed under reduced pressure. After 
column chromatography (0 to 10% Et2O in hexane), the corresponding pure product 163 
was obtained. 
Methyl (R)-2-phenylpropionate 163a 
 
Racemate: The product 163a was synthesised using general procedure GP1 at r.t. for 5 h 
(0.609 mmol scale) (62% yield, 62 mg, 0.378 mmol).  
Asymmetric: The product 163a was synthesised using general procedure GP3 at -20 °C 
for 24 h (0.186 mmol scale) (49% yield, 15 mg, 0.091 mmol).  
The spectroscopic data are in agreement with literature.[20] Colourless oil; 1H NMR 
(300 MHz, CDCl3): δ = 7.33 – 7.29 (m, 5H, H-Ar), 3.77 – 3.66 (overlapped q and s, 
Jq = 7.2 Hz, 1H+3H, CH and OCH3), 1.51 (d, J = 7.2 Hz, 3H, CH3). 13C NMR (125 MHz, 
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CDCl3): δ = 175.2 (C=O), 140.7 (CAr), 128.8 (2 CArH), 127.6 (2 CArH), 127.3 (CArH), 
52.2 (OCH3), 45.5 (CH), 18.7 (CH3) ppm; HRMS (EI): [M]
+ calc. 164.0837, found 
164.0837 [C10H12O2]
+; IR (neat): 2921, 1732, 1454, 1435, 1207, 1165, 698 cm-1; ee: 
53%, determined by HPLC analysis: Daicel Chiralcel OJ column (25 cm), 
hexane/i-PrOH: 99/1, 0.7 mL/min, 20 °C, 226 nm, Tr (minor, (S)-isomer) = 23.7 min, 
Tr (major, (R)-isomer) = 32.2 min; [𝛂]𝐃
𝟐𝟎 = -53.8 (c = 0.53, CHCl3) (lit.
[21] for the (R)-
isomer [𝛂]𝐃
𝟐𝟎 = -71.3 (c = 1.03, EtOH)). 
Methyl (R)-2-(4-isobutylphenyl)propionate 163b 
 
Racemate: The product 163b was synthesised using general procedure GP1 at r.t. for 24 h 
(0.394 mmol scale) (94% yield, 82 mg, 0.371 mmol).  
Asymmetric: The product 163b was synthesised using general procedure GP3 at r.t. for 
48 h (0.247 mmol scale) (72% yield, 39 mg, 0.177 mmol).  
The spectroscopic data are in agreement with literature.[22] Colourless oil; 1H NMR 
(400 MHz, CDCl3): δ = 7.21 – 7.19 (m, 2H, H-Ar), 7.10 – 7.08 (m, 2H, H-Ar), 3.70 (q, 
J = 7.2 Hz, 1H, CHCH3), 3.66 (s, 3H, OCH3), 2.44 (d, J = 7.2 Hz, 2H, CH2CH(CH3)2), 
1.89 – 1.79 (m, 1H, CH2CH(CH3)2), 1.49 (d, J = 7.2 Hz, 3H, CHCH3), 0.90 (d, J = 6.6 Hz, 
6H, CH2CH(CH3)2) ppm; 13C NMR (125 MHz, CDCl3): δ = 175.4 (C=O), 140.7 (CAr), 
137.9 (CAr), 129.5 (2 CArH), 127.3 (2 CArH), 52.1 (OCH3), 45.2 (CH2CH(CH3)2), 45.2 
(CHCH3), 30.3 (CH2CH(CH3)2), 22.5 (CH2CH(CH3)2), 18.8 (CHCH3) ppm; IR (neat): 
2953, 1736, 1513, 1433, 1204, 1161 cm-1; HRMS (NSI): [M+H]+ calc. 221.1536, found 
221.1535 [C14H21O2]
+; MS (EI): m/z 238 (55%), 221 ([M+H]+, 74%), 161 (100%); ee: 
35%, determined by HPLC analysis: Daicel Chiralcel OJ column (25 cm), 
hexane/i-PrOH: 99/1, 1.0 mL/min, 20 °C, 226 nm, Tr (minor, (S)-isomer) = 8.0 min, 
Tr (major, (R)-isomer) = 9.2 min; [𝛂]𝐃
𝟐𝟎 = -18.9 (c = 0.74, CHCl3) (lit.
[23] for the (S)-
isomer [𝛂]𝐃
𝟐𝟎 = +55.7 (c = 1.0, CHCl3)). 
The absolute configuration was established by comparison with the literature optical 
rotation. In 1987, Piccolo et al. synthesised methyl (S)-2-(4-isobutylphenyl)propionate 
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from (R)-2-chloropropionic acid which was itself prepared from (S)-lactic acid. The 
optical rotation measured for methyl (S)-2-(4-isobutylphenyl)propionate was +55.7 
(c = 1, CHCl3).
[23] 
Methyl (R)-2-(4-methoxyphenyl)propionate 163c 
 
a) Racemic synthesis using H2SO4: To a solution of 4-methoxy-propiophenone 
(100 mg, 0.609 mmol) and PhI(OAc)2 (235 mg, 0.731 mmol) in HC(OMe)3 (1.5 mL), 
H2SO4 (68 µL, 1.22 mmol) was added dropwise. The resulting mixture was stirred at 
room temperature for 1 h, quenched with water (1 mL), extracted with Et2O 
(3 x 2 mL), dried over a Telos® phase separator and the solvent was removed under 
reduced pressure. After column chromatography (0 to 10% EtOAc in hexane), the 
pure product 163c was obtained as a yellow oil (82% yield, 97 mg, 0.499 mmol). 
b) Asymmetric synthesis using H2SO4: To a solution of 4-methoxy-propiophenone 
(84 mg, 0.510 mmol) and Ishihara ester 6a (250 mg, 0.602 mmol) in HC(OMe)3 
(1.5 mL), H2SO4 (57 µL, 1.02 mmol) was added dropwise at 0 °C. The resulting 
mixture was stirred at 0 °C for 4 h, quenched with water (1 mL), extracted with Et2O 
(3 x 2 mL), dried over a Telos® phase separator and the solvent was removed under 
reduced pressure. After column chromatography (0 to 10% EtOAc in hexane), the 
pure product 163c was obtained as a yellow oil (45% yield, 45 mg, 0.232 mmol, 
14% ee of (R)-isomer). 
c) Racemic synthesis using TMSOTf: To a solution of 4-methoxy-propiophenone 
(100 mg, 0.609 mmol) and PhI(OAc)2 (235 mg, 0.731 mmol) in HC(OMe)3 (1.5 mL), 
TMSOTf (220 µL, 1.22 mmol) was added dropwise. The resulting mixture was 
stirred at room temperature for 4 h, quenched with water (1 mL), extracted with Et2O 
(3 x 2 mL), dried over a Telos® phase separator and the solvent was removed under 
reduced pressure. After column chromatography (0 to 10% EtOAc in hexane), the 
pure product 163c was obtained as a yellow oil (82% yield, 97 mg, 0.499 mmol). The 
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aqueous phase was kept and left to crystallise for two days showing the formation of 
diaryliodonium salt 168 as pale yellow crystals (11% yield, 34 mg, 0.066 mmol).  
d) Asymmetric synthesis using TMSOTf: To a solution of 4-methoxy-propiophenone 
(100 mg, 0.609 mmol) and Ishihara ester 6a (250 mg, 0.609 mmol) in HC(OMe)3 
(1.5 mL), TMSOTf (220 µL, 1.22 mmol) was added dropwise at 0 °C. The resulting 
mixture was stirred at 0 °C for 4 h, quenched with water (1 mL), extracted with Et2O 
(3 x 2 mL), dried over a Telos® phase separator and the solvent was removed under 
reduced pressure. After column chromatography (0 to 10% EtOAc in hexane), the 
pure product 163c was obtained as a yellow oil (20% yield, 24 mg, 0.124 mmol, 
7% ee of (R)-isomer). 
e) Asymmetric synthesis using TfOH: To a solution of 4-methoxy-propiophenone 
(34 mg, 0.205 mmol) and Ishihara amide 6b (150 mg, 0.205 mmol) in HC(OMe)3 
(1.0 mL), TfOH (36 µL, 0.41 mmol) was added dropwise at room temperature. The 
resulting mixture was stirred at room temperature for 24 h, quenched with water 
(1 mL), extracted with CH2Cl2 (3 x 2 mL), dried over a Telos
® phase separator and 
the solvent was removed under reduced pressure. After column chromatography (0 to 
10% Et2O in hexane), the pure product 163c was obtained as a pale yellow oil 
(80% yield, 32 mg, 0.165 mmol, 27% ee of (R)-isomer, [𝛂]𝐃
𝟐𝟎 = -23.8 (c = 0.589, 
CHCl3)) (lit.
[24] for the (R)-isomer [𝛂]𝐃
𝟐𝟎 = -69.7 (c = 0.32, CHCl3)). 
The spectroscopic data are in agreement with literature.[20] Pale yellow oil; 1H NMR 
(300 MHz, CDCl3): δ = 7.22 (d, J = 8.0 Hz, 2H, H-Ar), 6.86 (d, J = 8.0 Hz, 2H, H-Ar), 
3.79 (s, 3H, OCH3), 3.68 (q, J = 7.2 Hz, 1H, CH), 3.65 (s, 3H, OCH3), 1.46 (d, J = 7.2 Hz, 
3H, CH3) ppm; 13C NMR (75 MHz, CDCl3): δ = 175.4 (C=O), 158.8 (CAr-OMe), 132.8 
(CAr), 128.6 (2 CArH), 114.1 (2 CArH), 55.4 (OCH3), 52.1 (OCH3), 44.7 (CH), 18.8 (CH3) 
ppm; IR (neat): 2951, 1732, 1612, 1512, 1435, 1207, 1033, 968 cm-1; HRMS (EI): [M]+ 
calc. 194.0943, found 194.043 [C11H14O3]
+; ee were determined by HPLC analysis: 
Daicel Chiralcel OD-H column (25 cm), hexane/i-PrOH: 99/1, 0.5 mL/min, 10 °C, 
277 nm, Tr (minor, (S)-isomer) = 16.7 min, Tr (major, (R)-isomer) = 18.0 min. 
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 (5-(1-Carboxyethyl)-2-methoxyphenyl)(phenyl)iodonium 
trifluoromethanesulfonate 168 
 
Yellow oil; 1H NMR (300 MHz, CD3OD): δ = 8.15 (d, J = 2.1 Hz, 1H, H-Ar), 8.11 (dd, 
J = 8.0, 1.2 Hz, 2H, H-Ar), 7.67 (overlapped t and dd, Jt = 8.1 Hz, Jdd = 7.1, 2.0 Hz, 2H, 
H-Ar), 7.52 (t, J = 8.0 Hz, 2H, H-Ar), 7.26 (d, J = 9.0 Hz, 2H, H-Ar), 3.90 (s, 3H, OCH3), 
3.77 (q, J = 7.2 Hz, 1H, CH), 1.48 (d, J = 7.2 Hz, 3H, CH3) ppm; 13C NMR (75 MHz, 
CDCl3): δ = 179.9 (C=O), 157.5 (CAr - OMe), 137.8 (CAr), 137.1 (CArH), 136.5 (2 CArH), 
135.6 (CArH), 133.5 (CArH), 133.0 (2 CArH), 121.8 (q, J = 319 Hz, CF3), 115.1 (CAr), 
114.0 (CArH), 105.6 (CAr), 57.8 (OCH3), 45.2 (CH), 18.7 (CH3) ppm; IR (neat): 3402, 
1636, 1225, 1175, 1026 cm-1;  
X-Ray Crystallographic structure: CCDC-1487362 
 
No mass data could be obtained for this compound. 
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Methyl (R)-2-phenylbutanoate 163d 
 
Racemate: The product 163d was synthesised using general procedure GP1 at r.t. for 5 h 
(0.337 mmol scale) (58% yield, 35 mg, 0.196 mmol).  
Asymmetric: The product 163d was synthesised using general procedure GP3 at -20 °C 
for 48 h (0.289 mmol scale) (56% yield, 26 mg, 0.146 mmol).  
The spectroscopic data are in agreement with literature.[25] Colourless oil; 1H NMR 
(400 MHz, CDCl3): δ = 7.35 – 7.23 (m, 5H, H-Ar), 3.66 (s, 3H, OCH3), 3.46 (t, J = 
7.75 Hz, 1H, CH), 2.12 (dquint, J = 13.6, 7.4 Hz, 1H, CHAHB), 1.80 (dquint, J = 13.6, 
7.4 Hz, 1H, CHAHB), 0.89 (t, J = 7.4 Hz, 3H, CH3) ppm; 13C NMR (125 MHz, CDCl3): 
δ = 174.6 (C=O), 139.3 (CAr), 128.7 (2 CArH), 128.1 (2CArH), 127.3 (CAr), 53.6 (OCH3), 
52.0 (CH), 26.9 (CH2), 12.3 (CH3) ppm; IR (neat): 2966, 1732, 1454, 1435, 1203, 1165, 
698 cm-1; HRMS (ESI): [M+H]+ calc. 179.1067, found 179.1064 [C11H15O2]
+; ee: 63%, 
determined by HPLC analysis: YMC Chiral Amylose-C S-5µm (25 cm), hexane/i-PrOH: 
99.7/0.3, 1.0 mL/min, 20 °C, 254 nm, Tr (minor, (S)-isomer) = 5.7 min, Tr (major, 
(R)-isomer) = 6.1 min; [𝛂]𝐃
𝟐𝟎 = -28.6 (c = 0.21, CHCl3) (it is assumed to be the (R)-isomer 
by analogy with the other rearranged product). 
Methyl (R)-3-methyl-2-phenylbutanoate 163e 
 
Racemate: The product 163e was synthesised using general procedure GP1 at r.t. for 5 h 
(0.337 mmol scale) (93% yield, 62 mg, 0.322 mmol).  
Asymmetric: The product 163e was synthesised using general procedure GP3 at -20 °C 
for 48 h (0.119 mmol scale) (31% conversion, ~7 mg, 0.036 mmol). 
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The spectroscopic data are in agreement with literature.[26] Pale yellow oil; 1H NMR 
(400 MHz, CDCl3): δ = 7.36 – 7.23 (m, 5H, H-Ar), 3.65 (s, 3H, OCH3), 3.15 (d, J = 
10.6 Hz, 1H, CHCO2Me), 2.34 (dsept, J = 10.6, 6.6 Hz, 1H, CH(CH3)2), 1.03 (d, J = 
6.5 Hz, 3H, CH(CH3)2), 0.89 (d, J = 6.7 Hz, 3H, CH(CH3)2) ppm; 13C NMR (125 MHz, 
CDCl3): δ = 174.6 (C=O), 138.5 (CAr), 128.7 (2 CArH), 128.6 (2 CArH), 127.4 (CArH), 
60.2 (OCH3), 51.8 (CHCO2Me), 32.0 (CH), 21.6 (CH3), 20.3 (CH3) ppm; IR (neat): 
2959, 1732, 1454, 1435, 1203, 1153, 702 cm-1; HRMS (NSI): [M+H]+ calc. 193.1223, 
found 193.1221 [C12H17O2]
+; ee: 73%, determined by HPLC analysis: Daicel Chiralcel 
OD-H column (25 cm), hexane/i-PrOH: 99.5/0.5, 1.0 mL/min, 20 °C, 225 nm, Tr (minor, 
(S)-isomer) = 4.4 min, Tr (major, (R)-isomer) = 5.1 min; [𝛂]𝐃
𝟐𝟎 = -52.2 (c = 0.23, CHCl3) 
(it is assumed to be the (R)-isomer by analogy with the other rearranged product). 
Ethyl (R)-3-methyl-2-phenylbutanoate 163f 
 
Racemate: The product 163f was synthesised using general procedure GP1 (HC(OEt)3 
was used instead of HC(OMe)3) at r.t. for 5 h (0.337 mmol scale) (80% yield, 52 mg, 
0.267 mmol).  
Asymmetric: The product 163f was synthesised using general procedure GP3 (HC(OEt)3 
was used instead of HC(OMe)3) at -20 °C for 48 h (0.283 mmol scale) (31% yield, 18 mg, 
0.088 mmol). 
Colourless oil; 1H NMR (400 MHz, CDCl3): δ = 7.35 – 7.25 (m, 5H, H-Ar), 4.16 – 4.02 
(m, 2H, OCH2), 3.12 (d, J = 10.6 Hz, 1H, CHCO2Et), 2.33 (dsept, J = 10.6, 6.6 Hz, 1H, 
CH(CH3)2), 1.22 (t, J = 7.1 Hz, 3H, OCH2CH3), 1.04 (d, J = 6.5 Hz, 3H, CH3), 0.70 (d, 
J = 6.7 Hz, 3H, CH3) ppm; 13C NMR (125 MHz, CDCl3): δ = 174.1 (C=O), 138.7 (CAr), 
128.7 (2CArH), 128.5 (2CArH), 127.3 (CArH), 60.6 (OCH2), 60.4 (CHCO2Et), 
32.1(CH(CH3)2), 21.6 (CH3), 20.4 (CH3), 14.3 (CH2CH3) ppm; IR (neat): 2962, 1732, 
1454, 1369, 1288, 1153, 1030 cm-1; HRMS (ESI): [M+H]+ calc. 207.1380, found 
207.1379 [C13H19O2]
+; ee: 35%, determined by HPLC analysis: Daicel Chiralcel OJ 
column (25 cm), hexane/i-PrOH: 99/1, 1.0 mL/min, 20 °C, 254 nm, Tr (major, (R)-isomer) 
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= 5.0 min, Tr (minor, (S)-isomer) = 6.5 min; [𝛂]𝐃
𝟐𝟎 = -18.3 (c = 0.58, CHCl3) (it is assumed 
to be the (R)-isomer by analogy with the other rearranged product). 
Methyl (R)-2-(2-bromophenyl)propionate 163h 
 
Racemate: The product 163h was synthesised using general procedure GP1 at r.t. for 24 h 
(0.394 mmol scale) (79% yield, 76 mg, 0.313 mmol).  
Asymmetric: The product 163h was synthesised using general procedure GP3 at r.t. for 
48 h (0.211 mmol scale) (46% yield, 19 mg, 0.078 mmol).  
Colourless oil; 1H NMR (400 MHz, CDCl3): δ = 7.57 (d, J = 8.0 Hz, 1H, H-Ar), 
7.31 – 7.27 (m, 2H, H-Ar), 7.14 – 7.10 (m, 1H, H-Ar), 4.23 (q, J = 7.1 Hz, 1H, CH), 3.69 
(s, 3H, OCH3), 1.49 (d, J = 7.2 Hz, 3H, CH3) ppm; 13C NMR (125 MHz, CDCl3): 
δ = 174.6 (C=O), 140.3 (CAr), 133.2 (CArH), 128.7 (CArH), 128.5 (CArH), 128.0 (CArH), 
124.5 (CAr), 52.3 (OCH3), 44.8 (CH), 18.0 (CH3) ppm; IR (neat): 2938, 1736, 1472, 1433, 
1207, 1169, 1022, 750 cm-1; HRMS (NSI): [M+H]+ calc. 243.0015, found 243.0019 
[C10H12O2Br]
+; MS (EI): m/z 262 (49%), 260 (48%), 245 (96%), 243 ([M]+, 100%), 182 
(52%); ee: 44%, determined by HPLC analysis: Regis® Pirkle Covalent (R,R) Whelk-O 1 
(25 cm), hexane/i-PrOH: 99/1, 1.0 mL/min, 20 °C, 227 nm, Tr (major, (R)-isomer) = 
7.5 min, Tr (minor, (S)-isomer) = 8.5 min; [𝛂]𝐃
𝟐𝟎 = -46.7 (c = 0.129, CHCl3) (it is assumed 
to be the (R)-isomer by analogy with the other rearranged product). 
Methyl 2-(3-nitrophenyl)propionate 163i 
 
Racemate: The product 163i was synthesised using general procedure GP1 at r.t. for 24 h 
(0.394 mmol scale) (75% yield, 62 mg, 0.296 mmol).  
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Asymmetric: The product 163i was not obtained using general procedure GP3 at r.t. for 
48 h (0.171 mmol scale).  
Colourless oil; 1H NMR (400 MHz, CDCl3): δ = 8.10 (t, J = 2.0 Hz, 1H, H-Ar), 8.05 
(ddd, J = 8.2, 2.3, 1.0 Hz, 1H, H-Ar), 7.58 – 7.56 (m, 1H, H-Ar), 7.43 (t, J = 7.9 Hz, 1H, 
H-Ar), 3.77 (q, J = 7.2 Hz, 1H, CH), 3.61 (s, 3H, OCH3), 1.49 (d, J = 7.2 Hz, 3H, CH3) 
ppm; 13C NMR (125 MHz, CDCl3): δ = 173.9 (C=O), 148.6 (CAr), 142.5 (CAr), 133.9 
(CArH), 129.7 (CArH), 122.9 (CArH), 122.4 (CArH), 52.5 (OCH3), 45.2 (CH), 18.5 (CH3) 
ppm; IR (neat): 2953, 1732, 1528, 1348, 1211, 1165, 735 cm-1. 
Methyl (R)-2-(p-tolyl)propionate 163k 
 
Racemate: The product 163k was synthesised using general procedure GP1 at r.t. for 24 h 
(0.394 mmol scale) (86% yield, 60 mg, 0.339 mmol).  
Asymmetric: The product 163k was synthesised using general procedure GP3 at r.t. for 
48 h (0.211 mmol scale) (79% yield, 29 mg, 0.165 mmol).  
The spectroscopic data are in agreement with literature.[27] Colourless oil; 1H NMR 
(500 MHz, CDCl3): δ = 7.19 (d, J = 8.0 Hz, 2H, H-Ar), 7.14 (d, J = 7.9 Hz, 2H, H-Ar), 
3.70 (q, J = 7.2 Hz, 1H, CH), 3.65 (s, 3H, OCH3), 2.33 (s, 3H, CH3), 1.49 (d, J = 7.2 Hz, 
3H, CHCH3) ppm; 13C NMR (125 MHz, CDCl3): δ = 175.3 (C=O), 137.7 (CAr), 136.9 
(CAr), 129.5 (2 CArH), 127.5 (2 CArH), 52.1 (OCH3), 45.1 (CH), 21.2 (CH3), 18.6 
(CHCH3) ppm; IR (neat): 2951, 1734, 1514, 1433, 1204, 1163 cm
-1; HRMS (NSI): 
[M+H]+ calc. 179.1067, found 179.1064 [C11H15O2]
+; ee: 46%, determined by HPLC 
analysis: Daicel Chiralcel OJ column (25 cm), hexane/i-PrOH: 99/1, 1.0 mL/min, 20 °C, 
234 nm, Tr (major, (R)-isomer) = 16.2 min, Tr (minor, (S)-isomer) = 19.9 min; 
[𝛂]𝐃
𝟐𝟎 = -69.9 (c = 0.0286, CHCl3) (lit.
[24] for the (R)-isomer [𝛂]𝐃
𝟐𝟎 = -73.6 (c = 0.23, 
CHCl3)). 
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Methyl (R)-2-(4-ethylphenyl)propionate 163l 
 
Racemate: The product 163l was synthesised using general procedure GP1 at r.t. for 24 h 
(0.394 mmol scale) (91% yield, 69 mg, 0.358 mmol).  
Asymmetric: The product 163l was synthesised using general procedure GP3 at r.t. for 
48 h (0.211 mmol scale) (87% yield, 35 mg, 0.185 mmol).  
Colourless oil; 1H NMR (300 MHz, CDCl3): δ = 7.22 (d, J = 8.3 Hz, 2H, H-Ar), 7.16 (d, 
J = 8.2 Hz, 2H, H-Ar), 3.70 (q, J = 7.2 Hz, 1H, CH), 3.66 (s, 3H, OCH3), 2.63 (q, J = 
7.6 Hz, 2H, CH2CH3), 1.49 (d, J = 7.2 Hz, 3H, CHCH3), 1.23 (t, J = 7.6 Hz, 3H, CH2CH3) 
ppm; 13C NMR (125 MHz, CDCl3): δ = 175.3 (C=O), 143.2 (CAr), 137.9 (CAr), 128.3 
(2 CArH), 127.5 (2 CArH), 52.1 (OCH3), 45.2 (CH), 28.6 (CH2CH3), 18.6 (CHCH3), 15.6 
(CH2CH3) ppm; IR (neat): 2965, 1736, 1514, 1433, 1203, 1163 cm
-1; HRMS (NSI): 
[M+H]+ calc. 193.1223, found 193.1221 [C12H17O2]
+; ee: 44%, determined by HPLC 
analysis: Daicel Chiralcel OJ column (25 cm), hexane/i-PrOH: 99/1, 1.0 mL/min, 20 °C, 
234 nm, Tr (major, (R)-isomer) = 14.8 min, Tr (minor, (S)-isomer) = 16.9 min; 
[𝛂]𝐃
𝟐𝟎 = -22.8 (c =0.351, CHCl3) (it is assumed to be the (R)-isomer by analogy with the 
other rearranged product). 
Methyl (R)-2-(4-fluorophenyl)propionate 163m 
 
Racemate: The product 163m was synthesised using general procedure GP1 at r.t. for 
48 h (0.657 mmol scale) (92% yield, 110 mg, 0.604 mmol).  
Asymmetric: The product 163m was synthesised using general procedure GP3 at -20 °C 
for 48 h (0.146 mmol scale) (50% conversion, ~13 mg, 0.073 mmol). 
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The spectroscopic data are in agreement with literature.[28] Colourless oil; 1H NMR 
(400 MHz, CDCl3): δ = 7.28 (dt, J = 8.6, 3.3 Hz, 2H, H-Ar), 7.02 (tt, J = 8.7, 2.2 Hz, 2H, 
H-Ar), 3.72 (q, J = 7.2 Hz, 1H, CH), 3.68 (s, 3H, OCH3), 1.50 (d, J = 7.2 Hz, 3H, CH3) 
ppm; 13C NMR (125 MHz, CDCl3): δ = 175.0 (C=O), 162.1 (d, J = 245 Hz, C-F), 136.4 
(d, J = 3 Hz, 2 CAr), 129.1 (d, J = 8 Hz, CAr), 115.6 (d, J = 21 Hz, 2 CAr), 52.2 (OCH3), 
44.8 (CH), 18.8 (CH3) ppm; 19F NMR (283 MHz, CDCl3): δ = -115.5 (d, J = 14 Hz) 
ppm; IR (neat): 2955, 1732, 1508, 1435, 1222, 1157, 837 cm-1; HRMS (APCI): [M+H]+ 
calc. 183.0816, found 183.0812 [C10H12FO2]
+; MS (EI): m/z 183 ([M+H]+, 85%), 125 
(10%), 123 (100%), 103 (10%); ee: 45%, determined by HPLC analysis: Daicel Chiralcel 
OJ column (25 cm), hexane/i-PrOH: 90/10, 0.5 mL/min, 20 °C, 254 nm, Tr (major, 
(R)-isomer) = 13.3 min, Tr (minor, (S)-isomer) = 14.2 min; [𝛂]𝐃
𝟐𝟎 = -42.9 (c = 0.14, 
CHCl3) (lit.
[21] for the (R)-isomer [𝛂]𝐃
𝟐𝟎 = -5.6 (c = 1.0, EtOH)). 
Methyl (R)-2-(4-bromophenyl)propionate 163n 
 
Racemate: The product 163n was synthesised using general procedure GP1 at r.t. for 24 h 
(0.394 mmol scale) (76% yield, 69 mg, 0283 mmol).  
Asymmetric: The product 163n was synthesised using general procedure GP3 at r.t. for 
48 h (0.211 mmol scale) (28% yield, ~14 mg, 0.0576 mmol).  
The 1H NMR spectrum is in agreement with literature.[29] Colourless oil; 1H NMR 
(300 MHz, CDCl3): δ = 7.45 (d, J = 8.5 Hz, 2H, H-Ar), 7.18 (d, J = 8.4 Hz, 2H, H-Ar), 
3.70 (q, J = 7.2 Hz, 1H, CH), 3.66 (s, 3H, OCH3), 1.48 (d, J = 7.2 Hz, 3H, CH3) ppm; 
13C NMR (125 MHz, CDCl3): δ = 174.6 (C=O), 139.6 (CAr), 131.9 (2 CArH), 129.4 
(2 CArH), 121.2 (CAr), 52.3 (OCH3), 45.0 (CH), 18.6 (CH3) ppm; IR (neat): 2949, 1734, 
1487, 1163, 1011 cm-1; HRMS (NSI): [M+NH4]
+ calc. 260.0281, found 260.0284 
[C10H15O2NBr]
+; ee: could not be determined by HPLC analysis as the two enantiomers 
were not separable; [𝛂]𝐃
𝟐𝟎 = -24.1 (c = 0.249, CHCl3) (it is assumed to be the (R)-isomer 
by analogy with the other rearranged product). 
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Methyl (R)-2-(3-bromophenyl)propionate 163o 
 
Racemate: The product 163o was synthesised using general procedure GP1 at r.t. for 24 h 
(0.394 mmol scale) (98% yield, 94 mg, 0.385 mmol).  
Asymmetric: The product 163o was synthesised using general procedure GP3 at r.t. for 
48 h (0.211 mmol scale) (14% yield, ~7 mg, 0.0288 mmol).  
Colourless oil; 1H NMR (300 MHz, CDCl3): δ = 7.45 (t, J = 1.6 Hz, 1H, H-Ar), 7.39 (dt, 
J = 7.2, 1.8 Hz, 1H, H-Ar), 7.22 – 7.19 (m, 2H, H-Ar), 3.68 (q, J = 7.2 Hz, 1H, CH), 3.67 
(s, 3H, OCH3), 1.49 (d, J = 7.2 Hz, 3H, CH3) ppm; 13C NMR (125 MHz, CDCl3): 
δ = 174.5 (C=O), 142.8 (CAr), 130.8 (CArH), 130.5 (CArH), 130.3 (CArH), 126.3 (CArH), 
122.8 (CAr), 52.4 (OCH3), 45.2 (CH), 18.6 (CH3) ppm; IR (neat): 2949, 1734, 1568, 1427, 
1203, 1163, 692 cm-1; HRMS (NSI): [M+NH4]
+ calc. 260.0281, found 260.0284 
[C10H15O2NBr]
+; ee: 46%, determined by HPLC analysis: Daicel Chiralcel OJ column 
(25 cm), hexane/i-PrOH: 99/1, 0.5 mL/min, 20 °C, 230 nm, Tr (minor, (S)-isomer) = 
22.6 min, Tr (major, (R)-isomer) = 24.3 min; [𝛂]𝐃
𝟐𝟎 = -61.5 (c = 0.065, CHCl3) (it is 
assumed to be the (R)-isomer by analogy with the other rearranged product). 
Ethyl (R)-2-(3-(trifluoromethyl)phenyl)propionate 163p 
 
Racemate: The product 163p was synthesised using general procedure GP1 (HC(OEt)3 
was used instead of HC(OMe)3) at r.t. for 20 h (0.394 mmol scale) (73% yield, 71 mg, 
0.288 mmol).  
Asymmetric: The product 163p was synthesised using general procedure GP3 (HC(OEt)3 
was used instead of HC(OMe)3) at -20 °C for 48 h (0.247 mmol scale) (Traces).  
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Colourless oil; 1H NMR (500 MHz, CDCl3): δ = 7.56 (s, 1H, H-Ar), 7.53 – 7.50 (m, 2H, 
H-Ar), 7.45 (d, J = 7.7 Hz, 1H, H-Ar), 4.17 – 4.10 (m, 2H, OCH2CH3), 3.76 (q, J = 7.2 Hz, 
1H, CH), 1.52 (d, J = 7.2 Hz, 3H, CH3), 1.21 (t, J = 7.1 Hz, 3H, OCH2CH3) ppm; 
13C NMR (125 MHz, CDCl3): δ = 173.9 (C=O), 141.7 (CAr), 131.2 (q, J = 32 Hz, 
CAr-CF3), 131.1 (CAr), 129.2 (CAr), 124.6 (q, J = 4 Hz, CHAr-CAr-CF3), 124.2 (q, 
J = 272 Hz, CF3), 124.1 (q, J = 4 Hz, CArH – CAr – CF3), 61.1 (OCH2), 45.6 (CH), 18.6 
(CH3), 14.2 (CH3) ppm; 19F NMR (283 MHz, CDCl3): δ = -62.5 ppm; IR (neat): 2984, 
1732, 1450, 1327, 1161, 1072, 702 cm-1; HRMS (APCI): [M+H]+ calc. 247.0940, found 
247.0940 [C12H14O2F3]
+; ee: 44%, determined by HPLC analysis: Regis® Pirkle Covalent 
(R,R) Whelk-O 1 (25 cm), hexane/i-PrOH: 99/1, 0.5 mL/min, 20 °C, 254 nm, Tr (minor, 
(S)-isomer) = 11.6 min, Tr (major, (R)-isomer) = 12.9 min. [𝛂]𝐃
𝟐𝟎 = -38.8 (c = 0.11, CHCl3) 
(it is assumed to be the (R)-isomer by analogy with the other rearranged product). 
Methyl (R)-2-(naphthalen-2-yl)propionate 173a 
 
Racemate: The product 173a was synthesised using general procedure GP1 at r.t. for 5 h 
(0.271 mmol scale) (83% yield, 48 mg, 0.223 mmol).  
Asymmetric: The product 173a was synthesised using general procedure GP2 at -20 °C 
for 48 h (0.271 mmol scale) (52% yield, 30 mg, 0.140 mmol). 
The spectroscopic data are in agreement with literature.[30] Colourless oil; 1H NMR 
(400 MHz, CDCl3): δ = 7.83 – 7.81 (m, 3H, H-Ar), 7.75 (s, 1H, H-Ar), 7.48 – 7.43 (m, 
3H, H-Ar), 3.90 (q, J = 7.2 Hz, 1H, CH), 3.67 (s, 3H, OCH3), 1.60 (d, J = 7.2 Hz, 3H, 
CH3) ppm; 13C NMR (125 MHz, CDCl3): δ = 175.1 (C=O), 138.2 (CAr), 133.7 (CAr), 
132.8 (CAr), 128.5 (CArH), 127.9 (CArH), 127.8 (CArH), 126.31 (CArH), 126.28 (CArH), 
126.0 (CArH), 125.9 (CArH), 52.2 (OCH3), 45.7 (CH), 18.7 (CH3) ppm; IR (neat): 2936, 
1732, 1454, 1330, 1195 cm-1; HRMS (ESI): [M+H]+ calc. 215.1067, found 215.1067 
[C14H15O2]
+; ee: 24%, determined by HPLC analysis: Daicel Chiralcel OD-H column 
(25 cm), hexane/i-PrOH: 99.5/0.5, 0.7 mL/min, 10 °C, 254 nm, Tr (major, (R)-isomer) = 
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15.7 min, Tr (minor, (S)-isomer) = 17.8 min; [𝛂]𝐃
𝟐𝟎 = -12.6 (c = 0.63, CHCl3) (lit.
[24] for 
the (R)-isomer [𝛂]𝐃
𝟐𝟎 = -65.3 (c = 0.42, CHCl3)). 
Methyl (R)-2-(naphthalen-1-yl)propionate 174a 
 
Racemate: The product 174a was synthesised using general procedure GP1 at r.t. for 5 h 
(0.271 mmol scale) (87% yield, 50 mg, 0.233 mmol).  
Asymmetric: The product 174a was synthesised using general procedure GP3 at -20 °C 
for 48 h (0.271 mmol scale) (91% yield, 53 mg, 0.247 mmol). 
The spectroscopic data are in agreement with literature.[31] Colourless oil; 1H NMR 
(400 MHz, CDCl3): δ = 8.08 (d, J = 8.5 Hz, 1H, H-Ar), 7.88 (dd, J = 7.9, 1.3 Hz, 1H, 
H-Ar), 7.80 – 7.76 (m, 1H, H-Ar), 7.57 – 7.45 (m, 4H, H-Ar), 4.52 (q, J = 7.1 Hz, 1H, 
CH), 3.66 (s, 3H, OCH3), 1.66 (t, J = 7.1 Hz, 3H, CH3) ppm; 13C NMR (125 MHz, 
CDCl3): δ = 175.5 (C=O), 137.0 (CAr), 134.2 (CAr), 131.5 (CAr), 129.2 (CArH), 127.9 
(CArH), 126.5 (CArH), 125.8 (CArH), 125.7 (CArH), 124.7 (CArH), 123.2 (CArH), 52.2 
(OCH3), 41.5 (CH), 18.4 (CH3) ppm; IR (neat): 2951, 1732, 1454, 1199, 1095, 779 cm
-1; 
HRMS (ESI): [M+H]+ calc. 215.1067, found 215.1067 [C14H15O2]
+; ee: 46%, 
determined by HPLC analysis: Daicel Chiralcel OJ column (25 cm), hexane/i-PrOH: 
99/1, 0.7 mL/min, 20 °C, 254 nm, Tr (minor, (S)-isomer) = 34.3 min, Tr (major, 
(R)-isomer) = 38.1 min; [𝛂]𝐃
𝟐𝟎 = -60.7 (c = 0.89, CHCl3) (lit.
[24] for the (R)-isomer [𝛂]𝐃
𝟐𝟎 
= -89.5 (c = 0.34, CHCl3)). 
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Ethyl (R)-2-(naphthalen-1-yl)propionate 174b 
 
Racemate: The product 174b was synthesised using general procedure GP1 (HC(OEt)3 
was used instead of HC(OMe)3) at r.t. for 5 h (0.271 mmol scale) (53% yield, 33 mg, 
0.145 mmol).  
Asymmetric: The product 174b was synthesised using general procedure GP3 (HC(OEt)3 
was used instead of HC(OMe)3) at -20 °C for 48 h (0.119 mmol scale) (70% yield, 19 mg, 
0.083 mmol).  
The spectroscopic data are in agreement with literature.[32] Yellow oil; 1H NMR 
(400 MHz, CDCl3): δ = 7.89 (d, J = 8.5 Hz, 1H, H-Ar), 7.68 – 7.65 (m, 1H, H-Ar), 
7.58 – 7.56 (m, 1H, H-Ar), 7.36 – 7.25 (m, 4H, H-Ar), 4.29 (q, J = 7.1 Hz, 1H, CH), 
3.97 – 3.89 (m, 2H, OCH2CH3), 1.44 (d, J = 7.1 Hz, 3H, CH3), 0.96 (t, J = 7.1 Hz, 3H, 
OCH2CH3) ppm; 13C NMR (100 MHz, CDCl3): δ = 175.1 (C=O), 137.1 (CAr), 134.1 
(CAr), 131.4 (CAr), 129.1 (CArH), 127.8 (CArH), 126.4 (CArH), 125.7 (2 CArH), 124.5 
(CArH), 123.3 (CArH), 61.0 (OCH2), 41.5 (CH), 18.3 (CH3), 14.2 (CH3) ppm; IR (neat): 
2978, 1732, 1454, 1377, 1192, 1099, 779 cm-1; HRMS (ESI): [M+H]+ calc. 229.1223, 
found 229.1222 [C15H17O2]
+; ee: 62%, determined by HPLC analysis: Daicel Chiralcel 
OJ column (25 cm), hexane/i-PrOH: 98/2, 1.0 mL/min, 20 °C, 219 nm, Tr (minor, 
(S)-isomer) = 19.3 min, Tr (major, (R)-isomer) = 24.9 min; [𝛂]𝐃
𝟐𝟎 = -77.4 (c = 0.31, 
CHCl3) ) (it is assumed to be the (R)-isomer by analogy with the other rearranged 
product). 
2-Isopropoxy-1-(naphthalen-1-yl)propan-1-one 177c 
 
The product 177c was synthesised using general procedure GP1 (HC(OiPr)3 was used 
instead of HC(OMe)3) at r.t. for 5 h (0.271 mmol scale) (22% yield, 12 mg, 0.048 mmol).  
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Colourless oil; 1H NMR (400 MHz, CDCl3): δ = 8.39 (d, J = 8.4 Hz, 1H, H-Ar), 7.99 (d, 
J = 8.3 Hz, 1H, H-Ar), 7.91 – 7.87 (m, 2H, H-Ar), 7.61 – 7.49 (m, 3H, H-Ar), 4.83 (q, 
J = 7.0 Hz, 1H, CHCH3), 3.69 (sept, J = 6.1 Hz, 1H, CH(CH3)2), 1.44 (d, J = 7.0 Hz, 3H, 
CHCH3), 1.22 (d, J = 6.0 Hz, 3H, CH(CH3)2), 1.15 (d, J = 6.1 Hz, 3H, CH(CH3)2) ppm; 
13C NMR (125 MHz, CDCl3): δ = 205.7 (C=O), 134.8 (CAr), 134.1 (CAr), 132.5 (CArH), 
130.7 (CAr), 128.6 (CArH), 128.0 (CArH), 127.1 (CArH), 126.6 (CArH), 125.7 (CArH), 124.3 
(CArH), 78.0 (OCH), 71.6 (OCH), 23.0 (CH3), 21.9 (CH3), 19.3 (CH3) ppm; IR (neat): 
2970, 2341, 1693, 1508, 1084, 779 cm-1; HRMS (ESI): [M+H]+ calc. 243.1380, found 
243.1380 [C16H19O2]
+; MS (EI): m/z 243 ([M+H]+, 100%), 233 (13%), 183 (57%), 155 
(4%). 
4-Ethoxy-1-phenylbutan-1-one 180 
 
The product 180 was the undesired product from the rearrangement reaction of 
cyclopropyl(phenyl)methanone 29g using general procedure GP3 at r.t. for 24 h 
(0.247 mmol scale) (98% yield, 46 mg, 0.239 mmol).  
The 1H NMR spectra is in agreement with literature.[12] Colourless oil; 1H NMR 
(400 MHz, CDCl3): δ = 7.99 – 7.97 (m, 2H, H-Ar), 7.57 – 7.53 (m, 1H, H-Ar), 
7.48 – 7.44 (m, 2H, H-Ar), 3.51 and 3.47 (overlapped t and q, Jt = 6.1 Hz, Jq = 7.0 Hz, 
2H + 2H, OCH2 and OCH2CH3), 3.09 (t, J = 7.2 Hz, 2H, PhC(O)CH2), 2.06 – 1.99 (m, 
2H, CH2CH2CH2), 1.19 (t, J = 7.2 Hz, 3H, OCH2CH3) ppm; 13C NMR (125 MHz, 
CDCl3): δ = 200.2 (C=O), 137.3 (CAr), 133.0 (CArH), 128.7 (2 CArH), 128.2 (2 CArH), 
69.7 (OCH2), 66.2 (OCH2), 35.4 (CH2), 24.6 (CH2), 15.3 (CH3) ppm; IR (neat): 2860, 
2361, 1684, 1448, 1107, 690 cm-1; HRMS (NSI): [M+H]+ calc. 193.1223, found 
193.1222 [C12H17O2]
+; MS (EI): m/z 244 (10%), 193 ([M+H]+, 40%), 147 (100%).  
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Ethyl 4-ethoxy-2-phenylbutanoate 181 
 
Racemate: The product 181 was synthesised from cyclopropyl(phenyl)methanone 29g 
using general procedure GP1 at r.t. for 20 h (0.394 mmol scale) (65% yield, 60 mg, 
0.255 mmol).  
Asymmetric: Cyclopropyl(phenyl)methanone 29g did not rearrange but only gave 
4-ethoxy-1-phenylbutan-1-one 180 as the single product. 
Colourless oil; 1H NMR (500 MHz, CDCl3): δ = 7.34 – 7.23 (m, 5H, H-Ar), 4.15 (dq, 
J = 10.8, 7.1 Hz, 1H, HA), 4.08 (dq, J = 10.8, 7.1 Hz, 1H, HB), 3.77 (t, J = 7.7 Hz, 1H, 
CH), 3.50 – 3.36 (m, 3H, OCH2 (OEt) and HC), 3.29 (ddd, J = 9.6, 7.6, 5.5 Hz, 1H, HD), 
2.37 (dtd, J = 13.5, 7.7, 5.7 Hz, 1H, HE), 1.99 (ddd, J = 13.5, 7.6, 5.7 Hz, 1H, HF), 1.20 
(t, J = 7.1 Hz, 3H, CH3), 1.18 (t, J = 7.0 Hz, 3H, CH3) ppm; 13C NMR (125 MHz, CDCl3): 
δ = 174.0 (C=O), 139.0 (CAr), 128.7 (2 CArH), 128.1 (2 CArH), 127.3 (CArH), 67.9 (CH), 
66.3 (OCH2), 60.8 (OCH2), 48.3 (OCH2), 33.5 (CH2), 15.3 (CH3), 14.2 (CH3) ppm; 
HRMS (NSI): [M+H]+ calc. 237.1485, found 237.1485 [C14H21O3]
+; MS (EI): m/z 237 
([M+H]+, 100%), 191 (55%), 163 (11%). 
2-Ethoxy-1-(3-(trifluoromethyl)phenyl)propan-1-one 186 
 
Racemate: The product 186 was synthesised using general procedure GP1 (HC(OEt)3 
was used instead of HC(OMe)3) at r.t. for 24 h (0.394 mmol scale) (23% yield, 23 mg, 
0.091 mmol).  
Asymmetric: The product 186 was synthesised using general procedure GP3 (HC(OEt)3 
was used instead of HC(OMe)3) at -20 °C for 48 h (0.247 mmol scale) (13% yield, 8 mg, 
0.033 mmol).  
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Colourless oil; 1H NMR (500 MHz, CDCl3): δ = 8.39 (s, 1H, H-Ar), 8.30 (d, J = 7.8 Hz, 
1H, H-Ar), 7.83 (d, J = 7.8 Hz, 1H, H-Ar), 7.61 (t, J = 7.8 Hz, 1H, H-Ar), 4.59 (q, J = 
6.9 Hz, 1H, CH), 3.53 (qd, J = 7.0, 1.8 Hz, 2H, OCH2CH3), 1.52 (d, J = 6.9 Hz, 3H, CH3), 
1.21 (t, J = 7.0 Hz, 3H, OCH2CH3) ppm; 13C NMR (125 MHz, CDCl3): δ = 199.9 (C=O), 
135.3 (CAr), 132.1 (CAr), 131.2 (q, J = 33 Hz, CAr – CF3), 129.6 (q, J = 4 Hz, 
CArH – CAr – CF3), 129.1 (CAr), 126.0 (q, J = 4 Hz, CArH – CAr – CF3), 123.7 (q, J = 273 
Hz, CF3), 79.9 (OCH), 65.4 (OCH2), 18.5 (CH3), 18.3 (CH3) ppm; 19F NMR (283 MHz, 
CDCl3): δ = -62.7 ppm; IR (neat): 2922, 2361, 1732, 1629, 1460, 1325, 1128, 696 cm-1; 
HRMS (NSI): [M+H]+ calc. 247.0940, found 247.0943 [C12H14O2F3]
+; MS (EI): m/z 304 
(100%), 287 (72%), 263 (28%), 247 ([M+H]+, 83%), 199 (81%); ee: could not be 
determined by HPLC analysis as the two enantiomers were not separable; [𝛂]𝐃
𝟐𝟎 = -38.3 
(c = 0.18, CHCl3). 
2-(1,1-Dimethoxypropyl)pyridine trifluoromethanesulfonate 190 
 
The product 190 was synthesised using general procedure GP1 at room temperature for 
24 h (0.394 mmol scale) (99% conversion). This product could not be isolated as it 
decomposed over column chromatography but the crude NMRs were clear enough to do 
some characterisation. 
Pale yellow oil; 1H NMR (400 MHz, CDCl3): δ = 9.13 (d, J = 5.8 Hz, 1H, H-Ar), 8.54 
(td, J = 7.9, 1.5 Hz, 1H, H-Ar), 8.08 – 7.96 (m, 2H, H-Ar), 3.28 (s, 6H, 2 OCH3), 2.10 (q, 
J = 7.6 Hz, 2H, CH2), 0.64 (t, J = 7.6, 3H, CH3) ppm; 13C NMR (125 MHz, CDCl3): 
δ = 155.0 (CAr), 146.8 (CArH), 142.5 (CArH), 126.8 (CArH), 125.3 (CArH), 122.3 
(C(OMe)2), 49.8 (2 OCH3), 29.4 (CH2), 7.2 (CH3) ppm; 19F NMR (283 MHz, CDCl3): 
δ = -78.3 ppm. 
Stacked 1H NMR of the experiments performed on the crude sample is showed below and 
was discussed in the main text (see Page 69). 
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Figure 7.1. Stacked spectra for the formation of 2-(1,1-Dimethoxypropyl)pyridine trifluoromethanesulfonate. 
Reaction with dibenzoylmethane 
 
The products 193, 194 and 195 were synthesised using general procedure GP1 at r.t. for 
20 h (0.394 mmol scale). 
Ethyl benzoate 193 
 
41% yield (48 mg, 0.319 mmol); The spectroscopic data are in agreement with 
literature.[33] Colourless oil; 1H NMR (500 MHz, CDCl3): δ = 8.06 (dd, J = 8.3, 1.3 Hz, 
2H, H-Ar), 7.54 (tt, J = 7.4, 1.3 Hz, 1H, H-Ar), 7.44 (tt, J = 7.7, 1.6 Hz, 2H, H-Ar), 4.38 
(q, J = 7.1 Hz, 2H, OCH2), 1.40 (t, J = 7.1 Hz, 3H, CH3) ppm; 13C NMR (125 MHz, 
CDCl3): δ = 166.8 (C=O), 132.9 (CArH), 130.7 (CAr), 129.7 (2 CArH), 128.4 (2 CArH), 
61.1 (OCH2), 14.5 (CH3) ppm. 
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 2-Ethoxy-1-phenylethan-1-one 194 
 
22% yield (28 mg, 0.170 mmol); The 1H NMR spectra is in agreement with literature.[34] 
Colourless oil; 1H NMR (500 MHz, CDCl3): δ = 7.94 (dd, J = 8.2, 1.2 Hz, 2H, H-Ar), 
7.58 (tt, J = 7.4, 1.2 Hz, 1H, H-Ar), 7.47 (t, J = 7.8 Hz, 2H, H-Ar), 4.75 (s, 2H, OCH2), 
3.65 (q, J = 7.0 Hz, 2H, OCH2CH3), 1.29 (t, J = 7.0 Hz, 3H, CH3) ppm; 13C NMR 
(125 MHz, CDCl3): δ = 196.7 (C=O), 135.2 (CAr), 133.6 (CArH), 128.8 (2 CArH), 128.1 
(2 CArH), 73.7 (OCH2), 67.4 (OCH2CH3), 15.2 (CH3) ppm; HRMS (APCI): [M+H]
+ 
calc. 165.0910, found 165.0906 [C10H13O2]
+.  
2,2-Diethoxy-1-phenylethan-1-one 195 
 
19% yield (32 mg, 0.154 mmol); The spectroscopic data are in agreement with 
literature.[35] Colourless oil; 1H NMR (500 MHz, CDCl3): δ = 8.16 (dd, J = 8.5, 1.4 Hz, 
2H, H-Ar), 7.57 (tt, J = 7.4, 1.2 Hz, 1H, H-Ar), 7.45 (t, J = 7.9 Hz, 2H, H-Ar), 5.27 (s, 
1H, CH), 3.77 (dq, J = 9.6, 7.1 Hz, 2H, OCHAHBCH3), 3.66 (dq, J = 9.5, 7.0 Hz, 2H, 
OCHAHBCH3), 1.25 (t, J = 7.1 Hz, 6H, CH3) ppm; 13C NMR (125 MHz, CDCl3): 
δ = 194.2 (C=O), 134.0 (CAr), 133.5 (CArH), 129.9 (2 CArH), 128.5 (2 CArH), 102.8 
(OCH), 63.4 (2 OCH2), 15.3 (2 CH3) ppm; HRMS (NSI): [M+H]
+ calc. 209.1172, found 
209.1172 [C12H17O3]
+.  
Ethyl 2-ethoxy-3-oxo-3-phenylpropionate 206 
 
The product 206 was synthesised from ethyl 3-oxo-3-phenylpropionate 205 using general 
procedure GP1 at r.t. for 20 h (0.394 mmol scale) (56% yield, 52 mg, 0.220 mmol).  
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The spectroscopic data are in agreement with literature.[36] Colourless oil; 1H NMR 
(500 MHz, CDCl3): δ = 8.08 (dd, J = 8.5, 1.2 Hz, 2H, H-Ar), 7.59 (tt, J = 7.4, 1.7 Hz, 
1H, H-Ar), 7.46 (t, J = 7.6 Hz, 2H, H-Ar), 5.00 (s, 1H, CH), 4.23 (q, J = 7.1 Hz, 2H, 
OCH2CH3), 3.75 (dq, J = 9.1, 7.0 Hz, 1H, OC(O)CHAHBCH3), 3.64 (dq, J = 9.1, 7.0 Hz, 
1H, OC(O)CHAHBCH3), 1.27 (t, J = 7.0 Hz, 3H, OC(O)CHAHBCH3), 1.19 (t, J = 7.1 Hz, 
3H, OCH2CH3) ppm; 13C NMR (125 MHz, CDCl3): δ = 193.0 (C=O, ketone), 168.0 
(C=O, ester), 134.3 (CAr), 134.0 (CArH), 129.6 (2 CArH), 128.7 (2 CArH), 83.9 (CH), 67.0 
(OCH2), 62.0 (OCH2), 15.2 (CH3), 14.1 (CH3) ppm; HRMS (NSI): [M+H]
+ calc. 
237.1121, found 237.1121 [C13H17O4]
+; MS (EI): m/z 254 (53%), 237 ([M+H]+, 100%), 
163 (15%).  
2-Methoxy-3-oxo-3-phenylpropanenitrile 208 
 
The product 208 was synthesised from 3-oxo-3-phenylpropanenitrile 207 using general 
procedure GP1 at r.t. for 20 h (0.394 mmol scale) (42% yield, 31 mg, 0.165 mmol).  
Pale yellow oil; 1H NMR (400 MHz, CDCl3): δ = 8.07 (d, J = 8.4 Hz, 2H), 7.72 (t, J = 
6.9 Hz, 1H), 7.57 (t, J = 7.7 Hz, 2H), 4.03 (s, 3H), 3.64 (s, 1H) ppm; 13C NMR (126 MHz, 
CDCl3): δ = 186.0 (C=O), 134.9 (CAr), 130.1 (2 CAr), 128.9 (2 CAr), 128.7 (CAr), 126.1 
(CN), 53.6 (OMe), 52.7 (OMe) ppm. 
4-Methoxy-2,2,6,6-tetramethylheptane-3,5-dione 210 
 
The product 210 was synthesised from di-tert-butylmalonate 209 using general procedure 
GP1 (0.394 mmol scale) (73% yield, 62 mg, 0.289 mmol).  
Crystalline colourless solid; m.p. = 35 - 36 °C; 1H NMR (300 MHz, CDCl3): δ = 4.90 
(s, 1H, CH), 3.37 (s, 3H, OCH3), 1.19 (s, 18H, 6 CH3) ppm; 13C NMR (125 MHz, 
CDCl3): δ = 210.6 (2 C=O), 85.6 (CH), 59.0 (OCH3), 44.5 (2 C), 26.8 (6 CH3) ppm; 
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IR (neat): 2972, 1695, 1479, 1365, 1124, 1059, 948 cm-1; HRMS (NSI): [M+NH4]
+ calc. 
232.1907, found 232.1908 [C12H26O3N]
+.  
Methyl 2-phenyl-2-(p-tolyl)acetate 213a 
 
Racemate: The product 213a was synthesised using general procedure GP1 at r.t. for 24 h 
(0.657 mmol scale) (70% yield, 110 mg, 0.460 mmol).  
Asymmetric: The product 213a was synthesised using general procedure GP3 at -20 °C 
for 48 h (0.328 mmol scale) (62% yield, 48 mg, 0.200 mmol).  
The spectroscopic data are in agreement with literature.[37] Colourless oil; 1H NMR 
(400 MHz, CDCl3): δ = 7.28 – 7.19 (m, 5H, H-Ar), 7.16 (d, J = 7.1 Hz, 2H, H-Ar), 7.09 
(d, J = 7.1 Hz, 2H, H-Ar), 4.96 (s, 1H, CH), 3.69 (s, 3H, OCH3), 2.28 (s, 3H, CH3) ppm; 
13C NMR (125 MHz, CDCl3): δ = 173.2 (C=O), 139.0 (CAr), 137.1 (CAr), 135.8 (CAr), 
129.5 (2 CArH), 128.71 (2 CArH), 128.70 (2 CArH), 128.6 (2 CArH), 127.3 (CArH), 56.8 
(CH or OCH3), 52.4 (CH or OCH3), 21.2 (CH3) ppm; IR (neat): 3028, 2951, 1732, 1512, 
1435, 1195, 1149, 729 cm-1; HRMS (ESI): [M+H]+ calc. 241.1223, found 241.1224 
[C16H17O2]
+; MS (EI): m/z 263 (38%), 241 ([M+H]+, 98%), 209 (100%), 181 (14%); ee: 
25%, determined by HPLC analysis: Daicel Chiralcel OJ column (25 cm), 
hexane/i-PrOH: 99/1, 1.0 mL/min, 20 °C, 254 nm, Tr (major) = 44.0 min, Tr (minor) = 
53.3 min; [𝛂]𝐃
𝟐𝟎 = +4.6 (c = 0.863, CHCl3). 
Ethyl 2-phenyl-2-(p-tolyl)acetate 213b 
 
Racemate: The product 213b was synthesised using general procedure GP1 (HC(OEt)3 
was used instead of HC(OMe)3) at r.t. for 24 h (0.657 mmol scale) (54% yield, 90 mg, 
0.354 mmol).  
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Colourless oil; 1H NMR (400 MHz, CDCl3): δ = 7.37 – 7.34 (m, 4H, H-Ar), 7.31 – 7.29 
(m, 1H, H-Ar), 7.25 (d, J = 8.1 Hz, 2H, H-Ar), 7.17 (d, J = 8.1 Hz, 2H, H-Ar), 5.02 (s, 
1H, CH) 4.25 (q, J = 7.1 Hz, 2H, OCH2CH3), 2.37 (s, 3H, CH3), 1.30 (t, J = 7.1 Hz, 3H, 
OCH2CH3) ppm; 13C NMR (125 MHz, CDCl3): δ = 172.8 (C=O), 139.2 (CAr), 137.0 
(CAr), 136.0 (CAr), 129.4 (2 CArH), 128.71 (2 CArH), 128.67 (2 CArH), 128.6 (2 CArH), 
127.3 (CAr), 61.2 (OCH2CH3), 57.0 (CH), 21.2 (CH3), 14.3 (OCH2CH3) ppm; IR (neat): 
2978, 1732, 1512, 1305, 1147, 1026 cm-1; HRMS (APCI): [M+H]+ calc. 255.1380, found 
255.1378 [C17H19O2]
+.  
2-Methoxy-2-phenyl-1-(p-tolyl)ethan-1-one 214a 
  
Racemate: The product 214a was synthesised using general procedure GP1 at r.t. for 24 h 
(0.657 mmol scale) (10% yield, 15 mg, 0.064 mmol).  
Asymmetric: The product 214a was synthesised using general procedure GP3 at -20 °C 
for 48 h (0.328 mmol scale) (11% yield, 9 mg, 0.375 mmol).  
Colourless oil; 1H NMR (400 MHz, CDCl3): δ = 7.90 (d, J = 8.2 Hz, 2H, H-Ar), 7.45 (d, 
J = 7.0 Hz, 2H, H-Ar), 7.36 – 7.28 (m, 3H, H-Ar), 7.18 (d, J = 8.0 Hz, 2H, H-Ar), 5.50 
(s, 1H, CH), 3.45 (s, 3H, OCH3), 2.35 (s, 3H, CH3) ppm; 13C NMR (125 MHz, CDCl3): 
δ = 196.9 (C=O), 144.2 (CAr), 136.5 (CAr), 132.7 (CAr), 129.35 (2 CArH), 129.32 (2 CArH), 
128.9 (2 CArH), 128.6 (CArH), 127.7 (2 CArH), 86.6 (CH), 57.6 (OCH3), 21.8 (CH3) ppm; 
IR (neat): 2985, 1685, 1604, 4281, 1180, 1103 cm-1; HRMS (ESI): [M+H]+ calc. 
241.1223, found 241.1221 [C16H17O2]
+; MS (EI): m/z 263 (26%), 241 ([M+H]+, 100%), 
209 (91%), 181 (12%); ee: 7%, determined by HPLC analysis: YMC Chiral Amylose-C 
S-5µm (25 cm), hexane/i-PrOH: 99/1, 0.7 mL/min, 20 °C, 254 nm, Tr (major) = 39.5 min, 
Tr (minor) = 53.2 min; [𝛂]𝐃
𝟐𝟎 = -14.0 (c = 0.143, CHCl3). 
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Methyl 2-(4-methoxyphenyl)-2-(p-tolyl)acetate 215a 
 
Racemate: The product 215a was synthesised using general procedure GP1 at r.t. for 24 h 
(0.657 mmol scale) (10% yield, 18 mg, 0.065 mmol).  
Asymmetric: The product 215a was synthesised using general procedure GP3 at -20 °C 
for 48 h (0.328 mmol scale) (4% yield, 3 mg, 0.011 mmol).  
The spectroscopic data are in agreement with literature.[26] Colourless oil; 1H NMR 
(400 MHz, CDCl3): δ = 7.22 (d, J = 8.8 Hz, 2H, H-Ar), 7.18 (d, J = 8.1 Hz, 2H, H-Ar), 
7.13 (d, J = 8.1 Hz, 2H, H-Ar), 6.85 (d, J = 8.8 Hz, 2H, H-Ar), 4.95 (s, 1H, CH), 3.78 (s, 
3H, OCH3), 3.73 (s, 3H, OCH3), 2.32 (s, 3H, CH3) ppm; 13C NMR (125 MHz, CDCl3): 
δ = 173.5 (C=O), 158.9 (CAr – OMe), 137.0 (CAr), 136.0 (CAr), 131.2 (CAr), 129.8 
(2 CArH), 129.4 (2 CArH), 128.5 (2 CArH), 114.1 (2 CArH), 56.0 (CH or OCH3), 55.4 (CH 
or OCH3), 52.3 (CH or OCH3), 21.2 (CH3) ppm; IR (neat): 2951, 1732, 1508, 1249, 1149 
cm-1; HRMS (ESI): [M+NH4]
+ calc. 288.1594, found 288.1592 [C17H22O3N]
+; MS (EI): 
m/z 288 ([M+NH4]
+, 100%), 271 (M+, 30%), 211 (30%), 179 (20%), 163 (10%); ee: 5%, 
determined by HPLC analysis: Regis® Pirkle Covalent (R,R) Whelk-O 1 (25 cm) 
hexane/i-PrOH: 99/1, 1.0 mL/min, 20 °C, 232 nm, Tr (major) = 34.7 min, Tr (minor) = 
43.6 min. 
7.4.2.3. Mechanistic studies 
2-Methoxy-1-phenylpropan-1-one 165a 
 
To a solution of (Z)-trimethyl((1-phenylprop-1-en-1-yl)oxy)silane (Z)-226 (64 mg, 
0.309 mmol) and Ishihara amide 6b (271 mg, 0.371 mmol) in HC(OMe)3 (1.5 mL), TfOH 
(55 µL, 0.618 mmol) was added at -20 °C. The resulting solution was stirred at that 
temperature for 24 h, quenched with water (1 mL), left to warm up to room temperature 
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and extracted with CH2Cl2 (3 x 2 mL). The organic phase was dried over a Telos
® phase 
separator and concentrated under vacuum. After column chromatography, 2-methoxy-1-
phenylpropan-1-one 165a was obtained as the major product (80% yield, 41 mg, 
0.247 mmol, 78% ee) as well as the rearranged product 163a (~4% yield, ~2 mg, 
0.0124 mmol, 47% ee). 
The spectroscopic data for 165a are in agreement with literature.[38] Pale yellow oil; 
1H NMR (400 MHz, CDCl3): δ = 8.05 (dd, J = 8.5, 1.2 Hz, 2H, H-Ar), 7.59 (tt, J = 7.4, 
1.3 Hz, 1H, H-Ar), 7.48 (t, J = 7.9 Hz, 2H, H-Ar), 4.64 (q, J = 6.9 Hz, 1H, CH), 3.39 (s, 
3H, OCH3), 1.49 (d, J = 6.9 Hz, 3H, CH3) ppm; 13C NMR (125 MHz, CDCl3): δ = 200.7 
(C=O), 135.1 (CAr), 133.5 (CArH), 128.9 (2 CArH), 128.8 (2 CArH), 80.5 (CH), 57.4 
(OCH3), 18.6 (CH3) ppm; ee: 78%, determined by HPLC analysis: YMC Chiral 
Amylose-C S-5µm (25 cm), hexane/i-PrOH: 99/1, 1.0 mL/min, 20 °C, 254 nm, Tr (major) 
= 7.6 min, Tr (minor) = 8.9 min; [𝛂]𝐃
𝟐𝟎 = -35.1 (c = 0.057, CHCl3).  
The absolute stereochemistry of molecule 165a was determined by its synthesis via 
another route, starting with L-lactic acid [(S)-lactic acid]. 
Methyl (S)-2-methoxypropanoate 
 
n-BuLi (2.5 M in hexane, 4.60 mL, 11.6 mmol) was added dropwise to anhydrous DMSO 
(10 mL) at r.t. under inert atmosphere. (S)-lactic acid (460 µL, 5.11 mmol) was then added 
dropwise and the resulting solution was stirred for 15 minutes. Iodomethane (800 µL, 
12.7 mmol) was added dropwise and the reaction mixture was stirred at room temperature 
for 20 h. The mixture was poured in cold water (50 mL) and extracted with ether, dried 
over MgSO4 and concentrated under vacuum. The resulting yellow oil product was 
unstable and was used without further purification (47% yield, 286 mg, 2.42 mmol). 
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1H NMR (300 MHz, CDCl3): δ = 3.88 (q, J = 6.6 Hz, 1H, CH), 3.75 (s, 3H, OMe), 3.38 
(s, 3H, OMe), 1.39 (d, J = 6.7 Hz, 3H, CH3) ppm; 13C NMR (125 MHz, CDCl3): 
δ = 173.7 (C=O), 76.5 (CH), 57.8 (OMe), 52.0 (OMe), 18.5 (CH3) ppm; [𝛂]𝐃
𝟐𝟎 = -57.1 
(c = 0.7, CHCl3).  
(S)-N,2-Dimethoxy-N-methylpropanamide 
 
N,O-Dimethylhydroxylamine hydrochloride (545 mg, 5.59 mmol) was dissolved in dry 
CH2Cl2 (7 mL) and cooled down to -15 °C. AlMe3 (2 M in toluene, 2.8 mL, 5.59 mmol) 
was added dropwise and the reaction was warmed to r.t. After 1 h, the reaction was cooled 
down to -15 °C and a solution of methyl (S)-2-methoxypropanoate (220 mg, 1.86 mmol) 
in dry CH2Cl2 (7 mL) was added. The resulting mixture was warmed up to r.t. and stirred 
for 24 h. A 15% aqueous solution of potassium, sodium tartrate (20 mL) was added very 
slowly at 0 °C and the resulting mixture was stirred for 1 h and then filtered through celite. 
The filtrate was extracted with CH2Cl2 (3 x 20 mL) and the combined organic layers were 
dried over MgSO4 and concentrated under vacuum. After purification by column 
chromatography (0 to 100% EtOAc in hexane) the product was obtained as a pale yellow 
oil (51% yield, 140 mg, 0.951 mmol). 
1H NMR (300 MHz, CDCl3): δ = 4.23 (q, J = 6.1 Hz, 1H, CH), 3.71 (s, 3H, Me), 3.35 
(s, 3H, Me), 3.22 (s, 3H, Me), 1.36 (d, J = 6.6 Hz, 3H, CHCH3) ppm; 13C NMR (125 
MHz, CDCl3): δ = 173.9, 77.4, 74.3, 61.5, 57.2, 17.8 ppm; [α]D20 = –95.0 (c = 0.8, 
CHCl3).  
 (S)-2-Methoxy-1-phenylpropan-1-one (S)-165a 
 
(S)-N,2-Dimethoxy-N-methylpropanamide (25 mg, 0.17 mmol) was dissolved in dry THF 
(2 mL) and cooled down to 0 °C. A solution of phenyl magnesium bromide in ether (3 M, 
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85 µL, 0.25 mmol) was added dropwise and the resulting solution was stirred for 
15 minutes at 0 °C. The mixture was quenched with sat. aq. NH4Cl (1 mL) and extracted 
with Et2O (3 x 3 mL). The combined organic layers were washed with brine, dried 
through a Telos® phase separator and concentrated under vacuum. After purification by 
preparative TLC (20% Ether in hexane) the pure product was obtained as a colourless oil 
(82% yield, 23 mg, 0.14 mmol). [α]D20 = –76.9 (c = 0.676, CHCl3). This established a 
negative rotation for the (S)-enantiomer. 
(1,1-Dimethoxypropyl)benzene 179 
 
Propiophenone (665 µL, 5.00 mmol), p-TsOH•H2O (47.6 mg, 0.250 mmol) and trimethyl 
orthoformate (5.47 mL, 50.0 mmol) were dissolved in methanol (15 mL) and the resulting 
solution was stirred at reflux for 24 h. The solvent was remove using a rotary evaporator. 
Et2O (10 mL) was added and the organic phase was washed with sat. aq. NaHCO3 
solution, dried over MgSO4 and concentrated under vacuum. After purification by column 
chromatography (0 to 5% EtOAc in hexane) the pure product 179 was obtained as a 
colourless oil (75% yield, 676 mg, 3.75 mmol). 
The spectroscopic data are in agreement with literature.[39] 1H NMR (400 MHz, CDCl3): 
δ = 7.47 – 7.44 (m, 2H, H-Ar), 7.37 – 7.33 (m, 2H, H-Ar), 7.30 – 7.28 (m, 1H, H-Ar), 
3.16 (s, 6H, 2 OCH3), 1.91 (q, J = 7.5 Hz, 2H, CH2), 0.59 (t, J = 7.5 Hz, 3H, CH3) ppm; 
13C NMR (125 MHz, CDCl3): δ = 140.8 (CAr), 128.0 (2 CArH), 127.6 (CArH), 127.2 
(2 CArH), 48.7 (2 OCH3), 30.1 (CH2), 7.9 (CH3) ppm.  
Interconversion between 29a and 179 via the hemiketal 
In a NMR tube, propiophenone 29a or ketal 179 (10 mg or 13 mg, 0.075 mmol) were 
dissolved in CDCl3 (0.6 mL) and HC(OMe)3 (41 µL, 0.37 mmol) was added, followed by 
TfOH (14 µL, 0.15 mmol). The 1H NMR were measured and are shown below. 
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 (Z)-Trimethyl((1-phenylprop-1-en-1-yl)oxy)silane (Z)-226 
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To a solution of lithium diisopropylamide (4.1 mL, 2 M, 8.2 mmol) in THF (50 mL) 
at -78 °C under N2, propiophenone (1.00 mL, 7.45 mmol) was added dropwise. The 
resulting mixture was stirred at -78 °C for 20 minutes and then, TMSCl (1.04 mL, 
8.19 mmol) was added. After 3 h at -78 °C, the reaction was quenched with sat. aq. NH4Cl 
solution (50 mL), extracted with Et2O (3 x 50 mL), dried over MgSO4 and concentrated 
under vacuum. After purification by column chromatography (0 to 10% EtOAc in 
hexane) the pure product (Z)-226 was obtained as a colourless oil (40% yield, 610 mg, 
2.96 mmol). 
The spectroscopic data are in agreement with literature.[40] 1H NMR (400 MHz, CDCl3): 
δ = 7.47 – 7.44 (m, 2H, H-Ar), 7.31 – 7.21 (m, 3H, H-Ar), 5.34 (q, J = 6.9 Hz, 1H, CH), 
1.74 (d, J = 6.9 Hz, 3H, CH3), 0.14 (s, 9H, TMS) ppm; 13C NMR (125 MHz, CDCl3): 
δ = 150.1 (C1), 139.4 (CAr), 128.2 (2 CArH), 127.4 (CArH), 125.4 (2 CArH), 105.4 (C2), 
11.8 (C3), 0.7 (3 CH3 (TMS)) ppm; IR (neat): 2959, 1651, 1493, 1323, 1249, 1060, 
879 cm-1; HRMS (APCI): [M+H]+ calc. 207.1200, found 207.1196 [C12H19OSi]
+. 
(Z)-1-phenylprop-1-en-1-yl acetate 227 
 
To a solution of lithium diisopropylamide (4.8 mL, 2 M, 9.6 mmol) in dry THF (35 mL) 
under N2, propiophenone (1.06 mL, 8.00 mmol) was added at -78 °C. The resulting 
orange solution was stirred at that temperature for 45 minutes before adding acetic 
anhydride (1.5 mL, 16 mmol). After 30 minutes, the mixture was poured into sat. aq. 
NaHCO3 solution (100 mL) and extracted with EtOAc (3 x 100 mL). The combined 
organic layers were dried over MgSO4 and concentrated under vacuum. The pure product 
227 was obtained after purification by column chromatography (0 to 20% EtOAc in 
hexane) (52% yield, 0.735 g, 4.2 mmol).  
The spectroscopic data are in agreement with literature.[41] Colourless oil; 1H NMR 
(400 MHz, CDCl3): δ = 7.41 – 7.39 (m, 2H, H-Ar), 7.34 – 7.31 (m, 2H, H-Ar), 
7.28 – 7.24 (m, 1H, H-Ar), 5.91 (q, J = 7.0 Hz, 1H, CH), 2.31 (s, 3H, OC(O)CH3), 1.72 
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(d, J = 7.0 Hz, 3H, CH3) ppm; HRMS (APCI): [M+H]
+ calc. 177.0910, found 177.0907 
[C11H18O2]
+.  
7.4.2.4. Hydrolysis of the ester 163b to obtain ibuprofen 
(R)-Ibuprofen (R)-139 
 
To a solution of ester (R)-163b (30 mg, 0.136 mmol, 35% ee) in THF (1 mL) and MeOH 
(0.5 mL), NaOH (82 µL, 2 N, 0.163 mmol) was added and the resulting mixture was 
stirred at r.t. for 16 h. The basic solution was washed with CHCl3 (2 mL). The aqueous 
layer was then acidified to pH = 1 with 1 N HCl and extracted with CH2Cl2 (3 x 2 mL). 
The combined organic layers were then dried over a Telos® phase separator and 
concentrated under vacuum to yield pure product as a white solid (93% yield, 26 mg, 
0.126 mmol). 
The spectroscopic data are in agreement with literature.[42] m.p. = 74 - 75 °C (lit.[43] 76 - 
77 °C); 1H NMR (400 MHz, CDCl3): δ = 11.35 (s, 1H, COOH), 7.23 (d, J = 7.2 Hz, 2H, 
H-Ar), 7.11 (d, J = 7.4 Hz, 2H, H-Ar), 3.71 (q, J = 7.1 Hz, 1H, C*HCH3), 2.45 (d, J = 7.1 
Hz, 2H, CH2), 1.91 – 1.76 (m, 1H, CH(CH3)2), 1.50 (d, J = 7.1 Hz, 3H, C*HCH3), 0.90 
(d, J = 6.6 Hz, 6H, CH(CH3)2) ppm; 13C NMR (125 MHz, CDCl3): δ = 180.9 (C=O), 
141.0 (CAr), 137.1 (CAr), 129.5 (2 CArH), 127.4 (2 CArH), 45.2 (CH2CH(CH3)2), 45.1 
(C*HCH3), 30.3 (CH2CH(CH3)2), 22.5 (CH2CH(CH3)2), 18.3 (CHCH3) ppm; HRMS 
(EI): [M]+ calc. 206.1307, found 206.1311 [C13H18O2]
+; MS (EI): m/z 206 ([M]+, 64%), 
163 (86%), 161 (100%), 119 (31%), 117 (42%), 91 (30%), 83 (40%); ee: 22%, determined 
by HPLC analysis: Regis® Pirkle Covalent (R,R) Whelk-O 1 (25 cm), hexane/i-PrOH: 
99/1 + 0.05% AcOH, 0.9 mL/min, 20 °C, 267 nm, Tr (minor, (S)-isomer) = 15.0 min, Tr 
(major, (R)-isomer) = 17.4 min; [𝛂]𝐃
𝟐𝟎 = -9.5 (c = 0.42, CHCl3). (lit.
[44] for the (R)-
isomer [𝛂]𝐃
𝟐𝟎 = -54.3 (c = 2.0, EtOH)). 
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 Cyclisation of malonate derivatives 
7.4.3.1. Synthesis of substrates 
Alkylation of dimethyl malonate 
Sodium hydride (0.800 g, 33.3 mmol) was added portionwise to a solution of dimethyl 
malonate (4.00 g, 30.3 mmol) in dry THF (50 mL) at 0 °C. After 10 minutes, allyl bromide 
(2.90 mL, 33.3 mmol) was added dropwise. The resulting mixture was stirred for 18 h at 
room temperature, cooled down to 0 °C and quenched with water (20 mL). The organic 
phase was extracted with Et2O (3 x 50 mL), washed with brine (30 mL), dried over 
MgSO4 and concentrated under vacuum. The resulting crude dimethyl 2-allylmalonate 
was purified by column chromatography (0 to 10% EtOAc in hexane) to afford the mono- 
and di-alkylated malonate derivatives 294 and 295 as colourless oils. 
Dimethyl 2-allylmalonate 294 
 
50% yield (2.61 g, 15.2 mmol); The spectroscopic data are in agreement with literature.[45] 
1H NMR (400 MHz, CDCl3): δ = 5.76 (ddt, J = 17.0, 10.2, 6.8 Hz, 1H, CH2CH=CH2), 
5.16 – 5.02 (m, 2H, CH2CH=CH2), 3.73 (s, 6H, 2 OCH3), 3.46 (t, J = 7.6 Hz, 1H, CH), 
2.65 (t, J = 7.2 Hz, 2H, CH2CH=CH2) ppm. 
Dimethyl 2,2-diallylmalonate 295 
 
20% yield (1.29 g, 6.06 mmol); The spectroscopic data are in agreement with literature.[45] 
1H NMR (400 MHz, CDCl3): δ = 5.67 – 5.50 (m, 2H, 2 CH2CH=CH2), 5.08 – 4.99 (m, 
4H, 2 CH2CH=CH2), 3.65 (s, 6H, 2 OCH3), 2.57 (d, J = 7.4 Hz, 4H, 2 CH2CH=CH2) 
ppm; 13C NMR (125 MHz, CDCl3): δ = 171.3 (2 C=O), 132.4 (2 C=CH), 119.4 (2 
C=CH), 57.8 (C), 52.5 (2 OCH3), 37.1 (2 CH2) ppm. 
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Dimethyl 2-allyl-2-(prop-2-yn-1-yl)malonate 297 
 
Sodium hydride (0.510 g, 12.8 mmol) was added portionwise to a solution of dimethyl 
2-allylmalonate 294 (2.08 g, 11.6 mmol) in dry THF (40 mL) at 0 °C. After 10 minutes, 
propargyl bromide (solution, 80 wt.% in toluene, 4.35 mL, 17.5 mmol) was added 
dropwise. The resulting mixture was stirred for 18 h at room temperature, cooled down 
to 0 °C and quenched with water (20 mL). The organic phase was extracted with Et2O 
(3 x 50 mL), washed with brine (30 mL), dried over MgSO4 and concentrated under 
vacuum. The resulting crude was purified by column chromatography (pure hexane) to 
afford the pure product 297 (64% yield, 1.72 g, 8.19 mmol). 
The spectroscopic data are in agreement with literature.[46] Colourless oil; 1H NMR 
(300 MHz, CDCl3):  = 5.69 – 5.55 (m, 1H, CH=CH2), 5.22 – 5.11 (m, 2H, CH=CH2), 
3.74 (s, 6H, 2 OCH3), 2.82 – 2.80 (m, 4H, 2 CH2), 2.02 (t, J = 5.0 Hz, 1H, CCH) ppm; 
13C NMR (125 MHz, CDCl3): δ = 170.3 (2 C=O), 131.8 (C=CH2), 120.1 (C=CH2), 78.9 
(CCH), 71.6 (CCH), 57.0 (C), 52.9 (2 OCH3), 36.6 (CH2CH=CH2), 22.8 
(CH2CCH) ppm. 
Mono- and di-alkylation of ethyl 2-cyanoacetate 
To a solution of ethyl 2-cyanoacetate (2.28 g, 20.2 mmol) in dry THF (100 mL), sodium 
hydride (2.13 g, 44.4 mmol) was added portionwise at 0 °C. The resulting mixture was 
stirred for 15 minutes. Allyl bromide (7.68 mL, 44.4 mmol) was then added via syringe 
pump (0.1 mL/min). The reaction was warmed up to room temperature and stirred for 
22 h. The reaction was cooled to 0 °C, quenched with water and extracted with diethyl 
ether (3 x 100 mL). The combined organic layers were washed with brine, dried over 
MgSO4 and concentrated under vacuum. After column chromatography, both mono- and 
di-alkylated products 301 and 302 were isolated as colourless oils. 
Ethyl 2-cyanopent-4-enoate 301 
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22% yield (895 mg, 5.85 mmol); The spectroscopic data are in agreement with 
literature.[47] 1H NMR (400 MHz, CDCl3): δ = 5.91 – 5.77 (m, 1H, CH2CH=CH2), 
5.36 – 5.21 (m, 2H, CH2CH=CH2), 4.29 (q, J = 7.1 Hz, 2H, OCH2CH3), 3.58 (t, J = 
6.8 Hz, 1H, CH), 2.73 – 2.69 (m, 2H, CH2CH=CH2), 1.34 (t, J = 7.1 Hz, 3H, OCH2CH3) 
ppm; 13C NMR (125 MHz, CDCl3): δ = 165.6 (C=O), 131.5 (CH=CH2), 120.2 
(CH=CH2), 116.2 (CN), 63.0 (OCH2CH3), 37.6 (CH2), 34.0 (CH), 14.1 (OCH2CH3) 
ppm.  
Ethyl 2-allyl-2-cyanopent-4-enoate 302 
 
76% yield (2.98 g, 15.4 mmol); The spectroscopic data are in agreement with literature.[48] 
1H NMR (400 MHz, CDCl3): δ = 5.96 – 5.67 (m, 2H, 2 CH2CH=CH2), 5.25 – 5.22 (m, 
4H, 2 CH2CH=CH2), 4.25 (q, J = 7.1 Hz, 2H, OCH2CH3), 2.64 (dd, J = 13.8, 7.4 Hz, 2H, 
2 CHAHBCH=CH2 ), 2.54 (dd, J = 13.8, 7.2 Hz, 2H, 2 CHAHBCH=CH2), 1.30 (t, J = 7.1 
Hz, 3H, OCH2CH3) ppm; 13C NMR (125 MHz, CDCl3): δ = 168.1 (C=O), 130.6 (2 
CH=CH2), 121.1 (2 CH=CH2), 118.6 (CN), 62.8 (OCH2CH3), 49.4 (C), 40.8 (2 CH2), 
14.3 (OCH2CH3) ppm.  
2-(Methoxycarbonyl)-2-(prop-2-yn-1-yl)pent-4-enoic acid 306 
 
Dimethyl 2-allyl-2-(prop-2-yn-1-yl)malonate 297 (294 mg, 1.40 mmol) was dissolved in 
methanol (5 mL). Sodium hydroxide (1.4 mL, 2 N, 2.8 mmol) was added and the resulting 
solution was stirred at room temperature for 3 h. The reaction was cooled to 0 °C, 
quenched with HCl (5 mL, 1 N) and extracted with EtOAc (3 x 10 mL). The combined 
organic layers were dried over MgSO4 to yield the pure product as a colourless oil 
(96% yield, 263 mg, 1.34 mmol). 
The spectroscopic data are in agreement with literature.[49] 1H NMR (400 MHz, CDCl3): 
 = 5.65 (ddt, J = 17.5, 10.1, 7.5 Hz, 1H, CH=CH2), 5.24 – 5.15 (m, 2H, CH=CH2), 3.79 
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(s, 3H, OCH3), 2.88 – 2.77 (m, 4H, 2 CH2), 2.06 (t, J = 2.7 Hz, 1H, CCH) ppm; 
13C NMR (125 MHz, CDCl3): δ = 173.4 (COOH), 170. (COOMe), 131.4 (C=CH2), 
120.4 (C=CH2), 78.6 (CCH), 71.9 (CCH), 57.1 (C), 53.2 (OCH3), 37.4 
(CH2CH=CH2), 23.4 (CH2CCH) ppm. 
Mono- and di-alkylation of di-tert-butyl malonate 
To a solution of di-tert-butyl malonate (1.93 g, 8.93 mmol) in dry THF (20 mL), sodium 
hydride (0.357 g, 60% in mineral oil, 8.93 mmol) was added portionwise at 0 °C. The 
resulting mixture was stirred for 30 minutes. Allyl bromide (0.77 mL, 8.93 mmol) was 
added dropwise, the reaction was warmed up to room temperature and stirred for 20 h. 
The reaction was then cooled to 0 °C, quenched with water and extracted with diethyl 
ether (3 x 20 mL). The combined organic layers were washed with brine (25 mL), dried 
over MgSO4 and concentrated under vacuum. The resulting pale yellow oil was used 
without further purification for the second alkylation (70% conversion to the desired 
product). 
To a solution of di-tert-butyl 2-allylmalonate (1.5 g, 70% purity, 5.85 mmol) in dry THF 
(20 mL), sodium hydride (0.234 g, 60% in mineral oil, 5.85 mmol) was added portionwise 
at 0 °C. The resulting mixture was stirred for 30 minutes. Propargyl bromide (solution, 
80 wt.% in toluene, 0.87 mL, 5.85 mmol) was added dropwise, the reaction was warmed 
up to room temperature and stirred for 20 h. It was then cooled to 0 °C, quenched with 
water and extracted with diethyl ether (3 x 20 mL). The combined organic layers were 
washed with brine (25 mL), dried over MgSO4 and concentrated under vacuum. After 
purification by column chromatography, the pure product was obtained as colourless solid 
(68% yield, 820 mg, 2.79 mmol). 
Di-tert-butyl 2-allylmalonate 308 
 
1H NMR (300 MHz, CDCl3): δ = 5.78 (ddt, J = 17.0, 10.1, 6.8 Hz, 1H, CH2CH=CH2), 
5.18 – 4.97 (m, 2H, CH2CH=CH2), 3.21 (t, J = 7.6 Hz, 1H, CH), 2.55 (t, J = 7.2 Hz, 2H, 
CH2CH=CH2), 1.45 (s, 18H, 6 CH3) ppm. 
Florence Malmedy Experimental Part 
198 
 
Di-tert-butyl 2,2-diallylmalonate 309 
 
1H NMR (300 MHz, CDCl3): δ = 5.63 (ddt, J = 17.4, 10.0, 7.5 Hz, 1H, CH=CH2), 
5.24 – 5.08 (m, 2H, CH=CH2), 2.75 – 2.66 (m, 4H, 2 CH2), 2.00 (t, J = 2.7 Hz, 1H, 
CCH), 1.45 (s, 18H, 6 CH3) ppm; 13C NMR (125 MHz, CDCl3):  = 169.1 (2 C=O), 
132.3 (CH=CH2), 119.6 (CH=CH2), 81.9 (CCH), 71.2 (CCH), 57.4 (C), 36.3 
(CH2CH=CH2), 28.0 (6 CH3), 22.5 (CH2CCH) ppm. 
7.4.3.2. Cyclisation reaction 
General procedure for the cyclisation reaction GP4 
Iodine(III) reagent (1 to 1.5 eq.) was dissolved in dry dichloromethane (2 mL) under 
argon and cooled down to -20 °C. Lewis acid (2 or 3 eq.) was then added and the resulting 
mixture was stirred for 5 minutes. A solution of starting material (0.28 mmol) in dry 
dichloromethane (2 mL) was then added and the resulting mixture was stirred for 20 h at 
the temperature mentioned in Table 5.1. The reaction was quenched with sat. aq. solution 
of sodium bicarbonate (0. 5 mL) and the organic phase was extracted with 
dichloromethane (3 x 5 mL). The combined organic layers were dried through a Telos® 
phase separator and concentrated under vacuum. The pure product was obtained after 
purification by column chromatography (0 to 30% EtOAc in hexane). 
General procedure with the optimised conditions for the cyclisation reaction GP5. 
PhI(OAc)2 (108 mg, 0.340 mmol) was dissolved in dry dichloromethane (2 mL) under 
argon and the reaction was cooled down to -20 °C. BF3•OEt2 (70 µL, 0.56 mmol) and 
AcOH (200 µL, 3.5 mmol) was then added and the resulting mixture was stirred for 
5 minutes. A solution of starting material (0.28 mmol) in dry dichloromethane (2 mL) 
was then added and the resulting mixture was stirred for 19 h at -20 °C. The reaction was 
quenched with sat. aq. solution of sodium bicarbonate (0.5 mL) and the organic phase 
was extracted with dichloromethane (3 x 5 mL). The combined organic layers were dried 
through a Telos® phase separator and concentrated under vacuum. The pure product was 
obtained after purification by column chromatography (0 to 30% EtOAc in hexane). 
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Methyl 5-(acetoxymethyl)-2-oxo-3-(prop-2-yn-1-yl)tetrahydrofuran-3-carboxylate 
298a 
 
The product 298a was synthesised using general procedure GP5 at -20 °C for 20 h 
(0.28 mmol scale) (58% yield, 42 mg, 0.162 mmol).  
Colourless oil; 1H NMR (400 MHz, CDCl3):  = 4.87 (dtd, J = 9.7, 6.3, 3.1 Hz, 1H, HC), 
4.39 (dd, J = 12.4, 3.1 Hz, 1H, HA), 4.18 (dd, J = 12.4, 6.1 Hz, 1H, HB), 3.81 (s, 3H, 
OCH3), 2.90 (t, J = 2.4 Hz, 2H, CH2CCH), 2.71 (dd, J = 13.4, 6.6 Hz, 1H, HD), 2.41 
(dd, J = 13.4, 10.0 Hz, 1H, HE), 2.11 (s, 3H, CH3 (OAc)), 2.09 (t, J = 2.6 Hz, 1H, 
CH2CCH) ppm; 13C NMR (125 MHz, CDCl3):  = 172.2 (C=O), 170.6 (C=O), 168.7 
(C=O), 78.4 (CCH), 75.8 (CHOAc), 72.2 (CCH), 64.4 (OCH2), 54.7 (C), 53.7 (OCH3), 
32.2 (CH2), 23.9 (CH2CCH), 20.8 (CH3 (OAc)) ppm; IR (neat): 3281, 2916, 2387, 
1776, 1736, 1537, 1435, 1232, 1178, 1038 cm-1; HRMS (AP+): [M+H]+ calc. 255.0869, 
found 255.0869 [C12H15O6]
+. 
After 2 years at r.t. the colourless oil crystallised and the resulting crystal structure 
established the ring size of the lactone to be a 5-membered ring. 
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Methyl 5-(hydroxymethyl)-2-oxo-3-(prop-2-yn-1-yl)tetrahydrofuran-3-carboxylate 
298b 
 
The product 298b was synthesised using general procedure GP4 at -20 °C for 20 h 
(0.28 mmol scale) (39% yield of a mixture 2:1 of both enantiomers, 20 mg, 0.094 mmol).  
Colourless oil; 1H NMR (400 MHz, CDCl3):  = 4.73 – 4.68 (m, 1.5H, HC (major) + HC 
(minor)), 3.91 (dd, J = 12.8, 2.7 Hz, 1H, HA (major)), 3.83 (dd, J = 12.6, 3.1 Hz, 0.5H, 
HA (minor)), 3.74 (s, 3H , OCH3 (major)), 3.73 (s, 1.5H , OCH3 (minor)), 3.67 (dd, J = 
12.8, 4.3 Hz, 0.5H, HB (minor)), 3.63 (dd, J = 12.8, 4.3 Hz, 1H, HB (major)), 2.84 – 2.82 
(m, 3H, CH2 (major) + CH2 (minor)), 2.67 (dd, J = 13.7, 7.0 Hz, 0.5H, HD (minor)), 2.58 
(dd, J = 13.3, 6.6 Hz, 1H, HD (major)), 2.53 (dd, J = 13.7, 8.1 Hz, 0.5H, HE (minor)), 2.53 
(dd, J = 13.3, 9.7 Hz, 1H, HE (major)), 2.03 (t, J = 2.7 Hz, 0.5H, CCH (minor)), 2.02 (t, 
J = 2.6 Hz, 1H, CCH (major)) ppm; IR (neat): 3476, 3277, 1769, 1732, 1435, 1248, 
1180, 1030 cm-1; HRMS (ES-): [M-H]- calc. 211.0606, found 211.0605 [C10H11O]
-. 
Dimethyl 2-(3-acetoxy-2-oxopropyl)-2-allylmalonate 299 
 
The product 299 was a side-product synthesised using general procedure GP4 at -20 °C 
for 20 h (0.28 mmol scale).  
Colourless oil; 1H NMR (400 MHz, CDCl3):  = 5.66 – 5.56 (m, 1H, CH2CH=CH2), 
5.14 – 5.09 (m, 2H, CH2CH=CH2), 4.65 (s, 2H, CH2OAc), 3.74 (s, 6H, 2 OCH3), 3.05 (s, 
2H, CH2C=O), 2.77 (d, J = 7.0 Hz, 2H, CH2CH=CH2), 2.15 (s, 3H, CH3 (OAc)) ppm; 
13C NMR (125 MHz, CDCl3):  = 200.8 (C=O), 170.6 (2 C(O)OCH3), 170.2 (C=O 
(OAc)), 132.4 (CH=CH2), 120.2 (CH=CH2), 68.0 (CH2OAc), 55.2 (C), 53.0 (2 OCH3), 
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41.2 (CH2), 38.0 (CH2), 20.5 (CH3) ppm; IR (neat): 2957, 1732, 1435, 1221, 1040 cm
-1; 
HRMS (ES+): [M+Na]+ calc. 309.0950, found 309.0936 [C13H18NO7Na]
+. 
(4-Allyl-4-cyano-5-oxotetrahydrofuran-2-yl)methyl acetate 303a 
 
The product 303a was synthesised from molecule 302 using general procedure GP5 
at -20 °C for 20 h (0.24 mmol scale) (43% yield, 24 mg, 0.103 mmol).  
Pale yellow oil; 1H NMR (500 MHz, CDCl3): δ = 5.84 – 5.76 (m, 1H, CH2CH=CH2), 
5.36 – 5.31 (m, 2H, CH2CH=CH2), 4.91 – 4.86 (m, 1H, HC), 4.39 (dd, J = 12.6, 3.2 Hz, 
1H, HA), 4.17 (dd, J = 12.6, 5.4 Hz, 1H, HB), 2.87 (dd, J = 14.1, 7.2 Hz, 1H, HF), 2.69 
(dd, J = 13.5, 6.2 Hz, 1H, HD), 2.60 (dd, J = 15.0, 8.2 Hz, 1H, HG), 2.17 (dd, J = 13.5, 
10.1 Hz, 1H, HE), 2.11 (s, 3H, CH3 (OAc)) ppm; 13C NMR (125 MHz, CDCl3): δ = 170.3 
(C=O), 169.0 (C=O), 129.7 (CH=CH2), 122.4 (CH=CH2), 116.8 (CN), 75.6 (CHOAc), 
63.6 (OCH2), 43.5 (C), 39.3 (CH2), 34.9 (CH2), 20.7 (CH3 (OAc)) ppm; IR (neat): 2959, 
2320, 1778, 1742, 1443, 1370, 1236, 1182, 1011, 933 cm-1; HRMS (ES+): [M+H]+ calc. 
224.0923, found 224.0925 [C11H14NO4]
+. 
3-Allyl-5-(hydroxymethyl)-2-oxotetrahydrofuran-3-carbonitrile 303b 
 
The product 303b was synthesised from molecule 302 and iodosylbenzene using general 
procedure GP4 at -20 °C for 20 h (0.24 mmol scale) (37% yield for both diastereomers, 
44 mg, 0.089 mmol; 28% yield for major isomer, 12 mg, 0.066 mmol; 9% yield for minor 
isomer, 4 mg, 0.022 mmol).  
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Major diastereoisomer: Pale yellow oil; 1H NMR (400 MHz, CDCl3): δ = 5.88 – 5.76 
(m, 1H, CH2CH=CH2), 5.37 – 5.29 (m, 2H, CH2CH=CH2), 4.78 (ddd, J = 12.5, 6.2, 
3.1 Hz, 1H, HC), 4.05 (dd, J = 12.9, 2.6 Hz, 1H, HA), 3.65 (dd, J = 12.9, 3.3 Hz, 1H, HB), 
2.87 (ddt, J = 14.1, 6.9, 1.1 Hz, 1H, HF), 2.64 – 2.54 (m, 2H, HD + HG), 2.41 (dd, J = 13.5, 
9.7 Hz, 1H, HE) ppm; 13C NMR (125 MHz, CDCl3): δ = 169.7 (C=O), 131.5 (CH=CH2), 
121.9 (CH=CH2), 117.1 (CN), 78.4 (CHOH), 61.9 (OCH2), 43.7 (C), 39.1 
(CH2CH=CH2), 33.6 (CH2) ppm; IR (neat): 3424, 2936, 2981, 1771, 1439, 1350, 1184, 
1094, 995, 931 cm-1; HRMS (EI+): [M]+ calc. 181.0739, found 181.0737 [C9H11NO3]
+. 
Minor diastereoisomer: Pale yellow oil; 1H NMR (400 MHz, CDCl3): δ = 5.84 – 5.72 
(m, 1H, CH2CH=CH2), 5.35 – 5.24 (m, 2H, CH2CH=CH2), 4.56 (tdd, J = 7.3, 4.1, 2.9 Hz, 
1H, HC), 3.92 (dd, J = 12.6, 2.9 Hz, 1H, HA), 3.65 (dd, J = 12.6, 4.1 Hz, 1H, HB), 2.73 
(dd, J = 13.9, 6.8 Hz, 1H, HF), 2.63 (dd, J = 13.6, 7.6 Hz, 1H, HD), 2.54 (dd, J = 13.9, 
7.7 Hz, 1H, HG), 2.41 (dd, J = 13.6, 7.3 Hz, 1H, HE) ppm; 13C NMR (125 MHz, CDCl3): 
δ = 169.8 (C=O), 129.7 (CH=CH2), 122.5 (CH=CH2), 120.7 (CN), 78.4 (CHOH), 62.1 
(OCH2), 43.6 (C), 40.0 (CH2CH=CH2), 32.8 (CH2) ppm; IR (neat): 3420, 2934, 2289, 
1769, 1441, 1366, 1188, 1020, 932 cm-1. 
(4-Allyl-4-cyano-5-oxotetrahydrofuran-2-yl)methyl trifluoromethanesulfonate 303c 
 
The product 303c was synthesised using general procedure GP5 (TMSOTf was used 
instead of BF3•OEt2) at -20 °C for 20 h (0.24 mmol scale) (28% yield, 21 mg, 
0.067 mmol).  
Colourless oil; 1H NMR (300 MHz, CDCl3):  = 5.72 (ddt, J = 17.5, 10.3, 7.3 Hz, 1H, 
CH2CH=CH2), 5.36 – 5.23 (m, 2H, CH2CH=CH2), 4.89 (dddd, J = 10.2, 6.5, 4.1, 2.7 Hz, 
1H, HC), 4.75 (dd, J = 11.8, 2.7 Hz, 1H, HA), 4.49 (dd, J = 11.8, 4.1 Hz, 1H, HB), 2.82 
(dd, J = 14.1, 7.1 Hz, 1H, HF), 2.70 (dd, J = 13.7, 6.4 Hz, 1H, HD), 2.56 (dd, J = 14.1, 
7.4 Hz, 1H, HG), 2.23 (dd, J = 13.7, 10.0 Hz, 1H, HE) ppm; 13C NMR (125 MHz, CDCl3): 
 = 168.1 (C=O), 129.1 (CH=CH2), 123.0 (CH=CH2), 116.4 (CN), 74.0 (CHOTf), 73.1 
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(OCH2), 43.3 (C), 39.2 (CH2), 33.6 (CH2) ppm; IR (neat): 3437, 2920, 1765, 1641, 1441, 
1246, 1182, 1028, 930 cm-1. 
Methyl 5-(acetoxymethyl)-2-oxotetrahydrofuran-3-carboxylate 304 
 
The product 304 was synthesised from molecule 294 using general procedure GP5 
at -20 °C for 20 h (0.28 mmol scale) (61% conversion, could not be fully isolated).  
Pale yellow oil; 1H NMR (400 MHz, CDCl3):  = 4.78 (tdd, J = 6.6, 4.1, 2.6 Hz, 1H, 
CHOAc), 3.97 (dd, J = 13.0, 2.6 Hz, 1H, HA), 3.78 (s, 2H, OCH3), 3.75 (dd, J = 4.5, 2.7 
Hz, 2H, HF), 3.63 (dd, J = 13.0, 4.2 Hz, 1H, HB), 3.08 (dd, J = 13.6, 6.5 Hz, 1H, HD), 2.44 
(dd, J = 13.6, 9.5 Hz, 1H, HE), 2.14 (s, 2H, CH3 (OAc)) ppm; HRMS (ES+): [M+Na]
+ 
calc. 239.0532, found 239.0530 [C9H12O6Na]
+. 
(1,6-Dioxo-2,7-dioxaspiro[4.4]nonane-3,8-diyl)bis(methylene) diacetate 305 
 
The product 305 was synthesised from molecule 295 using general procedure GP5 
at -20 °C for 20 h (0.28 mmol scale) (15% yield, 13 mg, 0.042 mmol).  
Light yellow oil; 1H NMR (400 MHz, CDCl3):  = 5.16 – 5.06 (m, 2H, HC), 4.39 (dd, 
J = 12.6, 3.0 Hz, 2H, HA), 4.18 (dd, J = 12.6, 5.3 Hz, 2H, HB), 2.86 (dd, J = 13.2, 6.8 Hz, 
2H, HD), 2.15 (dd, J = 11.9, 7.6 Hz, 2H, HE), 2.12 (s, 6H, 2 CH3 (OAc)) ppm; 13C NMR 
(125 MHz, CDCl3):  = 172.7 (2 C=O), 170.4 (2 C=O), 76.2 (2 CHOAc), 64.0 (2 OCH2), 
52.6 (C), 34.6 (2 CH2), 20.8 (2 OAc) ppm; IR (neat): 2963, 1740, 1370, 1258, 1229, 
1018, 795 cm-1; HRMS (ES-): [M+Cl]- calc. 335.0534, found 335.0536 [C13H16NO8Cl]
- 
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tert-Butyl 5-(acetoxymethyl)-2-oxotetrahydrofuran-3-carboxylate 311 
 
The product 311 was synthesised using general procedure GP5 at -20 °C for 20 h 
(0.098 mmol scale) (70% yield for the mixture of both diastereomers (1.2:1 ratio 
cis:trans), 18 mg, 0.068 mmol).  
Pale yellow oil; 1H NMR (300 MHz, CDCl3):  = 4.91 – 4.81 (m, 1H, HC (Cis-isomer)), 
4.72 – 4.62 (m, 1H, HC (Trans-isomer)), 4.36 (dd, J = 7.1, 3.1 Hz, 1H, HA (Trans-isomer)), 
4.32 (dd, J = 7.1, 3.1 Hz, 1H, HA (Cis-isomer)), 4.20 (dd, J = 12.3, 6.6 Hz, 1H, HB (Trans-
isomer)), 4.13 (dd, J = 12.4, 4.9 Hz, 1H, HB (Cis-isomer)), 3.60 – 3.51 (m, 2H, HF (Both 
isomers)), 2.71 (ddd, J = 13.3, 7.9, 6.0 Hz, 1H, HD (Cis-isomer)), 2.58 – 2.36 (m, 2H, HD 
and HE (Trans-isomer)), 2.25 (ddd, 1H, HE (Cis-isomer)), 2.11 (s, 3H, OAc (Trans-
isomer)), 2.11 (s, 3H, OAc (Cis-isomer)), 1.50 (s, 9H, 3 CH3 (Cis-isomer)), 1.50 (s, 9H, 
3 CH3 (Trans-isomer)) ppm; 13C NMR (125 MHz, CDCl3): Cis-isomer:  = 171.7 (C=O), 
170.6 (C=O), 166.7 (C=O), 83.5 (C(CH3)3), 76.5 (CHCOAc), 65.2 (OCH2), 47.6 (CHF), 
28.3 (CH2), 28.0 (3 CH3 (
tBu)), 20.9 (CH3 (OAc)) ppm; Trans-isomer:  = 171.5 (C=O), 
170.8 (C=O), 166.5 (C=O), 83.4 (C(CH3)3), 76.0 (CHCOAc), 65.0 (OCH2), 47.6 (CHF), 
27.9 (CH2), 28.0 (3 CH3 (
tBu)), 20.8 (CH3 (OAc)) ppm; IR (neat): 2963, 1774, 1736, 
1369, 1258, 1231, 1080, 1013, 793 cm-1; HRMS (ES+): [M+Na]+ calc. 281.1001, found 
2813.0999 [C12H18O6Na]
+. 
NOESY NMR data:  
To determine which isomers were cis and trans, a NOESY experiment was recorded. In 
one of the two stereoisomers, an interaction through the space can be obserbed between 
HC and HF. This suggests that those two protons are cis to each other and that the major 
isomer was therefore the cis cyclised lactone 311. In the NOESY spectrum below (Figure 
7.2), the cis-isomer is shown in red while the trans-isomer is represented in green.  
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Figure 7.2. NOESY experiment of molecule 311. 
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 Synthesis of new iodine reagents and their application 
7.4.4.1. Iodopyridine 
4-Iodo-1-methylpyridin-1-ium iodide 320 
 
A solution of 4-iodopyridine (212 mg, 1.03 mmol) in methyl iodide (2.0 mL) was stirred 
at room temperature for 14 h under argon atmosphere and in the dark. After evaporation 
of the solvent under vacuum, the pure product was obtained as a pale yellow solid 
(95% yield, 340 mg, 0.978 mmol). 
m.p. = 65 - 68 °C; 1H NMR (300 MHz, DMSO-d6): δ = 8.64 (d, J = 6.8 Hz, 2H, H-Ar), 
8.59 (d, J = 6.9 Hz, 2H, H-Ar), 4.20 (s, 1H, CH3) ppm; 13C NMR (125 MHz, DMSO-d6): 
δ = 144.8 (2 CArH), 119.4 (CArH), 106.4 (CAr), 47.6 (CH3) ppm. 
1-Methylpyridin-4(1H)-one 321 
 
4-Iodo-1-methylpyridin-1-ium iodide 320 (50 mg, 0.14 mmol) was dissolved in glacial 
acetic acid. NaBO3•4H2O (222 mg, 1.44 mmol) was slowly added and the resulting 
mixture was stirred at 55 °C for 5 h and became progressively red coloured. The solvent 
was evaporated to yield an off-white solid. The resulting solid was diluted with CHCl3 
(4 mL) and the solid was discarded by filtration. The pure product was isolated as a pale 
yellow oil after evaporation of the solvent under vacuum (70% yield, 11 mg, 
0.101 mmol).  
The spectroscopic data are in agreement with literature.[50] 1H NMR (400 MHz, CDCl3): 
δ = 7.34 – 7.30 (m, 2H, H-Ar), 6.58 – 6.54 (m, 2H, H-Ar), 3.70 (s, 3H, CH3) ppm; 
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13C NMR (125 MHz, CDCl3): δ = 179.0 (C=O), 144.1 (2 CH), 117.1 (2 CH), 44.0 (CH3) 
ppm; MS (ES+): m/z 110 ([M+H]+. 
4-Iodo-1-methylpyridin-1-ium methyl sulfate 322 
 
To a solution of 4-iodopyridine (150 mg, 0.732 mmol) in CH2Cl2 (2 mL), methyl sulfate 
(139 µL, 1.46 mmol) was added under nitrogen. The resulting mixture was heated at 
reflux and stirred for 24 h. The solvent was evaporated under vacuum and the desired 
product was obtained as colourless solid (83% yield, 200 mg, 0.607 mmol). 
m.p. = 58 - 61 °C; 1H NMR (400 MHz, DMSO-d6): δ = 8.64 (d, J = 6.4 Hz, 2H, H-Ar), 
8.60 (d, J = 6.2 Hz, 2H, H-Ar), 4.20 (s, 3H, N-CH3), 3.36 (s, 3H, OCH3) ppm; 13C NMR 
(125 MHz, DMSO-d6): δ = 144.9 (2 CArH), 136.8 (2 CArH), 118.8 (CAr), 52.8 (OCH3), 
47.6 (N-CH3) ppm. 
4-Iodo-1-methylpyridin-1-ium 4-methylbenzenesulfonate 333 
 
A solution of Koser’s reagent (226 mg, 0.576 mmol) and 4-iodo-1-methylpyridin-1-ium 
iodide 320 (200 mg , 0.576 mmol) in acetonitrile (10 mL) was stirred at room temperature 
for 24 h. The resulting solid was filtered to yield pure 4-iodo-1-methylpyridin-1-ium 4-
methylbenzenesulfonate 333 as a pale yellow solid (95% yield, 214 mg, 0.547 mmol).  
1H NMR (300 MHz, DMSO-d6): δ = 8.63 (d, J = 6.8 Hz, 2H, H-Ar), 8.59 (d, J = 7.0 Hz, 
2H, H-Ar), 7.50 – 7.43 (m, 2H, H-Ar (Ts)), 7.11 (dd, J = 8.4, 0.6 Hz, 2H, H-Ar (Ts)), 
4.20 (s, 3H, N-CH3), 2.28 (s, 3H, CH3). 
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3-Iodo-1-methylpyridin-1-ium iodide 335 
 
A solution of 3-iodopyridine (424 mg, 2.06 mmol) in methyl iodide (4.0 mL) was stirred 
at room temperature for 14 h under argon atmosphere and in the dark. After evaporation 
of the solvent under vacuum, the pure product was obtained as a pale yellow solid 
(91% yield, 663 mg, 1.91 mmol). 
m.p. = 172 - 174 °C; 1H NMR (400 MHz, DMSO-d6): δ = 9.39 (s, 1H, H-Ar), 9.00 (d, 
J = 6.0 Hz, 1H, H-Ar), 8.92 (d, J = 8.2 Hz, 1H, H-Ar), 7.95 – 7.86 (m, 1H, H-Ar), 4.28 
(s, 3H, CH3) ppm; 13C NMR (125 MHz, DMSO-d6): δ = 152.4 (CArH), 150.7 (CArH), 
144.5 (CArH), 128.2 (CArH), 96.0 (CAr), 47.7 (CH3) ppm. 
3-Iodopyridine 1-oxide 337 
 
To a solution of 3-iodopyridine (200 mg, 0.976 mmol) in CH2Cl2 (20 mL), m-CPBA 
(240 mg, 1.073 mmol) was added. The resulting mixture was stirred at r.t. for 20 h. The 
solvent was evaporated. After addition of diethyl ether (5 mL), the product precipitate as 
a yellow crystalline compound (80% yield, 173 mg, 0.781 mmol). 
1H NMR (300 MHz, CDCl3): δ = 8.52 (t, J = 1.4 Hz, 1H, H-Ar), 8.17 (ddd, J = 6.5, 1.7, 
0.9 Hz, 1H, H-Ar), 7.59 (ddd, J = 8.1, 1.4, 0.9 Hz, 1H, H-Ar), 7.03 (dd, J = 8.0, 6.6 Hz, 
1H, H-Ar) ppm; 13C NMR (75 MHz, CDCl3): δ = 145.5 (CArH), 138.7 (CArH), 134.3 
(CArH), 126.4 (CArH), 91.1 (CAr) ppm; MS (AP+): m/z 222 ([M+H]
+). 
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7.4.4.2. Synthesis of (S)-316 
(S)-2-(1-(2-iodophenoxy)ethyl)pyridine (S)-344 
 
To a solution of 2-iodophenol 343 (357 mg, 1.62 mmol), (R)-2-(1-Hydroxyethyl)pyridine 
342 (250 mg, 2.03 mmol) and triphenylphosphine (532 mg, 2.03 mmol) in dry THF 
(25 mL), DIAD (400 µL, 2.03 mmol) was added at 0 °C under dark conditions. The 
resulting mixture was warmed up to room temperature and stirred for 20 h. The solvent 
was removed under vacuum and the pure product (S)-344 was obtained after column 
chromatography (0 to 20% EtOAc in hexane) as a colourless oil (92% yield, 486 mg, 
1.49 mmol). 
1H NMR (400 MHz, CDCl3): δ = 8.56 (ddd, J = 4.9, 1.8, 0.9 Hz, 1H, H-Ar), 7.77 (dd, 
J = 7.8, 1.6 Hz, 1H, H-Ar), 7.68 (td, J = 7.7, 1.8 Hz, 1H, H-Ar), 7.56 – 7.49 (m, 1H, 
H-Ar), 7.23 – 7.10 (m, 2H, H-Ar), 6.72 – 6.61 (m, 2H, H-Ar), 5.47 (q, J = 6.5 Hz, 1H, 
CH), 1.73 (d, J = 6.5 Hz, 3H, CH3) ppm; 13C NMR (75 MHz, CDCl3): δ = 162.0 (CAr), 
156.3 (CAr), 149.0 (CAr), 139.6 (CAr), 137.4 (CAr), 129.4 (CAr), 122.7 (CAr), 122.6 (CAr), 
120.0 (CAr), 114.0 (CAr), 87.2 (CAr-I), 78.3 (O-CH), 22.7 (CH3) ppm; IR (neat): 3059, 
2978, 2360, 1582, 1470, 1435, 1273, 1238, 1072, 1018, 748 cm-1; HRMS (EI): [M]+ calc. 
324.9964, found 324.9963 [C13H12NOI]
+; MS (EI): m/z 325 (M+, 10%), 220 (97%), 198 
(100%), 106 (99%), 78 (58%); ee: 92%, determined by HPLC analysis: YMC Chiral 
Amylose-C S-5µm (25 cm), hexane/i-PrOH: 99/1, 0.7 mL/min, 10 °C, 289 nm, Tr (major, 
(S)-isomer) = 16.0 min, Tr (minor, (R)-isomer) = 18.3 min; [𝛂]𝐃
𝟐𝟎 = +122.2 (c = 1.10, 
CHCl3). 
The absolute configuration of the major enantiomer was assumed to be the (S)-isomer as 
the Mitsunobu reaction proceeds with inversion of configuration and (R)-2-(1-
hydroxyethyl)pyridine was used as reagent. 
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(S)-(2-(1-(Pyridin-2-yl)ethoxy)phenyl)-l3-iodanediyl diacetate (S)-316 
 
(S)-2-(1-(2-iodophenoxy)ethyl)pyridine (S)-344 (100 mg, 0.308 mmol) and Selectfluor® 
(545 mg, 1.54 mmol) were flushed under a flow of N2 for 30 minutes. After addition of 
CH3CN (9.8 mL) and glacial acetic acid (3 mL), the mixture was stirred at room 
temperature for 20 h. The solvents were evaporated, water (30 mL) was added and the 
organic phase was extracted with CH2Cl2 (3 x 25 mL), dried over MgSO4 and 
concentrated under vacuum. The resulting oil slowly solidified to obtain a pale yellow 
solid that was used without further purification (92% yield, 126 mg, 0.284 mmol). For 
the analysis, a recrystallisation from CH2Cl2/hexane led to the formation of colourless 
crystals. 
m.p. = 128 - 131 °C; 1H NMR (400 MHz, CDCl3): δ = 8.59 (ddd, J = 5.0, 1.8, 0.9 Hz, 
1H, H-Ar), 8.13 (dd, J = 8.2, 1.6 Hz, 1H, H-Ar), 7.74 (td, J = 7.7, 1.7 Hz, 1H, H-Ar), 7.59 
(d, J = 7.9 Hz, 1H, H-Ar), 7.47 – 7.39 (m, 1H, H-Ar), 7.31 – 7.27 (m, 1H, H-Ar), 
7.03 – 6.96 (m, 2H, H-Ar), 5.68 (q, J = 6.5 Hz, 1H, CH), 2.01 (s, 3H, CH3 (OAc)), 1.93 
(s, 3H, CH3 (OAc)), 1.70 (d, J = 6.5 Hz, 3H, CH3) ppm; 13C NMR (125 MHz, CDCl3): 
δ = 176.8 (C=O), 175.8 (C=O), 160.8 (CAr), 154.3 (CAr), 148.3 (CAr), 138.5 (CAr), 137.8 
(CAr), 134.5 (CAr), 123.4 (CAr), 123.1 (CAr), 120.6 (CAr), 120.4 (CAr), 114.2 (CAr-I), 78.2 
(CH), 22.6 (CH3 (OAc)), 20.9 (CH3 (OAc)), 20.4 (CH3) ppm; IR (neat): 2935, 1645, 
1471, 1273, 748, 665 cm-1; HRMS (ESI): [M+H-2OAc]+ calc. 326.0036, found 326.0040 
[C13H13ONI ]
+; [α]D
20 = +76.0 (c = 1.0, CHCl3). 
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X-Ray Crystallographic structure: CCDC-1487361 
 
7.4.4.3. Evaluation of the reactivity and selectivity of (S)-316 
1-Oxo-1-phenylpropan-2-yl 4-methylbenzenesulfonate 30a 
 
a) Stoichiometric reaction at 40 °C: A solution of iodine(III) (S)-316 (150 mg, 
0.338 mmol) and p-TsOH•H2O (70 mg, 0.37 mmol) in dry CH3CN (1 mL) was 
stirred for 30 minutes at room temperature. A solution of (Z)-1-phenylprop-1-en-
1-yl acetate 227 (54 mg, 0.31 mmol) in dry CH3CN (1 mL) was then added to the 
first reaction mixture and the resulting solution was stirred at 40 °C for 40 h. The 
reaction was quenched with sat. aq. NaHCO3 and extracted with CH2Cl2 
(3 x 3 mL). After purification by column chromatography (0 to 5% EtOAc in 
hexane), the pure compound 30a was obtained as a white solid (63% yield, 59 mg, 
0.19 mmol, 6% ee). 
b) Catalytic reaction at room temperature: To a solution of iodine(I) (S)-344 
(15 mg, 0.046 mmol), m-CPBA (9.3 mg, 77% pure, 0.042 mmol) and 
p-TsOH•H2O (8 mg, 0.042 mmol) in dry CH3CN (1 mL), a solution of (Z)-1-
phenylprop-1-en-1-yl acetate 227 (40 mg, 0.23 mmol) in dry CH3CN (1 mL) and 
a solution of m-CPBA (51 mg, 77% pure, 0.23 mmol) and p-TsOH•H2O (44 mg, 
0.23 mmol) in dry CH3CN (1 mL) was added via syringe pump (0.01 mL/min). 
The resulting mixture was stirred at room temperature for 24 h, quenched with 
sat. aq. Na2S2O3 (1 mL) and extracted with EtOAc (3 x 5 mL). The combined 
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organic layers were washed with sat. aq. NaHCO3 (5 mL) and brine (5 mL), dried 
over MgSO4 and concentrated under vacuum. After purification by column 
chromatography (0 to 5% EtOAc in hexane), the pure compound 30a was 
obtained as a white solid (69% yield, 48 mg, 0.16 mmol, 7% ee). 
The racemate was synthesised following the stoichiometric procedure but using the 
racemate of the iodine(III) reagent (S)-316.  
The spectroscopic data are in agreement with literature.[51] 1H NMR (400 MHz, CDCl3): 
δ = 7.79 (d, J = 7.9 Hz, 2H, H-Ar), 7.67 (d, J = 7.3 Hz, 2H, H-Ar), 7.51 (t, J = 7.0 Hz, 
1H, H-Ar), 7.37 (t, J = 7.3 Hz, 2H, H-Ar), 7.18 (d, J = 7.7 Hz, 2H, H-Ar), 5.71 (q, J = 
6.9 Hz, 1H, CHCH3), 2.33 (s, 3H, CH3 (OTs)), 1.51 (d, J = 6.9 Hz, 3H, CHCH3) ppm; 
13C NMR (125 MHz, CDCl3): δ = 194.9 (C=O), 145.2 (CAr), 134.0 (CArH), 133.5 (CAr), 
129.9 (2 CArH), 128.9 (2 CArH), 128.8 (2 CArH), 128.6 (CAr), 128.0 (2 CArH), 77.5 
(CHCH3), 21.7 (CH3), 18.9 (CH3) ppm; HRMS (NSI): [M+NH4]
+ calc. 322.1108, found 
322.1105 [C16H20O4NS]
+; ee: determined by HPLC analysis: Daicel Chiralcel OB-H 
column (25 cm), hexane/i-PrOH: 60/40, 0.5 mL/min, 40 °C, 232 nm, Tr ((R)-isomer) = 
16.2 min, Tr ((S)-isomer) = 19.2 min;
[52] [𝛂]𝐃
𝟐𝟎 = +8.0 (c = 0.50, CHCl3). 
The absolute configuration was determined by comparison with the literature value.[53] 
The absolute configuration was determined by its independent synthesis from 
(S)-(-)-lactic acid.[54] 
 (E)-1-Phenyl-3-(p-tolyl)prop-2-en-1-one 345 
 
To a solution of acetophenone (1.20 g, 10.0 mmol) and 4-methylbenzaldehyde (1.20 g, 
10.0 mmol) in MeOH (25 mL), an aqueous solution of NaOH (1 mL, 50% w/v) was added 
dropwise. The resulting mixture was stirred at room temperature for 24 h. The reaction 
was quenched with 1 N HCl (10 mL) and extracted with EtOAc (3 x 20 mL). The 
combined organic layers were dried over MgSO4 and concentrated under vacuum. The 
pure product 345 was obtained after column chromatography (0% to 10% EtOAc in 
hexane) as a yellow solid (82% yield, 1.83 g, 8.21 mmol).  
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The spectroscopic data are in agreement with literature.[55] Pale yellow solid; m.p. = 
79 - 81 °C (lit.[55] 80 – 84 °C); 1H NMR (400 MHz, CDCl3): δ = 8.02 (d, J = 7.7 Hz, 2H, 
H-Ar), 7.80 (d, J = 15.7 Hz, 1H, CH=CH), 7.62 – 7.46 (m, 6H, 5 H-Ar and CH=CH), 
7.23 (d, J = 7.7 Hz, 2H, H-Ar), 2.40 (s, 3H, CH3) ppm. 
1-Phenyl-2-(p-tolyl)-3,3-bis(2,2,2-trifluoroethoxy)propan-1-one 346 
 
To a solution of iodine(III) (S)-316 (180 mg, 0.393 mmol) in dry CH2Cl2 (2.4 mL) and 
2,2,2-trifluoroethanol (2.4 mL), TMSOTf (97 µL, 0.523 mmol) was added dropwise 
at -20 °C. The resulting mixture was stirred for 30 minutes before the addition of (E)-1-
phenyl-3-(p-tolyl)prop-2-en-1-one 345 (60 mg, 0.262 mmol). The reaction was stirred at 
-20 °C for 20 h, quenched with sat. aq. NaHCO3 (1 mL) and extracted with CH2Cl2. The 
combined organic layers were passed through a Telos® phase separator and concentrated 
under vacuum. After column chromatography (0 to 5% EtOAc in hexane), the pure 
product 346 could be obtained as a pale yellow oil (80% yield, 88 mg, 0.21 mmol). 
The racemate product was obtained following the same procedure using racemate 
iodine(III) reagent (rac)-316 (82% yield).  
The spectroscopic data are in agreement with literature.[55] 1H NMR (400 MHz, CDCl3): 
δ = 7.85 (d, J = 7.6 Hz, 2H, H-Ar), 7.44 (t, J = 7.2 Hz, 1H, H-Ar), 7.33 (t, J = 7.4 Hz, 2H, 
H-Ar), 7.19 (d, J = 7.6 Hz, 2H, H-Ar), 7.06 (d, J = 7.5 Hz, 2H, H-Ar), 5.39 (d, J = 8.4 Hz, 
1H, CH), 4.78 (d, J = 8.4 Hz, 1H, CH), 4.10 – 3.81 (m, 2H, CH2CF3), 3.61 (q, J = 8.4 Hz, 
2H, CH2CF3), 2.22 (s, 1H, CH3) ppm; 13C NMR (125 MHz, CDCl3): δ = 196.6 (C=O), 
138.3 (CAr), 136.3 (CAr), 133.6 (CArH), 130.14 (CAr), 130.07 (2 CArH), 128.9 (2 CArH), 
128.81 (2 CArH), 128.79 (2 CArH), 123.5 (q, J = 278 Hz, CF3), 123.4 (q, J = 278 Hz, CF3), 
105.8 (CH), 65.7 (q, J = 66 Hz, CH2CF3), 63.8 (q, J = 64 Hz, CH2CF3), 57.1 (CH), 21.2 
(CH3) ppm; HRMS (NSI): [M+NH4]
+ calc. 438.1498, found 438.1495 [C13H12NOI]
+; ee: 
26%, determined by HPLC analysis: Daicel Chiralcel OD-H column (25 cm), 
hexane/i-PrOH: 99.7/0.3, 0.5 mL/min, 20 °C, 254 nm, Tr (minor, (R)) = 15.0 min, 
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Tr (major, (S)) = 19.1 min; [𝛂]𝐃
𝟐𝟎 = -14.3 (c = 1.82, CHCl3) (lit. for the (R) isomer: [𝛂]𝐃
𝟐𝟎 = 
+48.6 (c = 1.64, CHCl3)). 
The absolute configuration was determined by comparison with the literature data. The 
authors confirmed the stereochemistry of the chiral centre to be (R) by recrystallizing 2-
(4-bromophenyl)-1-phenyl-3,3-bis(2,2,2-trifluoroethoxy)propan-1-one and it was 
assumed that the absolute configuration would be the same for every substrates. 
Pent-1-ene-1,1-diyldibenzene 347 
 
To a solution of butyltriphenylphosphonium bromide (1.32 g, 3.29 mmol) in dry THF 
(10 mL), n-BuLi (1.57 mL, 2.1 M in hexane, 3.29 mmol) was added at 0 °C. The resulting 
mixture was stirred at 0 °C until complete dissolution of the salt. A solution of 
benzophenone (500 mg, 2.74 mmol) in dry THF (5 mL) was then added to the reaction 
mixture. It was warmed up to room temperature and stirred for 20 h. The resulting mixture 
was quenched with sat. aq. NH4Cl and extracted with Et2O. The combined organic layers 
were washed with brine, dried over MgSO4 and dried under vacuum. After purification 
by column chromatography, the pure product 347 was obtained a pale yellow oil 
(82% yield, 500 mg, 2.25 mmol). 
The spectroscopic data are in agreement with literature.[8] 1H NMR (400 MHz, CDCl3): 
δ = 7.43 – 7.18 (m, 10H, H-Ar), 6.12 (t, J = 7.4 Hz, 1H, CHPh), 2.12 (q, J = 7.3 Hz, 2H, 
CH2CH2CH3), 1.49 (sext, J = 7.4 Hz, 2H, CH2CH2CH3), 0.93 (t, J = 7.3 Hz, 3H, 
CH2CH2CH3) ppm; 13C NMR (125 MHz, CDCl3): δ = 142.9 (C), 141.6 (C), 140.4 (C), 
130.2 (CH), 130.0 (2 CArH), 128.1 (2 CArH), 128.1 (2 CArH), 127.2 (2 CArH), 126.8 (CH), 
126.8 (CH), 31.8 (CH2CH2CH3), 23.2 (CH2CH2CH3), 13.9 (CH2CH2CH3) ppm. 
1,2-Diphenylpentan-1-one 348 and 1,1-diphenylpentan-2-one 349 
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Pent-1-ene-1,1-diyldibenzene 347 (67 mg, 0.30 mmol) was dissolved in a mixture of 
CH2Cl2/TFE (10:1, 3.5 mL) at 0 °C. Iodoarene (S)-344 (20 mg, 0.060 mmol), m-CPBA 
(52 mg, 0.30 mmol), MeOH (97 µL, 2.4 mmol) and p-TsOH•H2O (85 mg, 0.451 mmol) 
were successively added to the reaction mixture. The resulting solution was stirred at 0 °C 
for 4 h, then warmed up to room temperature and stirred for additional 16 h. The reaction 
mixture was quenched with sat. aq. NaHCO3 solution (1.5 mL), diluted with water 
(10 mL) and extracted with CH2Cl2 (3 x 5 mL). The combined organic layers were dried 
over a Telos® phase separator and concentrated under vacuum. In the crude mixture, 
product 348 was observed in 23% conversion whilst product 349 was obtained with 55% 
conversion. After purification by preparative TLC (10% EtOAc in hexane), a mixture of 
both compounds 348 and 349 (1:1 ratio) was isolated as a colourless oil (49% total yield, 
35 mg, 0.15 mmol). 
The spectroscopic data for are in agreement with literature.[8] 1H NMR (300 MHz, 
CDCl3): δ = 7.90 – 7.88 (m, 2H, H-Ar, 348), 7.43 – 7.10 (m, 18H, H-Ar, 348 and 349), 
5.05 (s, 1H, CH, 349), 4.49 (t, J = 7.3 Hz, 1H, CH, 348), 2.45 (t, J = 7.4 Hz, 1H, 
CH2CH2CH3, 349), 2.14 – 2.02 (m, 1H, CHAHBCH2CH3, 348), 1.78 – 1.70 (m, 1H, 
CHAHBCH2CH3, 348), 1.58 – 1.50 (m, 2H, CH2CH2CH3, 349), 1.27 – 1.16 (m, 2H, 
CH2CH2CH3, 348), 0.84 (t, J = 7.4 Hz, 3H, CH3, 348), 0.79 (t, J = 7.4 Hz, 3H, CH3, 
349) ppm; 13C NMR (125 MHz, CDCl3, 348): δ = 200.3 (C=O), 139.9 (CAr), 137.1 (CAr), 
132.9 (CArH), 129.0 (2 CArH), 128.8 (2 CArH), 128.6 (2 CArH), 128.4 (2 CArH), 127.1 
(CArH), 53.6 (CH), 36.3 (CH2CH2CH3), 21.0 (CH2CH2CH3), 14.2 (CH3) ppm; 13C NMR 
(125 MHz, CDCl3, 349): δ = 208.7 (C=O), 138.6 (2 CAr), 129.1 (4 CArH), 128.8 (4 CArH), 
127.3 (2 CArH), 64.3 (CH), 45.0 (CH2CH2CH3), 17.6 (CH2CH2CH3), 13.8 (CH3) ppm; 
ee (348): 6%, determined by HPLC analysis: YMC Chiral Amylose-C S-5µm (25 cm), 
hexane/i-PrOH: 99.5/0.5, 1.0 mL/min, 10 °C, 243 nm, Tr ((S)-isomer) = 9.3 min, 
Tr
 ((R)-isomer) = 12.3 min. 
The absolute configuration of 348 was determined by comparison using the HPLC data 
available in the literature.[8] The authors established the absolute configuration by 
comparison of the optical rotation. In this paper, the independent synthesis of (S)-1,2-
diphenylpropan-1-one from (S)-ethyl lactate is described.[56] 
 (Methylsulfinyl)benzene 351 
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A solution of iodine(III) (S)-316 (200 mg, 0.450 mmol) and p-TsOH•H2O (85 mg, 
0.45 mmol) in dry CH2Cl2 (4 mL) was stirred at -78 °C for 1 h. Thioanisole 350 (44 µL, 
0.38 mmol) was added dropwise and the reaction mixture was then stirred at -78 °C for 
an additional hour. The resulting mixture was quenched with sat. aq. NaHCO3 (1 mL) and 
extracted with CH2Cl2. The combined organic layers were passed through a Telos
®
 phase 
separator and concentrated under vacuum. After purification by column chromatography, 
the pure product 351 was obtained as a pale yellow oil (94% yield, 50 mg, 0.36 mmol). 
The racemate was synthesised following the same procedure but using the racemate of 
the iodine(III) reagent (rac)-316 and at room temperature.  
The spectroscopic data are in agreement with literature.[57] 1H NMR (400 MHz, CDCl3): 
δ = 7.66 – 7.64 (m, 2H, H-Ar), 7.53 – 7.51 (m, 3H, H-Ar), 2.73 (s, 3H, CH3) ppm; 
13C NMR (125 MHz, CDCl3): δ = 145.7 (CAr), 131.2 (CArH), 129.5 (2 CArH), 123.6 
(2 CArH), 44.0 (CH3) ppm; HRMS (EI+): [M]
+ calc. 140.0296, found 140.0302 
[C7H8OS]
+; ee: 2%, determined by HPLC analysis: Daicel Chiralcel OB-H column 
(25 cm), hexane/i-PrOH: 80/20, 1.0 mL/min, 20 °C, 254 nm, Tr ((S)-isomer) = 11.2 min, 
Tr ((R)-isomer) = 18.9 min;
[57] [𝛂]𝐃
𝟐𝟎 = -2.1 (c = 0.93, CHCl3). 
The absolute configuration was determined by comparison with the optical rotation in the 
literature. They established it by the reduction of the corresponding (S)-sulfinate ester to 
the sulfoxide.[58]  
1-Phenylethane-1,2-diyl diacetate 352 
 
To a solution of iodoarene (S)-344 (65 mg, 0.20 mmol) and triflic acid (9 µL, 0.1 mmol) 
in acetic acid (10 mL), peracetic acid (135 µL, 32 wt.% in AcOH, 2 mmol) was added 
and the resulting mixture was stirred at r.t. for 1 h. A solution of freshly distilled styrene 
(115 µL, 1 mmol) in acetic acid (7.5 mL) was then added via a syringe pump 
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(0.03 mL/min) and the reaction was stirred at r.t. for additional 16 h. Water (10 mL) and 
brine (20 mL) were added and the organic phase was extracted with CH2Cl2 (3 x 20 mL). 
The combined organic layers were dried over MgSO4 and concentrated under vacuum to 
obtain a yellow oil which was used without further purification in the next step. 
The crude mixture was dissolved in dry CH2Cl2 (3 mL) and acetic anhydride (236 µL, 
2.5 mmol), pyridine (201 µL, 2.5 mmol) and DMAP (30 mg, 0.25 mmol) were added 
successively. The resulting mixture was stirred at r.t. for 18 h. The reaction was quenched 
with 2 N HCl and extracted with CH2Cl2 (3 x 5 mL). The combined organic layers were 
passed through a Telos® phase separator and dried under vacuum. After purification by 
column chromatography (0 to 10% EtOAc in hexane), the pure product was obtained as 
a colourless oil (44% yield, 98 mg, 0.441 mmol). 
The racemate was synthesised following the same procedure but using the racemate of 
the iodine(III) reagent (37% yield, 81 mg, 0.365 mmol). 
The spectroscopic data are in agreement with literature.[59] 1H NMR (400 MHz, CDCl3): 
δ = 7.43 – 7.28 (m, 5H, H-Ar), 6.06 – 5.96 (m, 1H, CHOAc), 4.40 – 4.22 (m, 2H, 
CH2OAc), 2.12 (s, 3H, CH3 (OAc)), 2.06 (s, 3H, CH3 (OAc)) ppm; 13C NMR (125 MHz, 
CDCl3): δ = 170.8 (C=O), 170.2 (C=O), 136.6 (CAr), 128.8 (2 CArH), 128.6 (CArH), 126.8 
(2 CArH), 73.4 (CHOAc), 66.2 (CH2OAc), 21.2 (CH3 (OAc)), 20.9 (CH3 (OAc)) ppm; 
HRMS (NSI): [M+NH4]
+ calc. 240.1230, found 240.1229 [C12H18O4N]
+; ee: 0%, 
determined by HPLC analysis: Daicel Chiralcel OD-H (25 cm), hexane/i-PrOH: 99.7/0.3, 
1.0 mL/min, 20 °C, 218 nm, Tr = 32.9 min, Tr = 38.1 min; [𝛂]𝐃
𝟐𝟎 = 0.0 (c = 0.81, CHCl3). 
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 Crystallographic data 
(5-(1-Carboxyethyl)-2-methoxyphenyl)(phenyl)iodonium 
trifluoromethanesulfonate 168 
   
 
Audit creation method: SHELXL-2013 
Chemical formula sum: 'C17 H16 F3 I O6 S'  
Chemical formula weight: 532.26 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4': 'C'  'C'   0.0181   0.0091 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4': 'H'  'H'   0.0000   0.0000 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4': 'F'  'F'   0.0727   0.0534 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4': 'O'  'O'   0.0492   0.0322 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4': 'S'  'S'   0.3331   0.5567 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4': 'I'  'I'  -0.3257   6.8362 
Space group crystal system: triclinic 
Space group IT number: 2 
Space group name H-M alt: 'P -1' 
Space group name Hall: '-P 1' 
  
Shelx space group comment: The symmetry employed for this shelxl refinement is 
uniquely defined by the following loop, which should always be used as a source of 
symmetry information in preference to the above space-group names. 
Cell length a: 9.7588(5) 
Cell length b: 10.9245(6) 
Cell length c: 11.1613(8) 
Cell angle alpha: 69.878(6) 
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Cell angle beta: 68.181(6) 
Cell angle gamma: 68.636(5) 
Cell volume: 998.36(12) 
Cell formula units Z: 2 
Cell measurement temperature: 200(2) 
Exptl crystal density diffrn: 1.771           
Exptl crystal F 000: 524 
Exptl crystal size max: 0.202 
Exptl crystal size mid: 0.149 
Exptl crystal size min: 0.081 
Exptl absorpt coefficient mu: 14.129 
Shelx estimated absorpt T min: 0.163 
Shelx estimated absorpt T max: 0.394 
Diffrn ambient temperature: 200(2) 
Diffrn radiation wavelength: 1.54184 
Diffrn radiation type: CuK\a 
Diffrn reflns number: 6818 
Diffrn reflns av unetI/netI: 0.0310 
Diffrn reflns av R equivalents: 0.0260 
Diffrn reflns limit h min: -11 
Diffrn reflns limit h max: 12 
Diffrn reflns limit k min:  -13 
Diffrn reflns limit k max: 11 
Diffrn reflns limit l min: -13 
Diffrn reflns limit l max: 13 
Diffrn reflns theta min: 4.397 
Diffrn reflns theta max: 74.056 
Diffrn reflns theta full: 67.684 
Diffrn measured fraction theta max: 0.960 
Diffrn measured fraction theta full: 0.995 
Diffrn reflns Laue measured fraction max: 0.960 
Diffrn reflns Laue measured fraction full: 0.995 
Diffrn reflns point group measured fraction max: 0.960 
Diffrn reflns point group measured fraction full: 0.995 
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Reflns number total: 3898 
Reflns number gt: 3717 
Reflns threshold expression: 'I > 2\s(I)' 
Reflns Friedel coverage: 0.000 
Reflns special details: Reflections were merged by SHELXL according to the crystal class 
for the calculation of statistics and refinement. Reflns Friedel fraction is defined as the 
number of unique Friedel pairs measured divided by the number that would be possible 
theoretically, ignoring centric projections and systematic absences. 
 
Computing structure refinement   'SHELXL-2013 (Sheldrick, 2013)' 
Refine ls structure factor coef: Fsqd 
Refine ls matrix type: full 
Refine ls weighting scheme: calc 
Refine ls weighting details:  'w=1/[\s^2^(Fo^2^)+(0.0511P)^2^+1.3498P]  
where P=(Fo^2^+2Fc^2^)/3' 
Atom sites solution hydrogens: geom 
Refine ls hydrogen treatment: constr 
Refine ls extinction method: none 
Refine ls number reflns: 3898 
Refine ls number parameters: 256 
Refine ls number restraints: 0 
Refine ls R factor all: 0.0375 
Refine ls R factor gt: 0.0359 
Refine ls wR factor ref: 0.0930 
Refine ls wR factor gt: 0.0916 
Refine ls goodness of fit ref: 1.068 
Refine ls restrained S all: 1.068 
Refine ls shift/su max: 0.001 
Refine ls shift/su mean: 0.000 
Atomic coordinates and equivalent isotropic displacement parameters  
C1 C -0.0234(4) 0.5381(4) 0.7584(4) 0.0307(7) Uani 1 1 d  
C2 C -0.0355(5) 0.4108(5) 0.7802(5) 0.0429(10) Uani 1 1 d  
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H2 H 0.0165 0.3609 0.7137 0.052 Uiso 1 1 calc R U 
C3 C -0.1264(6) 0.3568(5) 0.9030(5) 0.0534(12) Uani 1 1 d  
H3 H -0.1377 0.2689 0.9209 0.064 Uiso 1 1 calc R U  
C4 C -0.2000(7) 0.4302(6) 0.9987(5) 0.0594(14) Uani 1 1 d  
H4 H -0.2610 0.3923 1.0828 0.071 Uiso 1 1 calc R U  
C5 C -0.1857(8) 0.5568(6) 0.9730(6) 0.0646(16) Uani 1 1 d  
H5 H -0.2378 0.6067 1.0396 0.078 Uiso 1 1 calc R U  
C6 C -0.0967(6) 0.6144(5) 0.8522(5) 0.0468(11) Uani 1 1 d  
H6 H -0.0865 0.7026 0.8343 0.056 Uiso 1 1 calc R U  
C7 C 0.3052(4) 0.5890(4) 0.6268(4) 0.0308(8) Uani 1 1 d  
C8 C 0.3824(4) 0.4556(4) 0.6740(4) 0.0329(8) Uani 1 1 d  
C9 C 0.5139(5) 0.4343(4) 0.7082(4) 0.0373(9) Uani 1 1 d 
H9 H 0.5690 0.3449 0.7425 0.045 Uiso 1 1 calc R U  
C10 C 0.5647(5) 0.5437(5) 0.6924(4) 0.0408(9) Uani 1 1 d 
H10 H 0.6543 0.5273 0.7170 0.049 Uiso 1 1 calc R U  
C11 C 0.4893(5) 0.6758(4) 0.6421(4) 0.0381(9) Uani 1 1 d  
C12 C 0.3564(4) 0.6989(4) 0.6098(4) 0.0348(8) Uani 1 1 d  
H12 H 0.3010 0.7885 0.5766 0.042 Uiso 1 1 calc R U  
C13 C 0.3930(6) 0.2203(5) 0.7407(6) 0.0539(12) Uani 1 1 d  
H13A H 0.4967 0.1924 0.6827 0.081 Uiso 1 1 calc R U  
H13B H 0.3327 0.1616 0.7488 0.081 Uiso 1 1 calc R U  
H13C H 0.3987 0.2128 0.8289 0.081 Uiso 1 1 calc R U  
C14 C 0.5439(6) 0.7988(5) 0.6211(6) 0.0515(12) Uani 1 1 d  
H14 H 0.4775 0.8806 0.5743 0.062 Uiso 1 1 calc R U  
C15 C 0.7083(5) 0.7851(5) 0.5359(5) 0.0451(10) Uani 1 1 d  
C16 C 0.5291(9) 0.8220(8) 0.7511(8) 0.081(2) Uani 1 1 d  
H16A H 0.5878 0.7405 0.8015 0.121 Uiso 1 1 calc R U  
H16B H 0.4209 0.8419 0.8026 0.121 Uiso 1 1 calc R U  
H16C H 0.5689 0.8986 0.7339 0.121 Uiso 1 1 calc R U  
C17 C -0.2153(7) 1.0091(6) 0.8926(6) 0.0613(14) Uani 1 1 d  
O1 O 0.3207(3) 0.3584(3) 0.6847(3) 0.0419(7) Uani 1 1 d  
O2 O 0.8124(3) 0.6836(3) 0.5378(3) 0.0446(7) Uani 1 1 d  
O3 O 0.7259(5) 0.9012(4) 0.4503(6) 0.0786(14) Uani 1 1 d  
H3A H 0.8192 0.8990 0.4225 0.118 Uiso 1 1 calc R U  
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O4 O -0.2269(6) 1.1212(7) 0.6546(5) 0.114(2) Uani 1 1 d  
O5 O -0.0307(8) 0.9150(5) 0.6940(6) 0.106(2) Uani 1 1 d  
O6 O -0.0171(6) 1.1231(5) 0.7070(5) 0.0887(15) Uani 1 1 d  
S1 S -0.11063(14) 1.04254(11) 0.71590(12) 0.0459(3) Uani 1 1 d  
I1 I 0.10698(2) 0.62744(2) 0.57237(2) 0.03271(10) Uani 1 1 d  
F1 F -0.3089(6) 0.9358(5) 0.9172(4) 0.1024(16) Uani 1 1 d  
F2 F -0.1292(7) 0.9502(9) 0.9678(5) 0.160(3) Uani 1 1 d  
F3 F -0.3049(6) 1.1213(5) 0.9287(5) 0.1058(17) Uani 1 1 d  
Anisotropic displacement parameters  
C1 0.0244(17) 0.0363(19) 0.0277(18) -0.0043(15) -0.0023(14) -0.0126(15) 
C2 0.043(2) 0.043(2) 0.045(2) -0.0131(19) -0.0049(19) -0.0176(19) 
C3 0.061(3) 0.045(3) 0.055(3) -0.002(2) -0.009(2) -0.032(2) 
C4 0.060(3) 0.066(3) 0.039(3) -0.001(2) 0.003(2) -0.031(3) 
C5 0.078(4) 0.058(3) 0.041(3) -0.019(2) 0.012(3) -0.023(3) 
C6 0.057(3) 0.035(2) 0.039(2) -0.0116(18) 0.001(2) -0.014(2) 
C7 0.0243(17) 0.037(2) 0.0279(18) -0.0063(15) -0.0039(14) -0.0098(15) 
C8 0.0270(18) 0.0358(19) 0.0287(18) -0.0065(15) 0.0013(14) -0.0110(15) 
C9 0.0294(19) 0.041(2) 0.034(2) -0.0037(16) -0.0069(16) -0.0071(16) 
C10 0.0271(19) 0.057(3) 0.038(2) -0.0119(19) -0.0072(16) -0.0123(18) 
C11 0.0281(19) 0.043(2) 0.041(2) -0.0140(18) -0.0011(16) -0.0128(17) 
C12 0.0266(18) 0.038(2) 0.036(2) -0.0089(16) -0.0023(15) -0.0117(15) 
C13 0.059(3) 0.035(2) 0.059(3) -0.004(2) -0.012(2) -0.015(2) 
C14 0.040(2) 0.048(3) 0.074(3) -0.018(2) -0.018(2) -0.015(2) 
C15 0.034(2) 0.043(2) 0.064(3) -0.007(2) -0.019(2) -0.0168(19) 
C16 0.081(5) 0.092(5) 0.088(5) -0.048(4) -0.010(4) -0.034(4) 
C17 0.074(4) 0.054(3) 0.051(3) -0.008(2) -0.009(3) -0.025(3) 
O1 0.0373(15) 0.0337(14) 0.0513(18) -0.0070(13) -0.0097(13) -0.0117(12) 
O2 0.0338(15) 0.0453(17) 0.057(2) -0.0075(14) -0.0132(14) -0.0169(14) 
O3 0.050(2) 0.049(2) 0.118(4) 0.004(2) -0.023(2) -0.0141(17) 
O4 0.059(3) 0.166(6) 0.055(3) 0.010(3) -0.009(2) -0.003(3) 
O5 0.130(5) 0.050(2) 0.096(4) -0.024(2) 0.026(3) -0.031(3) 
O6 0.094(3) 0.095(3) 0.083(3) -0.028(3) 0.010(3) -0.062(3) 
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S1 0.0482(6) 0.0363(5) 0.0435(6) -0.0043(4) -0.0049(5) -0.0138(4) 
I1 0.02662(14) 0.04001(15) 0.02842(14) -0.00446(10) -0.00523(9) -0.01176(10) 
F1 0.121(4) 0.116(3) 0.074(3) -0.025(2) 0.021(2) -0.084(3) 
F2 0.109(4) 0.269(8) 0.064(3) 0.030(4) -0.044(3) -0.051(5) 
F3 0.126(4) 0.104(3) 0.080(3) -0.051(3) 0.026(3) -0.052(3) 
  
geom special details: All esds (except the esd in the dihedral angle between two l.s. 
planes) are estimated using the full covariance matrix. The cell esds are taken into account 
individually in the estimation of esds in distances, angles and torsion angles; correlations 
between esds in cell parameters are only used when they are defined by crystal symmetry. 
An approximate (isotropic) treatment of cell esds is used for estimating esds involving 
l.s. planes. 
 
Geom bond atom site label 1 
Geom bond atom site label 2 
Geom bond distance 
Geom bond site symmetry 2 
Geom bond publ flag 
 
C1 C2 1.369(6)  C1 C6 1.383(6)  C1 I1 2.105(4)  
  
C2 C3 1.390(7)  C3 C4 1.378(8)  C4 C5 1.362(8) 
C5 C6 1.383(7)  C7 C8 1.391(6)  C7 C12 1.392(6) 
C7 I1 2.096(4)   C8 O1 1.351(5)  C8 C9 1.391(6) 
C9 C10 1.388(6)  C10 C11 1.384(6)  C11 C12 1.386(6) 
C11 C14 1.534(6)   C13 O1 1.438(6)  C14 C16 1.504(9) 
C14 C15 1.513(7)  C15 O2 1.201(6)  C15 O3 1.324(6) 
C17 F2 1.258(8)  C17 F3 1.313(7)  C17 F1 1.322(7)  
C17 S1 1.829(6)   O4 S1 1.399(5)  O5 S1 1.382(5)  
O6 S1 1.440(5)  
  
Geom angle atom site label 1 
Geom angle atom site label 2 
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Geom angle atom site label 3 
Geom angle 
Geom angle site symmetry 1 
Geom angle site symmetry 3 
Geom angle publ flag 
 
C2 C1 C6 123.2(4)  C2 C1 I1 119.5(3)   C6 C1 I1 117.3(3)  
C1 C2 C3 117.8(4)   C4 C3 C2 120.3(5)   C5 C4 C3 120.1(5)  
C4 C5 C6 121.4(5)   C1 C6 C5 117.2(4)   C8 C7 C12 122.9(4)   
C8 C7 I1 119.0(3)   C12 C7 I1 118.0(3)   O1 C8 C9 125.9(4)   
O1 C8 C7 116.8(4)   C9 C8 C7 117.2(4)   C10 C9 C8 120.0(4)  
C11 C10 C9 122.3(4)  C10 C11 C12 118.3(4)  C10 C11 C14 123.6(4) 
C12 C11 C14 118.0(4) C11 C12 C7 119.1(4)  C16 C14 C15 108.8(5) 
C16 C14 C11 111.7(5)  C15 C14 C11 112.2(4)  O2 C15 O3 121.8(5)  
O2 C15 C14 126.7(4)  O3 C15 C14 111.4(4)  F2 C17 F3 107.2(7)   
F2 C17 F1 109.1(6)   F3 C17 F1 104.9(6)   F2 C17 S1 113.4(5)  
F3 C17 S1 111.6(4)   F1 C17 S1 110.2(4)   C8 O1 C13 118.0(4)   
O5 S1 O4 118.9(5)  O5 S1 O6 115.0(4)   O4 S1 O6 110.8(4)  
O5 S1 C17 103.8(3)   O4 S1 C17 103.0(3)   O6 S1 C17 102.8(3)   
C7 I1 C1 97.58(15)  
  
Refine diff density max: 0.995 
Refine diff density min: -1.010 
Refine diff density rms: 0.100 
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Methyl 5-(acetoxymethyl)-2-oxo-3-(prop-2-yn-1-yl)tetrahydrofuran-3-carboxylate  
  
Audit creation method: SHELXL-2013 
Chemical name systematic 
Chemical formula sum: C12H14O6  
Chemical formula weight: 254.23 
International Tables Vol C Tables 4.2.6.8 and 6.1.1.4: 'C'  'C'   0.0181   0.0091 
International Tables Vol C Tables 4.2.6.8 and 6.1.1.4: 'H'  'H'   0.0000   0.0000 
International Tables Vol C Tables 4.2.6.8 and 6.1.1.4: 'O'  'O'   0.0492   0.0322 
Space group crystal system: orthorhombic 
Space group IT number: 33 
Space group name H-M alt: 'P n a 21' 
Space group name Hall: 'P 2c -2n' 
 Shelx space group comment:  
The symmetry employed for this shelxl refinement is uniquely defined by the following 
loop, which should always be used as a source of symmetry information in preference to 
the above space-group names. 
They are only intended as comments. 
 Space group symop operation xyz 
 'x, y, z' 
 '-x, -y, z+1/2' 
 'x+1/2, -y+1/2, z' 
 '-x+1/2, y+1/2, z+1/2' 
 Cell length a: 7.0545(3) 
Cell length b: 16.5628(5) 
Cell length c: 10.7323(4) 
Cell angle alpha: 90 
Cell angle beta: 90 
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Cell angle gamma: 90 
Cell volume: 1253.99(8) 
Cell formula units Z: 4 
Cell measurement temperature: 293(2) 
Exptl crystal density diffrn: 1.347           
Exptl crystal F 000: 536 
Exptl crystal size max: 0.176 
Exptl crystal size mid: 0.157 
Exptl crystal size min: 0.049 
Exptl absorpt coefficient mu: 0.929 
Shelx estimated absorpt T min: 0.854 
Shelx estimated absorpt T max: 0.956 
Diffrn ambient temperature: 293(2) 
Diffrn radiation wavelength: 1.54184 
Diffrn radiation type: CuK\a 
Diffrn reflns number: 20059 
Diffrn reflns av unetI/netI: 0.0251 
Diffrn reflns av R equivalents: 0.0597 
Diffrn reflns limit h min: -8 
Diffrn reflns limit h max: 8 
Diffrn reflns limit k min: -20 
Diffrn reflns limit k max: 20 
Diffrn reflns limit l min: -13 
Diffrn reflns limit l max: 13 
Diffrn reflns theta min: 4.910 
Diffrn reflns theta max: 74.123 
Diffrn reflns theta full: 67.684 
Diffrn measured fraction theta max: 0.996 
Diffrn measured fraction theta full: 1.000 
Diffrn reflns Laue measured fraction max: 0.996 
Diffrn reflns Laue measured fraction full: 1.000 
Diffrn reflns point group measured fraction max: 0.993 
Diffrn reflns point group measured fraction full: 1.000 
Reflns number total: 2532 
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Reflns number gt: 2350 
Reflns threshold expression: 'I > 2\s(I)' 
Reflns Friedel coverage: 0.887 
Reflns Friedel fraction max: 0.988 
Reflns Friedel fraction full: 1.000 
Reflns special details: 
Reflections were merged by SHELXL according to the crystal class for the calculation of 
statistics and refinement. 
Reflns Friedel fraction is defined as the number of unique Friedel pairs measured divided 
by the number that would be possible theoretically, ignoring centric projections and 
systematic absences. 
Computing structure refinement: 'SHELXL-2013 (Sheldrick, 2013)' 
Refine ls structure factor coef: Fsqd 
Refine ls matrix type: full 
Refine ls weighting scheme: calc 
Refine ls weighting details:  'w=1/[\s^2^(Fo^2^)+(0.0563P)^2^+0.2518P]  
where P=(Fo^2^+2Fc^2^)/3' 
 
Atom sites solution hydrogens: geom 
Refine ls hydrogen treatment: constr 
Refine ls extinction method: none 
Refine ls abs structure details: Flack x determined using 1050 quotients [(I+)-(I-
)]/[(I+)+(I-)] 
(Parsons and Flack (2004), Acta Cryst. A60, s61). 
Refine ls abs structure Flack: -0.14(12) 
Refine ls number reflns: 2532 
Refine ls number parameters: 165 
Refine ls number restraints: 1 
Refine ls R factor all: 0.0398 
Refine ls R factor gt: 0.0359 
Refine ls wR factor ref: 0.0968 
Refine ls wR factor gt: 0.0925 
Refine ls goodness of fit ref: 1.036 
Refine ls restrained S all: 1.035 
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Refine ls shift/su max: 0.000 
Refine ls shift/su mean: 0.000 
loop 
Atom site label 
Atom site type symbol 
Atom site fract x 
Atom site fract y 
Atom site fract z 
Atom site U iso or equiv 
Atom site adp type 
Atom site occupancy 
Atom site site symmetry order   
Atom site calcflag 
Atom site refinement flags posn 
Atom site refinement flags adp 
Atom site refinement flags occupancy 
Atom site disorder assembly 
Atom site disorder group 
 
Atomic coordinates and equivalent isotropic displacement parameters  
C1 C 1.0956(5) 0.81923(18) 0.0820(3) 0.0423(7) Uani 1 1 d  
H1A H 1.0759 0.8750 0.1027 0.063 Uiso 1 1 calc R U 
H1B H 1.0078 0.8035 0.0181 0.063 Uiso 1 1 calc R U  
H1C H 1.2229 0.8119 0.0525 0.063 Uiso 1 1 calc R U  
C2 C 1.0648(4) 0.76849(16) 0.1949(3) 0.0332(6) Uani 1 1 d  
C3 C 1.0690(4) 0.63505(15) 0.2731(2) 0.0315(6) Uani 1 1 d  
H3A H 0.9422 0.6402 0.3071 0.038 Uiso 1 1 calc R U  
H3B H 1.1595 0.6477 0.3384 0.038 Uiso 1 1 calc R U  
C4 C 1.1006(4) 0.55056(15) 0.2267(2) 0.0268(5) Uani 1 1 d  
H4 H 1.2235 0.5467 0.1845 0.032 Uiso 1 1 calc R U  
C5 C 0.8793(4) 0.45552(14) 0.1643(2) 0.0259(5) Uani 1 1 d  
C6 C 0.9718(3) 0.41922(14) 0.2795(2) 0.0247(5) Uani 1 1 d  
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C7 C 1.0897(4) 0.48929(15) 0.3322(2) 0.0291(5) Uani 1 1 d  
H7A H 1.0284 0.5126 0.4048 0.035 Uiso 1 1 calc R U  
H7B H 1.2153 0.4710 0.3557 0.035 Uiso 1 1 calc R U 
C8 C 1.1014(4) 0.34952(15) 0.2431(2) 0.0288(5) Uani 1 1 d  
C9 C 1.3141(5) 0.30175(19) 0.0899(3) 0.0500(8) Uani 1 1 d  
H9A H 1.2600 0.2488 0.0972 0.075 Uiso 1 1 calc R U  
H9B H 1.4258 0.3051 0.1407 0.075 Uiso 1 1 calc R U  
H9C H 1.3471 0.3119 0.0045 0.075 Uiso 1 1 calc R U  
C10 C 0.8193(4) 0.38841(15) 0.3696(2) 0.0287(5) Uani 1 1 d  
H10A H 0.7493 0.3448 0.3305 0.034 Uiso 1 1 calc R U 
H10B H 0.8795 0.3672 0.4440 0.034 Uiso 1 1 calc R U 
C11 C 0.6878(4) 0.45294(17) 0.4046(3) 0.0339(6) Uani 1 1 d  
C12 C 0.5868(4) 0.5064(2) 0.4332(3) 0.0453(7) Uani 1 1 d  
H12 H 0.5070 0.5487 0.4558 0.054 Uiso 1 1 calc R U  
O1 O 1.0190(4) 0.79169(12) 0.2966(2) 0.0486(6) Uani 1 1 d  
O2 O 1.0930(3) 0.68971(11) 0.16960(17) 0.0330(4) Uani 1 1 d  
O3 O 0.9482(3) 0.52952(10) 0.14075(17) 0.0286(4) Uani 1 1 d  
O4 O 0.7593(3) 0.42453(11) 0.10045(18) 0.0350(4) Uani 1 1 d  
O5 O 1.1339(3) 0.29260(12) 0.3086(2) 0.0436(5) Uani 1 1 d  
O6 O 1.1767(3) 0.36170(12) 0.13125(19) 0.0404(5) Uani 1 1 d 
  
Anisotropic displacement parameters  
C1 0.0446(16) 0.0322(14) 0.0500(18) 0.0097(12) -0.0078(14) -0.0028(12) 
C2 0.0312(13) 0.0291(12) 0.0393(15) -0.0022(10) -0.0084(12) -0.0015(10) 
C3 0.0413(15) 0.0279(11) 0.0253(12) 0.0021(10) -0.0005(10) -0.0037(10) 
C4 0.0271(12) 0.0278(11) 0.0254(11) 0.0019(9) -0.0020(10) -0.0022(9) 
C5 0.0282(12) 0.0270(11) 0.0226(12) -0.0012(9) -0.0023(10) 0.0025(9) 
C6 0.0270(12) 0.0261(10) 0.0210(11) 0.0015(9) -0.0026(9) 0.0009(9) 
C7 0.0304(13) 0.0308(12) 0.0261(12) 0.0038(9) -0.0070(10) -0.0033(10) 
C8 0.0283(12) 0.0297(12) 0.0284(12) 0.0020(10) -0.0016(10) 0.0013(10) 
C9 0.0483(18) 0.0474(17) 0.0544(19) 0.0025(14) 0.0221(17) 0.0132(14) 
C10 0.0320(14) 0.0275(11) 0.0265(11) 0.0027(9) 0.0026(10) -0.0025(9) 
C11 0.0298(14) 0.0382(14) 0.0337(13) -0.0016(10) 0.0035(11) -0.0070(11) 
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C12 0.0335(15) 0.0472(16) 0.0553(19) -0.0143(15) 0.0014(13) 0.0025(12) 
O1 0.0650(15) 0.0373(10) 0.0434(13) -0.0078(10) -0.0068(11) 0.0076(10) 
O2 0.0454(11) 0.0244(8) 0.0292(9) 0.0024(7) 0.0016(8) -0.0021(7) 
O3 0.0363(9) 0.0266(8) 0.0230(8) 0.0026(7) -0.0058(7) -0.0005(7) 
O4 0.0356(10) 0.0383(9) 0.0309(9) 0.0004(8) -0.0097(8) -0.0034(8) 
O5 0.0536(13) 0.0372(10) 0.0402(12) 0.0103(9) 0.0043(10) 0.0145(9) 
O6 0.0435(11) 0.0411(10) 0.0366(11) 0.0053(9) 0.0133(9) 0.0122(9) 
  
Geom special details: 
 All esds (except the esd in the dihedral angle between two l.s. planes)  are estimated 
using the full covariance matrix.  The cell esds are taken into account individually in the 
estimation of esds in distances, angles and torsion angles; correlations between esds in 
cell parameters are only used when they are defined by crystal symmetry.  An 
approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. 
planes. 
  
loop 
Geom bond atom site label 1 
Geom bond atom site label 2 
Geom bond distance 
Geom bond site symmetry 2 
Geom bond publ flag 
 
C1 C2 1.490(4)  C1 H1A 0.9600  C1 H1B 0.9600   
C1 H1C 0.9600  C2 O1 1.202(4)  C2 O2 1.347(3) 
C3 O2 1.443(3)  C3 C4 1.502(3)  C3 H3A 0.9700 
C3 H3B 0.9700  C4 O3 1.459(3)  C4 C7 1.523(3) 
C4 H4 0.9800   C5 O4 1.204(3)  C5 O3 1.343(3) 
C5 C6 1.522(3)  C6 C8 1.524(3)  C6 C10 1.534(3) 
C6 C7 1.536(3)  C7 H7A 0.9700  C7 H7B 0.9700 
C8 O5 1.198(3)  C8 O6 1.328(3)  C9 O6 1.457(3) 
C9 H9A 0.9600   C9 H9B 0.9600  C9 H9C 0.9600 
C10 C11 1.464(4)  C10 H10A 0.9700  C10 H10B 0.9700 
C11 C12 1.178(4)   C12 H12 0.9300     
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loop 
Geom angle atom site label 1 
Geom angle atom site label 2 
Geom angle atom site label 3 
Geom angle 
Geom angle site symmetry 1 
Geom angle site symmetry 3 
Geom angle publ flag 
 
C2 C1 H1A 109.5   C2 C1 H1B 109.5  H1A C1 H1B 109.5  
C2 C1 H1C 109.5  H1A C1 H1C 109.5  H1B C1 H1C 109.5 
O1 C2 O2 122.2(3)   O1 C2 C1 126.7(3)   O2 C2 C1 111.2(3)  
O2 C3 C4 108.2(2)   O2 C3 H3A 110.1  C4 C3 H3A 110.1 
O2 C3 H3B 110.1  C4 C3 H3B 110.1  H3A C3 H3B 108.4  
O3 C4 C3 108.8(2)   O3 C4 C7 105.89(19)  C3 C4 C7 111.5(2)   
O3 C4 H4 110.2   C3 C4 H4 110.2  C7 C4 H4 110.2 
O4 C5 O3 122.4(2)   O4 C5 C6 126.6(2)  O3 C5 C6 111.0(2) 
C5 C6 C8 110.4(2)  C5 C6 C10 110.1(2)  C8 C6 C10 109.33(19) 
C5 C6 C7 103.46(18)  C8 C6 C7 110.0(2)  C10 C6 C7 113.5(2) 
C4 C7 C6 104.89(19)  C4 C7 H7A 110.8  C6 C7 H7A 110.8 
C4 C7 H7B 110.8  C6 C7 H7B 110.8  H7A C7 H7B 108.8 
O5 C8 O6 125.0(2)  O5 C8 C6 124.0(2)  O6 C8 C6 110.9(2) 
O6 C9 H9A 109.5   O6 C9 H9B 109.5  H9A C9 H9B 109.5 
O6 C9 H9C 109.5  H9A C9 H9C 109.5  H9B C9 H9C 109.5 
C11 C10 C6 111.3(2)  C11 C10 H10A 109.4  C6 C10 H10A 109.4 
C11 C10 H10B 109.4  C6 C10 H10B 109.4  H10A C10 H10B 108.0
  
C12 C11 C10 177.9(3) C11 C12 H12 180.0  C2 O2 C3 115.8(2)  
C5 O3 C4 111.44(18)  C8 O6 C9 116.0(2) 
  
Refine diff density max: 0.136 
Refine diff density min:  -0.145 
Refine diff density rms: 0.038 
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(S)-(2-(1-(Pyridin-2-yl)ethoxy)phenyl)-l3-iodanediyl diacetate 
   
 
Audit creation method: SHELXL-2013 
Chemical name systematic 
Chemical formula sum:  C17H18INO5  
Chemical formula weight: 443.22 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4': 'C'  'C'   0.0181   0.0091 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4': 'H'  'H'   0.0000   0.0000 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4': 'O'  'O'   0.0492   0.0322 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4': 'I'  'I'  -0.3257   6.8362 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4': 'N'  'N'   0.0311   0.0180 
Space group crystal system: monoclinic 
Space group IT number: 14 
Space group name H-M alt: 'P 21/n' 
Space group name Hall: '-P 2yn' 
Cell length a: 8.9340(2) 
Cell length b: 11.6335(3) 
Cell length c: 17.3231(4) 
Cell angle alpha: 90 
Cell angle beta: 96.746(2) 
Cell angle gamma: 90 
Cell volume: 1787.99(7) 
Cell formula units Z: 4 
Cell measurement temperature: 150(2) 
Exptl crystal density diffrn: 1.647           
Exptl crystal F 000: 880 
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Exptl crystal size max: 0.490 
Exptl crystal size mid: 0.304 
Exptl crystal size min: 0.230 
Exptl absorpt coefficient mu: 14.303 
Shelx estimated absorpt T min: 0.054 
Shelx estimated absorpt T max: 0.137 
Diffrn ambient temperature: 150(2) 
Diffrn radiation wavelength: 1.54184 
Diffrn radiation type: CuK\a 
Diffrn reflns number: 6790 
Diffrn reflns av unetI/netI: 0.0356 
Diffrn reflns av R equivalents: 0.0391 
Diffrn reflns limit h min: -10 
Diffrn reflns limit h max: 10 
Diffrn reflns limit k min: -14 
Diffrn reflns limit k max: 10 
Diffrn reflns limit l min: -21 
Diffrn reflns limit l max: 17 
Diffrn reflns theta min: 4.588 
Diffrn reflns theta max: 74.101 
Diffrn reflns theta full: 67.684 
Diffrn measured fraction theta max: 0.962 
Diffrn measured fraction theta full: 0.996 
Diffrn reflns Laue measured fraction max: 0.962 
Diffrn reflns Laue measured fraction full: 0.996 
Diffrn reflns point group measured fraction max: 0.962 
Diffrn reflns point group measured fraction full: 0.996 
Reflns number total: 3503 
Reflns number gt: 3400 
Reflns threshold expression: 'I > 2\s(I)' 
Reflns Friedel coverage: 0.000 
Reflections were merged by SHELXL according to the crystal class for the calculation of 
statistics and refinement. 
Florence Malmedy Appendix 
239 
 
Reflns Friedel fraction is defined as the number of unique Friedel pairs measured divided 
by the number that would be possible theoretically, ignoring centric projections and 
systematic absences. 
Computing structure refinement: 'SHELXL-2013 (Sheldrick, 2013)' 
Refine ls structure factor coef: Fsqd 
Refine ls matrix type: full 
Refine ls weighting scheme: calc 
Refine ls weighting details:  'w=1/[\s^2^(Fo^2^)+(0.0886P)^2^+0.1459P]  
where P=(Fo^2^+2Fc^2^)/3' 
  
Atom sites solution hydrogens: geom 
Refine ls hydrogen treatment: constr 
Refine ls extinction method: none 
Refine ls number reflns: 3503 
Refine ls number parameters: 220 
Refine ls number restraints: 0 
Refine ls R factor all: 0.0446 
Refine ls R factor gt: 0.0439 
Refine ls wR factor ref: 0.1140 
Refine ls wR factor gt: 0.1128 
Refine ls goodness of fit ref: 1.074 
Refine ls restrained S all: 1.074 
Refine ls shift/su max: 0.001 
Refine ls shift/su mean: 0.000 
Atomic coordinates and equivalent isotropic displacement parameters  
C1 C 0.6666(4) 0.1650(3) 0.1013(2) 0.0191(7) Uani 1 1 d 
C2 C 0.5789(5) 0.0802(4) 0.1302(3) 0.0294(8) Uani 1 1 d 
H2 H 0.5089 0.0995 0.1654 0.035 Uiso 1 1 calc R U 
C3 C 0.5947(6) -0.0329(4) 0.1073(3) 0.0386(10) Uani 1 1 d 
H3 H 0.5369 -0.0925 0.1267 0.046 Uiso 1 1 calc R U 
C4 C 0.6968(5) -0.0563(4) 0.0554(3) 0.0359(10) Uani 1 1 d 
H4 H 0.7100 -0.1326 0.0379 0.043 Uiso 1 1 calc R U 
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C5 C 0.7786(5) 0.0322(4) 0.0297(2) 0.0328(10) Uani 1 1 d 
H5 H 0.8479 0.0148 -0.0062 0.039 Uiso 1 1 calc R U 
C6 C 0.6561(4) 0.2888(4) 0.12692(18) 0.0175(7) Uani 1 1 d 
H6 H 0.7211 0.3381 0.0973 0.021 Uiso 1 1 calc R U 
C7 C 0.7000(4) 0.3056(4) 0.2135(2) 0.0274(8) Uani 1 1 d 
H7A H 0.6911 0.3871 0.2265 0.041 Uiso 1 1 calc R U 
H7B H 0.8044 0.2804 0.2275 0.041 Uiso 1 1 calc R U 
H7C H 0.6330 0.2601 0.2425 0.041 Uiso 1 1 calc R U 
C8 C 0.4382(3) 0.3472(3) 0.03915(18) 0.0116(6) Uani 1 1 d 
C9 C 0.2861(4) 0.3782(3) 0.02921(19) 0.0102(6) Uani 1 1 d 
C10 C 0.2098(4) 0.4031(3) -0.0436(2) 0.0168(7) Uani 1 1 d 
H10 H 0.1070 0.4257 -0.0484 0.020 Uiso 1 1 calc R U 
C11 C 0.2849(5) 0.3945(3) -0.1091(2) 0.0203(8) Uani 1 1 d 
H11 H 0.2341 0.4102 -0.1593 0.024 Uiso 1 1 calc R U 
C12 C 0.4365(4) 0.3625(3) -0.0999(2) 0.0196(7) Uani 1 1 d 
H12 H 0.4889 0.3568 -0.1444 0.023 Uiso 1 1 calc R U 
C13 C 0.5124(4) 0.3387(3) -0.0269(2) 0.0164(6) Uani 1 1 d 
H13 H 0.6154 0.3165 -0.0220 0.020 Uiso 1 1 calc R U 
C14 C 0.1166(4) 0.1718(3) 0.1831(2) 0.0176(7) Uani 1 1 d 
C15 C 0.1018(5) 0.0426(3) 0.1859(2) 0.0278(8) Uani 1 1 d 
H15A H 0.0772 0.0193 0.2373 0.042 Uiso 1 1 calc R U 
H15B H 0.1972 0.0071 0.1761 0.042 Uiso 1 1 calc R U 
H15C H 0.0213 0.0176 0.1461 0.042 Uiso 1 1 calc R U 
C16 C 0.1271(4) 0.6345(3) 0.1510(2) 0.0168(7) Uani 1 1 d 
C17 C 0.1244(5) 0.7601(3) 0.1358(2) 0.0277(8) Uani 1 1 d 
H17A H 0.0330 0.7935 0.1527 0.042 Uiso 1 1 calc R U  
H17B H 0.1252 0.7738 0.0800 0.042 Uiso 1 1 calc R U 
H17C H 0.2133 0.7960 0.1646 0.042 Uiso 1 1 calc R U 
O1 O 0.5010(3) 0.3286(2) 0.11333(13) 0.0162(5) Uani 1 1 d 
O2 O 0.1781(3) 0.2083(3) 0.12238(13) 0.0201(6) Uani 1 1 d 
O3 O 0.0751(3) 0.2351(2) 0.23194(15) 0.0239(5) Uani 1 1 d 
O4 O 0.1908(3) 0.5742(2) 0.09967(14) 0.0169(5) Uani 1 1 d 
O5 O 0.0738(3) 0.5888(2) 0.20544(17) 0.0237(6) Uani 1 1 d 
I1 I 0.17266(2) 0.39308(2) 0.12663(2) 0.01054(13) Uani 1 1 d  
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N1 N 0.7671(4) 0.1425(3) 0.0521(2) 0.0264(7) Uani 1 1 d 
Anisotropic displacement parameters  
C1 0.0145(16) 0.0237(19) 0.0189(16) 0.0034(14) 0.0008(12) 0.0096(14) 
C2 0.027(2) 0.028(2) 0.036(2) 0.0028(18) 0.0123(16) 0.0038(18) 
C3 0.043(2) 0.021(2) 0.052(3) 0.0024(19) 0.006(2) 0.0003(18) 
C4 0.038(2) 0.023(2) 0.044(2) -0.0080(18) -0.0041(18) 0.0137(18) 
C5 0.029(2) 0.036(2) 0.0348(19) -0.0041(18) 0.0079(16) 0.0205(18) 
C6 0.0072(14) 0.0236(19) 0.0217(17) 0.0023(12) 0.0019(12) 0.0049(12) 
C7 0.0179(17) 0.034(2) 0.0285(18) -0.0066(16) -0.0053(14) 0.0080(15) 
C8 0.0128(15) 0.0049(14) 0.0177(14) 0.0028(11) 0.0036(11) 0.0029(11) 
C9 0.0105(15) 0.0067(13) 0.0146(14) -0.0014(10) 0.0062(12) 0.0002(11) 
C10 0.0166(17) 0.0146(17) 0.0189(17) -0.0025(12) 0.0009(13) 0.0052(12) 
C11 0.026(2) 0.0175(19) 0.0174(17) -0.0014(12) 0.0012(17) 0.0027(13) 
C12 0.0276(19) 0.0141(16) 0.0195(16) -0.0001(14) 0.0132(14) 0.0014(15) 
C13 0.0138(15) 0.0133(15) 0.0236(15) 0.0009(12) 0.0091(12) 0.0030(12) 
C14 0.0144(16) 0.0127(17) 0.0259(17) 0.0024(14) 0.0024(13) -0.0012(13) 
C15 0.034(2) 0.0135(19) 0.0347(19) 0.0069(15) -0.0018(16) -0.0057(15) 
C16 0.0116(15) 0.0147(16) 0.0249(17) -0.0056(15) 0.0058(13) 0.0032(14) 
C17 0.036(2) 0.0073(17) 0.0411(19) -0.0070(15) 0.0104(17) 0.0021(15) 
O1 0.0095(11) 0.0218(12) 0.0179(11) 0.0017(9) 0.0041(8) 0.0104(9) 
O2 0.0282(16) 0.0060(12) 0.0278(14) -0.0014(8) 0.0106(12) 0.0021(8) 
O3 0.0245(13) 0.0183(13) 0.0311(13) 0.0035(11) 0.0121(10) 0.0006(10) 
O4 0.0242(13) 0.0066(11) 0.0229(12) 0.0000(10) 0.0147(10) 0.0012(10) 
O5 0.0300(16) 0.0164(12) 0.0275(13) -0.0014(10) 0.0149(12) 0.0033(11) 
I1 0.00806(17) 0.00721(18) 0.01717(17) -0.00083(5) 0.00492(10) 0.00235(5) 
N1 0.0237(17) 0.0269(18) 0.0304(16) 0.0027(14) 0.0108(13) 0.0133(15) 
  
Geom special details: 
All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using 
the full covariance matrix. The cell esds are taken into account individually in the 
estimation of esds in distances, angles and torsion angles; correlations between esds in 
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cell parameters are only used when they are defined by crystal symmetry. An approximate 
(isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. 
 
Geom bond atom site label 1 
Geom bond atom site label 2 
Geom bond distance 
Geom bond site symmetry 2 
Geom bond publ flag 
 
C1 N1 1.334(5)  C1 C2 1.390(6)  C1 C6 1.513(6) 
C2 C3 1.386(6)  C2 H2 0.9500   C3 C4 1.381(7)  
C3 H3 0.9500    C4 C5 1.366(7)  C4 H4 0.9500  
C5 N1 1.349(6)  C5 H5 0.9500    C6 O1 1.453(4) 
C6 C7 1.518(4)  C6 H6 1.0000    C7 H7A 0.9800 
C7 H7B 0.9800  C7 H7C 0.9800  C8 O1 1.358(4) 
C8 C13 1.391(4)  C8 C9 1.398(4)   C9 C10 1.391(5) 
C9 I1 2.075(3)   C10 C11 1.388(6)  C10 H10 0.9500  
C11 C12 1.395(6)  C11 H11 0.9500   C12 C13 1.392(5) 
C12 H12 0.9500   C13 H13 0.9500   C14 O3 1.212(5) 
C14 O2 1.314(4)  C14 C15 1.510(5)  C15 H15A 0.9800 
C15 H15B 0.9800  C15 H15C 0.9800  C16 O5 1.226(5)  
C16 O4 1.315(5)  C16 C17 1.484(5)  C17 H17A 0.9800 
C17 H17B 0.9800  C17 H17C 0.9800  O2 I1 2.151(3) 
O4 I1 2.168(3) 
  
Geom angle atom site label 1 
Geom angle atom site label 2 
Geom angle atom site label 3 
Geom angle 
Geom angle site symmetry 1 
Geom angle site symmetry 3 
Geom angle publ flag 
 
N1 C1 C2 122.8(4)   N1 C1 C6 116.3(4)   C2 C1 C6 120.8(3) 
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C3 C2 C1 119.3(4)  C3 C2 H2 120.3   C1 C2 H2 120.3  
C4 C3 C2 118.1(4)  C4 C3 H3 121.0   C2 C3 H3 121.0  
C5 C4 C3 118.9(4)  C5 C4 H4 120.5  C3 C4 H4 120.5 
N1 C5 C4 124.1(4)  N1 C5 H5 117.9   C4 C5 H5 117.9  
O1 C6 C1 110.3(3)   O1 C6 C7 104.5(3)   C1 C6 C7 113.3(3)  
O1 C6 H6 109.6   C1 C6 H6 109.6   C7 C6 H6 109.6  
C6 C7 H7A 109.5  C6 C7 H7B 109.5  H7A C7 H7B 109.5 
C6 C7 H7C 109.5   H7A C7 H7C 109.5  H7B C7 H7C 109.5 
O1 C8 C13 125.7(3)  O1 C8 C9 116.5(3)   C13 C8 C9 117.9(3) 
C10 C9 C8 122.1(3)  C10 C9 I1 119.1(2)   C8 C9 I1 118.8(2)  
C11 C10 C9 119.6(3)  C11 C10 H10 120.2  C9 C10 H10 120.2  
C10 C11 C12 118.8(3)  C10 C11 H11 120.6   C12 C11 H11 120.6  
C13 C12 C11 121.3(3) C13 C12 H12 119.3   C11 C12 H12 119.3  
C8 C13 C12 120.3(3)  C8 C13 H13 119.8  C12 C13 H13 119.8 
O3 C14 O2 123.6(3)  O3 C14 C15 123.2(3)  O2 C14 C15 113.2(3) 
C14 C15 H15A 109.5  C14 C15 H15B 109.5  H15A C15 H15B 109.5 
C14 C15 H15C 109.5  H15A C15 H15C 109.5 H15B C15 H15C 109.5 
O5 C16 O4 121.8(4)   O5 C16 C17 124.3(3)  O4 C16 C17 113.9(3)  
C16 C17 H17A 109.5  C16 C17 H17B 109.5  H17A C17 H17B 109.5 
C16 C17 H17C 109.5  H17A C17 H17C 109.5 H17B C17 H17C 109.5 
C8 O1 C6 118.9(2)   C14 O2 I1 106.4(2)  C16 O4 I1 108.9(2) 
C9 I1 O2 82.75(11)  C9 I1 O4 81.36(11)  O2 I1 O4 163.91(9) 
C1 N1 C5 116.7(4)  
  
Refine diff density max: 1.603 
Refine diff density min: -2.411 
Refine diff density rms: 0.208 
 
 
